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1 Introduction 
1.1 Tetrapyrroles 
Some dominant colours in nature point towards fundamental biochemical processes which 
dominate life on earth like the green colour of leaves and the red colour of blood. A class 
of molecules known as tetrapyrroles is responsible for these phenomenons. Tetrapyrroles 
are distributed ubiquitously, being indispensable components of the metabolism of almost 
all organisms on earth. 
Tetrapyrroles play a central role in electron transfer-dependent energy generating 
processes such as photosynthesis and respiration. Further, they function as prosthetic 
groups for a variety of enzymes. Due to their strong colours, they have been referred to as 
"pigments of life" (Battersby, 2000). The most commonly found tetrapyrrole in nature is the 
green, magnesium-containing chlorophyll. It is essential for light harvesting and energy 
transduction during photosynthesis and responsible for the green colour of plants. Iron-
chelating tetrapyrroles such as hemes represent the prosthetic group of hemoglobin and 
myoglobin (Panek and O'Brian, 2002). They are involved in the transport of oxygen and 
are responsible for the red colour of blood. More importantly, as prosthetic groups of 
cytochromes they are indespensable for photosynthesis and oxidative phosphorylation. 
 
1.2 Structure and Functions of Tetrapyrroles 
All tetrapyrroles consist of four pyrrole derived groups, linked to each other by single 
carbon bridges either in linear or in a cyclic arrangement. The basic cyclic structure is 
termed porphyrin, with four pyrrole rings being covalently connected via methine bridges. 
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Fig. 1: Basic structure of cyclic tetrapyrroles, the porphyrin ring. 
Pyrrole rings are denoted A to D, carbon and nitrogen atoms are numbered. α-position: carbon atoms next to 
nitrogen atoms. β-positiion: carbon atoms without a direct bond to nitrogen. Meso-position: Bridging carbon 
atoms between pyrrole rings. 
 
The pyrrole rings of the porphyrin are denoted A to D in a clockwise orientation. 
Numbering of the carbon and nitrogen atoms is also clockwise and illustrated in figure 1. 
Carbon atoms adjacent to the nitrogen atoms are termed α-carbons (e.g. C1 and C4 in 
ring A), while carbon atoms without a direct bond to a nitrogen atom are termed β-carbons 
(e.g. C2 and C3 in ring A). The methine bridges between the pyrrole rings are constituted 
of carbon atoms in meso-position (e.g. C5 between ring A and B). During the past 100 
years, more and more structural information about these molecules became available 
(Battersby, 2000). The first structures - those of heme and chlorophyll - were determined 
in the beginning of the 20th century.  
 
Today, seven different groups of cyclic tetrapyrroles are known. The individual functional 
properties of each group are determined by the nature of the metal ion chelated by the 
nitrogen atoms in the center of the ring system as well as by the oxidation state of the 
macrocycle and sidechain substituents (Frankenberg et al., 2003; Jahn et al., 1996). 
Figure 2 shows the structures of representatives of the different groups of tetrapyrroles. 
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Fig. 2: Structures of important representatives of the seven tetrapyrrole groups. 
Depicted are naturally occurring tetrapyrroles and their common precursor molecule uroporphyrinogen III.  
A = acetate side chain; P = propionate side chain; M = methyl group; V = vinyl group. 
 
Hemes are true porphyrins. They function as prosthetic groups of e.g. hemoglobin and 
myoglobin, but also of cytochromes, catalases and peroxidases. Heme, an iron-chelating 
tetrapyrrole, possesses characteristic spectroscopic properties and a red colour due to a 
complete aromatic ring system. Variations of the basic porphyrin structure lead to 
tetrapyrroles known as porphinoids, e.g. chlorophylls (chlorins) and bacteriochlorophylls 
(bacteriochlorins). These molecules contain magnesium as central atom and function as 
photoreceptors during photosynthesis (Beale 1999). Siroheme (an isobacteriochlorin) and 
heme d1 are the cofactors of assimilatory sulfite and nitrite reductase and of dissimilatory 
nitrite reductase, respectively (Chang, 1994; Warren et al., 1994). Like hemes, both 
contain iron as central atom. Cofactor F430 - the tetrapyrrole discovered most recently - 
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chelates nickel and serves as prosthetic group of methyl coenzyme M reductase, an 
enzyme involved in archaeal methanogenesis (Friedmann et al., 1990; Thauer and 
Bonacker, 1994). Finally, coenzyme B12 belongs to the class of corrinoids, cobalt-
containing tetrapyrroles which are characterized by a missing methine bridge (C20) 
between pyrrole rings A and D (Scott et al., 1987). Members of the corrinoids are e.g. 
cofactors for enzymes catalyzing various transfer and radical - dependent reactions. The 
seventh group is formed by linear tetrapyrroles such as bilirubin. Like corronoids, they 
also contain only three bridging carbons. They derive from oxidatively cleaved cyclic 
tetrapyrroles. The cleavage product of heme, biliverdin, serves as a precursor for the 
biosynthesis of phycobilins and phytochrome chromophores (Beale and Yeh, 1999).  The 
variety of functions fulfilled by tetrapyrroles underscores their importance in nature. Life 
without tetrapyrroles would be very different from what we know.  
 
1.3 Biosynthesis of Hemes and Chlorophylls  
The shared structural core of tetrapyrroles implies a highly conserved biosynthetic 
pathway. All tetrapyrroles derive from a common precursor 5-aminolevulinic acid (ALA). 
This molecule is the exclusive source of all carbon and nitrogen atoms required for the 
formation of the tetrapyrrole macrocycle. The initial steps of the biosynthetic pathway from 
ALA are conserved throughout the different biosynthetic routes until the formation of the 
first cyclic intermediate, uroporphyrinogen III (uro´gen III). This intermediate is the last 
common precursor for two distinct groups of tetrapyrroles: the porphinoids (siroheme, 
coenzyme F430 and vitamin B12), and the porphyrins (hemes and chlorophylls). 
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Fig. 3: The biosynthesis of tetrapyrroles. 
The names of the enzymes and their respective genes (bacterial) are given above the arrows. A = acetate side 
chain; P = propionate side chain; M = methyl group; V = vinyl group. 
 
The precursors of chlorophylls and hemes are synthesised by the successive 
decarboxylation of the four acetate side chains of uro´gen III to produce 
coproporphyrinogen III. Uro´gen III decarboxylase catalyses this decarboxylation in 
clockwise direction beginning with the acetate side chain of ring D (Luo and Lim, 1993). In 
the next step, coproporphyrinogen III oxidases catalyse the conversion of 
coproporphyrinogen III into protoporphyrinogen IX. Then, protoporphyrinogen IX is 
converted by the protoporphyrinogen IX oxidase into the aromatic and coloured 
protoporphyrin IX. The latter step will be described in detail in section 1.4. Protoporphyrin 
IX represents the branching point of heme and chlorophyll biosynthesis. Insertion of iron 
into protoporphyrin IX catalysed by ferrochelatase directs the intermediates towards heme 
biosynthesis (Dailey, 2002), whereas the chelation of magnesium into protoporphyrin IX 
leads towards the biosynthesis of chlorophylls and bacteriochlorophylls (Willows, 2003).  
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Fig. 4: The biosynthesis of (bacterio-)chlorophyll from protoporphyrin IX 
Short names of the enzymes are shown in blue. The branch point towards heme (red) is depicted as well. 
MV: monovinyl; DV: divinyl 
 
 
The insertion of magnesium into the macrocycle is catalysed by magnesium 
protoporphyrin chelatase in an ATP - dependent manner (Viney et al., 2007). 
Subsequently, magnesium protoporphyrin IX is converted into magnesium protoporphyrin 
IX monomethyl ester by S-adenosyl-L-methionine (SAM) dependent magnesium 
protoporphyrin IX methyl transferase (Shepherd and Hunter, 2004). Conversion of 
magnesium protoporphyrin IX monomethyl ester into 3,8-protochlorophyllide introduces an 
isocyclic fifth ring to the porphyrin macrocycle which is characteristic for all chlorophylls 
and bacteriochlorophylls and is described in detail in section 1.6. After this reaction, being 
performed by magnesium protoporphyrin IX monomethyl ester oxidative cyclases (Bollivar 
and Beale, 1996), the reduction of the 8-vinyl side chain occurs. It is catalysed by 3,8-
divinyl protochlorophyllide a 8-vinyl reductase and leads to 3-monovinyl 
protochlorophyllide. This compound is the substrate for protochlorophyllide 
oxidoreductases which can be divided into two classes. In angiosperms, the reaction 
giving chlorophyllide is facilitated from a light - dependent enzyme (McFarlane et al., 
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2005). On the other hand, in bacteria performing anoxygenic photosynthesis, the reaction 
is catalysed by a multi-subunit protein complex in a light-independent manner (Nomata et 
al., 2006). Cyanobacteria, algae and gymnosperms possess both types of enzymes. 
Esterification of chlorophyllide with phytol by chlorophyll a synthase leads to chlorophyll in 
plants and cyanobactieria. The pathway towards bacteriochlorophyll includes further 
modifications at the tetrapyrrole backbone until phytol is attached by bacteriochlorophyll 
synthase (Rüdiger et al., 2005). 
 
1.4 Formation of Protoporphyrin IX 
The penultimate step of heme biosynthesis – the conversion of protoporphyrinogen IX 
(proto'gen) into protoporphyrin IX (proto) – is catalysed by protoporphyrinogen IX oxidases 
(PPO). During this reaction, two of the four imino groups of the pyrrole and the four 
bridging carbons (C5, C10, C15 and C20) are oxidised (Dailey, 2002). This six electron 
oxidation gives rise to a completely conjugated, planar and coloured macrocycle (fig. 5). 
 
Fig. 5: Conversion of protoporphyrinogen IX into protoporphyrin IX.  
P = propionate side chain; M = methyl group; V = vinyl group. 
 
1.4.1 The Oxygen-Dependent Protoporphyrinogen IX Oxidase 
 
The oxygen-dependent protoporphyrinogen IX oxidase (O2-dependent PPO) is encoded 
by the gene hemY and mainly produced in eukaryotes. It is also found in procaryots like 
(HemG, HemY) 
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Myxobacteria (Dailey and Dailey, 1996) and Gram positive bacteria (Hansson and 
Hederstedt, 1994). During the formation of proto, molecular oxygen serves as the terminal 
electron acceptor. It is proposed that three moles of dioxygen are consumed per mole of 
substrate, yielding three moles of H2O2 (Koch et al., 2004). 
Most investigated HemYs in plants, animals and α-Proteobacteria occur as a dimeric 
enzyme. Only HemY of Bacillus subtilis has been reported to exist as monomer (Dailey et 
al., 1994). The relative molecular masses of PPO monomers range from Mr = 36,000 
(barley) to Mr = 65,000 (cattle). Two isoforms have been found in plants: plastidal PPO I 
and mitochondrial PPO II (Jacobs and Jacobs, 1984; Jacobs and Jacobs, 1987). PPO I 
and II from Nicotiana tabacum share a sequence identity of only 27 % (Lermontova et al., 
1997). PPO II is located in the inner mitochondrial membrane with the active site facing 
the cytosolic face of the membrane (Ferreira et al., 1988).  
The O2-dependent PPO belongs to the superfamily of flavin-containing oxidases (Dailey 
and Dailey, 1998) and utilizes FAD as a cofactor (Camadro et al., 1994; Siepker et al., 
1987). PPO II of N. tabacum was the first PPO for which the crystal structure was solved 
(Koch et al., 2004). The structure reveals a homodimeric conformation in which each 
monomer consists of a FAD-, a substrate- and a membrane-binding domain. The structure 
was successfully modelled onto the structure of the subsequent enzyme, the human 
ferrochelatase (Wu et al., 2001). Together with experimental data this points towards a 
possible physical interaction of the two enzymes. During this interaction, the intermediate 
substrate proto is channelled from PPO directly to ferrochelatase (Ferreira et al., 1988). 
Possibly coproporphyrinogen III oxidase, the antepenultimate enzyme of heme 
biosynthesis, is also part of this protein complex (Koch et al., 2004).  
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Fig. 6: Structure of the mitochondrial protoporphyrinogen IX oxidase (PPO II) of Nicotiana tabacum. 
The tobacco mitochondrial PPO is a homodimer. Monomers consist of FAD-, substrate- and membrane-
binding domains. The inhibitor phenylpyrazole (green), the FAD-cofactor (orange) and bound Triton® X-100 
(blue) are also shown. (Koch et al., 2004) 
 
A prokaryotic HemY from Myxococcus xanthus has been co-crystallised with the common 
herbicide Acifluorfen, a potent inhibitor of HemY (Corradi et al., 2006). Aciflourfen is a 
diphenylether that inhibits investigated HemY´s by blocking the substrate binding site 
(Table 1).  
 
Table 1: HemY´s of specified organisms and their acifluorfen IC50 values  
The organisms are grouped in eucaryots and procaryots. The concentrations of acifluorfen where half of the 
activity is diminished (IC50 values) are given except for Bacillus subtilis. 
 
 
cucumber:                 
 
500 nM 
yeast:                      7 nM 
mouse 250 nM 
 
     
    (Camadro et al., 1991) 
   
Myxococcus xanthus:             2 µM (Dailey and Dailey, 1996) 
Porphyromonas gingivalis:       6 µM (Kusaba et al., 2002) 
Bacillus subtilis:   18% at 100 µM (Dailey et al., 1994) 
 
 
Bilirubin has also been reported to possess an inhibitory effect on murine HemY with a Ki 
of 25 µM (Ferreira et al., 1988). 
substrate-binding 
domain FAD-binding 
domain 
membrane-binding domains 
substrate-binding 
domain 
 
FAD-binding 
domain 
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1.4.2 The Oxygen-Independent Oxidation of Protoporphyrinogen IX 
 
O2-dependent HemY is found in eukaryotes as well as in many Gram positive bacteria, but 
not in anaerobic or facultative bacteria like the Enterobacteriaceae. For these organisms, 
a second, oxygen-independent (O2-independent) system must exist in nature. O2-
independent PPO activity was solubilised from cytoplasmic membranes of Desulfovibrio 
gigas (Klemm and Barton, 1987). The enzyme was described as a complex of three 
polypeptides with relative molecular masses of Mr = 12,000, 18,500 and 57,000,  
respectively. In activity assays performed, the artificial electron acceptor 
dichloroindophenol (DCIP) was used. For this molecule auto-oxidation of the substrate 
has been demonstrated previously (Breckau, 2005). Therefore, it remains unclear if the 
purified enzyme complex indeed possessed PPO activity. 
O2-independent PPO activity was also detected in cell-free extracts of Escherichia coli 
when nitrate or fumarate served as electron acceptors. It was suggested that electrons 
evolving from the oxidation of protoporphyrinogen IX are transferred via the respiratory 
chains to these molecules (Jacobs and Jacobs, 1975; Jacobs and Jacobs, 1976). Proto 
formation was sensitve to ultra-violet irradiation and could be restored by adding 
menadione. Cell-free extracts treated with 2-heptyl-4-hydroxy quinoline-N-oxide (HQNO), 
an electron transport inhibitor, uncoupled protoporphyrinogen oxidation from fumarate 
reduction. Taken together, these findings suggest that the overall PPO-reaction in E. coli 
is dependent upon quinones as electron transport carriers (Jacobs and Jacobs, 1978).  
The chemically mutated E. coli K12 strain SASX38 accumulates proto and is reduced in 
anaerobic PPO-activity. The accumulation of product was explained with the 
nonenzymatical conversion of substrate. The phenotype was tracked down to a mutation 
of the gene hemG (Sasarman et al., 1979). Complementation of SASX38 with hemG 
restores PPO-activity, suggesting that the gene product is involved in the O2-independent 
PPO-reaction (Sasarman et al., 1993). Due to the small size of HemG (Mr = 21'200 in  
E. coli) and the fact that PPO-activity could not be clearly attributed to the recombinantly 
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produced protein, it was been assumed that E. coli HemG may be a subunit of a larger 
PPO complex (Dailey and Dailey, 1996; Panek and O'Brian, 2002). 
In our laboratory, Dr. Daniela Breckau was able to establish a reproducible activity test for 
the anaerobic PPO from E. coli. Therein, PPO activity is monitored by the formation of the 
fluorescent product proto. A 60-fold increase of proto formation was found in purified 
membrane fractions of E. coli compared to whole cell lysates. In accordance to Sasarman 
(1993) and Klemm (1987) it was concluded that the oxygen-independent PPO is either 
membrane-integral or -associated (Breckau, 2005). A screen for electron acceptors with 
cell-free extracts of E. coli showed that O2-independent PPO acitivity involves an electron 
transfer to fumarate. This was in agreement with previous findings (Jacobs & Jacobs, 
1975). The fumarate reductase (FRD) deficient E. coli strain DW35 was impaired in proto 
formation. It was concluded that FRD, which oxidises quinones to reduce fumarate, is 
involved in the flow of electrons from PPO to fumarate. Therefore, fumarate may act as 
the physiological electron acceptor while the menaquinone pool serves as a redox carrier. 
Apart from fumarate, triphenyl tetrazoliumchloride (TTC) was found to act as an artificial 
electron acceptor. This compound has previously been shown to interact with respiratory 
chains (Rich et al., 2001). The postulated flow of electrons from proto'gen via the 
menaquinone pool to FRD is shown in figure 7. 
 
 
Fig. 7: Working hypothesis of the electron flow during oxidation of protoporphyrinogen IX. 
Electrons from the protoporphyrinogen IX oxidase are transferred via the quinone pool to fumarate reductase. 
HemG is assumed to be a component for the proto´gen oxidation process. PPO, protoporphyrinogen IX 
oxidase; FRD, fumarate reductase (subunits A-D); MQ, menaquinone; MQH2, reduced menaquinone 
(Breckau, 2005). 
 
??? 
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1.5 Respiratory Chains of Escherichia coli 
In E. coli, the respiratory chains and the aerobic and anaerobic regulation of the 
corresponding genes are well characterised (Darwin et al., 1996; Unden and Bongaerts, 
1997). The various electron-transport chains of the facultative anaerobic bacterium involve 
numerous dehydrogenases and quinone-linked terminal oxidases. The three quinones of 
E. coli are ubiquinone (Q), menaquinone (MQ) and demethylmenaquinone (DMQ). During 
aerobic respiration, Q serves as the main electron carrier. When O2 is not present, E. coli 
is capable of utilising other molecules as terminal electron acceptors. If fumarate or 
dimethyl sulfoxide (DMSO) function as terminal electron acceptors, Q is largely replaced 
by MQ in anaerobic respiration. Nitrate-dependent growth mainly requires the electron 
carrier DMQ.  
The presence of terminal electron acceptors regulate the expression of six terminal oxido-
reductases. O2 is the preferred electron acceptor producing the highest energy yield.  
E. coli possesses two cytochrome oxidases which are produced differentially depending 
on the availability of O2. At high O2 tensions in the growth medium, cytochrome bo3 
oxidase dominates over all other terminal oxidases. This enzyme is constituted of four 
subunits and belongs to the heme-copper superfamily of proton-pumping respiratory 
oxidases (Rumbley et al., 1997). At low O2 tensions, the second cytochrome oxidase, 
termed bd, is present in the cytoplasmic membrane. It is composed of two subunits and 
three heme prosthetic groups (Kaysser et al., 1995). 
Nitrate stimulates the synthesis of nitrate reductase (NarGHI). This enzyme consists of 
three subunits and possesses molybdo and heme cofactors as well as iron-sulphur-
clusters. It is efficiently inhibited by pentachlorophenol (PCP) (Bertero et al., 2005). 
Fumarate reductase (FRD) from E. coli is a membrane-bound flavoprotein catalysing the 
cytoplasmic reduction of fumarate to succinate, as well as the oxidation of quinones in the 
membrane (Luna-Chavez et al., 2000). The enzyme consists of four polypeptides 
encoded by the frdABCD operon (Jones and Gunsalus, 1985). The gene frdA encodes a 
flavoprotein subunit (FrdA) that binds a FAD cofactor. FrdB contains three iron-sulphur 
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clusters. The FrdAB-dimer represents the catalytic portion of the complex and is attached 
to the inner membrane of E. coli by the hydrophobic gene products of frdC and frdD. 
Subunits C and D are required for the interaction with quinones which serve as proton 
carriers during the reaction (Cecchini et al., 2003). It should be noted that although 
preferring a specific quinone (see above), fumarate reductase as well as nitrate reductase 
are able to utilize MQ as well as Q1 as electron donor (Giordani and Buc, 2004; 
Maklashina et al., 2006). 
The hierarchy of terminal electron acceptor utilisation by E. coli is O2 > nitrate > DMSO > 
TMAO > fumarate. 
 
1.6 Formation of Protochlorophyllide during Chlorophyll 
Biosynthesis 
The addition of the isocyclic, fifth ring to magnesium protoporphyrin IX monomethyl ester 
(MgPME) is catalysed by MgPME oxidative cyclases (cyclases). This step leads to the 
formation of protochlorophyllide. To date, two cyclases are known: AcsF (Aerobic enzyme 
Fe-containing subunit), which, as the name suggests, is dependent on O2, while the 
cyclase BchE is O2-independent. Some organisms contain both enzymes, as shown for 
Rubrivivax gelatinosus (Ouchane et al., 2004). However, the anaerobic enzyme is usually 
found in anaerobic organisms like Chlorobaculum tepidum. 
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Fig. 8: Conversion of magnesium protoporphrin IX monomethyl ester to protochlorophyllide 
O2-dependent and -independent cyclases (marked in blue) catalyse the conversion of magnesium 
protoporphrin IX monomethyl ester to protochlorophyllide. The arising oxygen atom at the 132 carbon atom 
(marked in red) is derived from molecular oxygen (AcsF) or from water (BchE). 
 
1.6.1 The Oxygen-Dependent oxidative Cyclisation of  
Mg-Protoporphyrin IX monomethyl ester 
 
Activity of the O2-dependent cyclase was detected in chloroplasts of Chlamydomonas 
reinhardtii and cucumber (Chereskin et al., 1982), in Barley (Rzeznicka et al., 2005) and in 
cell lysates of Synechocystis PCC 6803 (Bollivar and Beale, 1996). As shown in figure 8, 
the oxygen at position 132 of the tetrapyrrole derives from molecular oxygen. For all 
organisms investigated, cyclase activity was only detectable if cytosolic and membrane 
fraction were combined. In all the experiments carried out so far, the AcsF subunit was 
found in the membrane fraction. This points towards a multi-subunit arrangement of the 
O2-dependent cyclase (Walker et al., 1991). To date, none of the cytosolic subunits could 
be identified. 
1.6.2 The Oxygen-Independent Mg-Protoporphyrin IX monomethyl 
ester oxidative Cyclase 
 
Organisms performing anoxygenic photosynthesis possess an O2-independent enzyme 
system for the cyclisation of MgPME. A Rhodobacter capsulatus mutant deficient in bchE 
was found to accumulate MgPME (Biel and Marrs, 1983). Homologs of bchE are only 
O 
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found in phototrophs (Ouchane et al., 2004). Consequently, BchE was annotated as O2-
independent cyclase (Bollivar et al., 1994). Isotope labelling experiments with the O2-
independent cyclase showed that the oxygen at the 132 position of protochlorophyllide 
was derived from water (Porra et al., 1995).  
All orthologous BchE sequences show a highly conserved motif containing three cysteines 
(CXXXCXXC). This sequence motif is also found in enzymes containing [4Fe-4S] clusters. 
UV-Vis spectra of the purified BchE protein from R. gelatinosus were obtained exhibiting 
properties typical for proteins coordinating [4Fe-4S] clusters (Ouchane et al., 2004). 
These clusters are found in proteins of the radical-SAM family. Members of this family are 
involved in radical reaction mechanisms associated with the cleavage of (SAM) (Sofia et 
al., 2001). Hence, SAM has been postulated as cofactor for BchE which, however, has not 
been experimentally verified. The amino-terminus of R. capsulatus BchE shares 
similarities with cobalamin binding domains, e.g from P-methylase from Streptomyces 
hygroscopicus. Indeed, mutants of R. capsulatus, deficient in vitamin B12 biosynthesis 
have been shown to accumulate MgPME. This effect was abolished by the addition of 
exogenous cobalamin or vitamin B12 (Gough et al., 2000). On the basis of these results, 
the following reaction mechanism for the formation of the fifth ring was postulated  
(fig. 9). 
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Fig. 9: Proposed reaction mechanism for the formation of protochlorophyllide by O2-independent 
cyclase (Gough et al., 2000). 
 
In this reaction, six hydrogen atoms are formally removed from the substrate and from 
water. It is proposed that the enzyme catalyses the formation of an adenosyl radical from 
adenosyl-cobalamin. Possibly by a protein radical, a free electron is transferred onto the 
substrate. Hydrogen is abstracted (fig. 9,1), forming the 131-radical of the methyl 
propionate side chain of MgMPE. Withdrawal of an electron (2) leads to the 131-cation of 
MgMPE, which is attacked by OH- derived from water (3) yielding the 131-hydroxy 
derivative of MgMPE.  
Abstraction of a hydrogen gives the 131-OH radical (4) which is postulated to attack the 
Fe(III)-ion of the FeS-cluster of the enzyme. 131-keto-MgMPE is formed by intermolecular 
electron transfer (5), removal of an hydrogen atom leads to the 132-radical (6). This radical 
attacks the adjacent 15-methene carbon. A last abstraction of a hydrogen gives the 
isocyclic ring of Pchlide (7). If a radical termination occurs during the reactions, 
regenerated adenosyl radical reinitiates the process. 
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1.7 Aim of this study 
The penultimate step of heme biosynthesis – the conversion of protoporphyrinogen IX into 
protoporphyrin IX – is catalysed by two different protoporphyrinogen IX oxidases. To date 
only the O2-dependent enzyme system of eukaryotes and Gram positive bacteria has 
been extensively characterised. Many prokaryotes, as obligate or facultative anaerobes, 
make use of an O2-independent PPO. The objective of this work was to identify the 
O2-independent PPO. For this purpose, a chromatographic purification strategy for the  
O2-independent PPO had to be developed. Once identified, the O2-independent PPO 
should be recombinantly produced, purified and biochemically characterised. Beyond the 
biochemical analysis of this O2-independent enzyme itself, its integration into various 
electron transport chains had to be clarified. 
An additional aim was to study the O2-independent conversion from magnesium 
protoporphyrin IX monomethyl ester to protochlorophyllide during (bacterio-)chlorophyll 
biosynthesis. For this purpose, the polypeptide BchE was recombinantly produced, 
purified and biochemically analysed.  
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2 Materials and Methods 
 
2.1 Instruments and Chemicals  
 
2.1.1 Instruments  
 
agarose gel electrophoresis Agargel Biometra 
agarose gel documentation GelDoc Bio-Rad 
anaerobic workstations Type B Flexible vinyl chamber COY Laboratory Products Inc. 
autoclave LVSA 50/70 Zirbus 
centrifuges Centrifuge 5415 C Eppendorf 
 Centrifuge 5804 Eppendorf 
 Minispin Eppendorf 
 RC 5B Plus Sorvall 
 L8 70M Ultracentrifuge Beckmann 
DNA sequencing ABI PrismTM 310 Genetic 
Analyser 
Applied Biosystems 
 
electroporation Gene-Pulser™ II Bio-Rad 
FPLC ÄKTApurifier™ GE Healthcare 
French®  Press French® Pressure Cell SLM Aminco 
HPLC Jasco 1500 Jasco 
luminescence (fluorescence) 
spectrometer 
LS50B Perkin Elmer 
pH determination pH-Meter C 6840 B Schott 
photometer Ultrospec 2000 Pharmacia 
scales SBA 52 Scaltec 
 BP61S Sartorius 
SDS-PAGE Mini Protean III Bio-Rad 
thermocycler Tpersonal Biometra 
thermomixer Thermomixer 5436 Eppendorf 
UV/Visible spectrophotometer Lambda 2 Perkin Elmer 
vortex Vortex-Genie 2 Scientific Industries 
water purification Milli-Q System Millipore 
western blotting Semidry-Blot Trans-Blot®SD Bio-Rad 
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2.1.2 Materials 
  
cannulas “Sterican” Braun 
DEAE-Sepharose Fast Flow HR 5/5 GE Healthcare 
dialysis Visking, type 27/32 exclusion 14,000 Roth 
Filter Minisart SRP4 Sartorius 
"Gel Blotting Papers” Roth 
glutathione sepharose 4 Fast Flow GE Healthcare 
gravity flow column “Poly-Prep”, 0.8 x 4 cm Bio-Rad 
Ni-NTA Superflow Qiagen 
Precision cuvettes 115F-QS Hellma 
“Roti-PVDF-membrane” Roth 
sterile filter  Millipore, Sartorius 
Superdex 200 HR 10/30 GE Healthcare 
syringes (1 ml, 5 ml) Braun 
  
2.1.3 Chemicals, Enzymes and Kits 
 
Antarctic Phosphatase New England Biolabs 
anti-goat HRP-conjugate (rabbit) Sigma 
anti-GST-antibody (goat) GE Healthcare 
anti-His-antibody (mouse) GE Healthcare 
anti-mouse HRP-conjugate FC specific Sigma 
Benzonase Merck 
Bio-Rad Protein Assay Bio-Rad  
BiothermTM DNA polymerase Biotherm 
FAD Fluka 
FMN Fluka 
GelStar® Nucleic Acid Gel Stain Cambrex 
magnesium protoporphyrin IX monomethyl ester Frontier Scientific 
nucleotides (dNTPs) Fermentas 
Oligonucleotides MWG Biotech, Biomers 
PreScissionTM Protease GE Healthcare 
protease inhibitor tablets mini complete EDTA free Roche 
protoporphyrin IX Sigma 
QIAquick Gel Extraction Kit Qiagen 
QIAquick PCR purification kit Qiagen 
QuikChange® Site-Directed Mutagenesis Kit Stratagene 
restriction enzymes and reaction buffers New England Biolabs 
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size standard for agarose gels: 
-GeneRuler™ DNA Ladder Mix 
-MassRuler™ DNA Ladder Mix 
 
Fermentas 
Fermentas 
size standards for SDS-PAGE: 
-Protein Molecular Weight Marker  
-PageRuler™ Prestained Protein Ladder 
 
Fermentas 
Fermentas 
T4 ligase New England Biolabs 
 
Chemicals and reagents not specifically listed here were purchased from the following 
manufacturers: GE Healthcare, Fluka, Macherey-Nagel, Merck, Riedel-de Haën, Roche, Roth and 
Sigma. 
2.2 Bacterial Strains, Plasmids and Primers  
2.2.1 Bacterial Strains  
 
All bacterial strains and plasmids used in this work are listed in table 2 and 3. 
 
Table 2: Bacterial strains used in this work 
 
Strain Genotype Reference/Source 
 
Bacillus megaterium WH323 
 
Mutant of WH320, lac- xyl- 
φ(xylA1-spoVG-lacZ) 
 
(Rygus and Hillen, 1992) 
Chlorobaculum tepidum TSL wildtype DSMZ 
 
Rhodobacter capsulatus  
DSM 938 
wildtype DSMZ 
 
Escherichia coli strains: 
 
 
 
 
BL21 (λDE3) F-ompZ r-m- λlysPlacUV5-T7-
GenlPlacq-lacI 
Stratagene 
DH5α F- Ф80dlacZ∆M15(lacZYA-
ArgF) U169 recA1 endA1 
hsdR17(rk-, mk+) phoA supE44 
λ
-
 thi-1 gyrA96 relA1 
Invitrogen 
 
DW35 Zjd::Tn10∆(frdABCD)18 
sdhC::Kan araD139∆(argF-
lac)U169 rpsL150 relA1 
flbB5301 deoC1 pfsF25 rbsR 
G. Cecchini, University of 
California 
DS 253 W3110 DlacU169 tna-2 
∆cyd::cam ∆cyo::kan  
D. Siegele, Texas A + M 
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FB20172 MG1655 cyoB::Tn5KAN-2,  
-pKD46 
Blattner Laboratories, U of 
Wisconsin 
FB20228 MG1655 cydA::Tn5KAN-2, 
- pKD46 
Blattner Laboratories, U of 
Wisconsin 
GO105 ∆(cydAB')455 zbg-2200::kan 
cyo-123 recA srlC300::Tn10 
pRG110 
R. Gennis, U of Illinois 
JCB4023 RK4353 narG::ery DnapA-B 
narZ::W 
Potter et al., 1999 
 
2.2.2 Plasmids  
 
Table 3: Plasmids used in this work 
 
Plasmid Description Reference/Source 
 
pC-His1622 
 
Shuttle vector for cloning in E. coli 
(Ampr) and gene expression 
under xylose control in  
B. megaterium (Tetr) for the 
intracellular production of C-
terminal His6-tagged proteins in B. 
megaterium; PxylA-MCS-His6-Tag-
Stop 
 
Biedendieck et al., 2007 
pC-His1622 hemG E. coli hemG cloned into SphI and 
BglII of pC-HIS1622 creating 
PxylA-His6-Tag-hemG-Stop 
this work 
pETDuet 1 hemG Expression vector encoding the 
sequence for His6x-E. coli HemG 
fusion protein under the control of 
a lac promoter, Ampr 
Schröder, 2006 
pH3 frdA+B+C+D+ Ampr G. Cecchini, Universtiy of 
California 
pJRHisA cyoA+, cyoB-histag+, cyoC+, cyoD+ R. Gennis, Universtiy of 
Illinois 
pTK1 cydA+, cydB+ R. Gennis, Universtiy of 
Illinois 
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pGEX-6P-1 bchE Expression vector encoding lac 
promoter and sequence for:  
N-terminal fusion protein of GST 
from Schistosoma japonicum, 
PreScission™ Protease cleavage 
site and BchE from C. tepidum, 
ampr 
this work 
pGEX-6P-1 bchE His4x Derivative from pGEX-6P-1 bchE 
with an additional sequence for a 
C-terminal His-tag 
this work 
 
2.2.3 Primers 
 
Oligonucleotide primers for the amplification and cloning of E. coli hemG and C. tepidum bchE into 
different vectors were designed. All oligonucleotide primers used in this work are listed below. 
Recognition sequences of restriction endonucleases are cursive and the extensions homologous to 
the E. coli genome and the C.tepidum chromosome are underlined. Primers were purchased from 
MWG Biotech AG or biomers.net GmbH. 
 
Primers for the cloning of E. coli hemG into pCHis1622 
HemG for Bmfor  GCAAGCAGATCTCTAAAACATTAATTCTTTTCTC 
HemG for Bmrev  AGTAGTGCATGCTTCAGCGTCGGTTTG 
Primers for the cloning of C. tepidum into pGEX-6P-1 
CTpGEXCT   GGAATTCATGAAAATTCTGATGATTC 
CTpGEX/ACYCrev CATGTCGACTCAGCAGTTGCGG 
Primers for the insertion of a C-terminal His4x-tag sequence 
 
2FCtBchEHisF 
 ACCGTCCGCAACTGCGCGCTCGAACATCATCATCATTGAGTCGACTCGAGCGGC 
2RCtBchEHisR 
GCCGCTCGAGTCGACTCAATGATGATGATGTTCGAGCGCGCAGTTGCGGACGGT 
 
2.3 Media and Additives 
2.3.1 Media  
 
As a standard medium for growth of all bacterial strains Luria broth (LB) medium was used unless 
indicated otherwise (Sambrook et al., 1989). For the production of fumarate reductase glycerol-
fumarate-medium was employed (Luna-Chavez et al., 2000). Some E. coli mutants deficient in  
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components of respiration chains where cultivated in modified glycerol-fumarate or  
-nitrate media. For solid media 1.5 % (w/v) agar-agar was added before sterilization. 
 
Luria Bertani (LB) yeast extract 5.0 g/l 
 NaCl 10.0 g/l 
 tryptone 10.0 g/l 
 
glycerol-fumarate-medium KH2PO4 5.44 g/l 
 K2HPO4 10.49 g/l 
 (NH4)2SO4 2.0 g/l 
 MgSO4 x 7 H2O 50 mg/l 
 FeSO4 x 7 H2O 125 µg/l 
 CaCl2  500 µg/l 
 glucose 2.0 g/l 
 glycerol 3.96 g/l 
 casamino acids 500 mg/l 
 tryptone 2.0 g/l 
 yeast extract 1.0 g/l 
 sodium fumarate 6.4 g/l 
 
modified glycerol medium Tris-HCl pH 7.5 25 mM 
 glucose 0.3 % (w/v) 
 casaminoacids 1 % (w/v) 
 yeast extract 0.1 % (w/v) 
 glycerol 40 mM 
 sodium fumarate 0.6 % (w/v) 
 or   
 KNO3 0.2 % (w/v) 
 
 
2.3.2 Additives 
 
Antibiotics and other additives were prepared as concentrated stock solutions, sterilised by filtration 
(pore width 0.2 µm) and added to the medium after autoclaving. Solutes and concentrations are 
summarised in Table 4. 
  
Table 4: Media additives 
 
Substance Solute Concentration of 
stock solution 
Final 
concentration 
ampicillin 
 
H2O 
 
100 mg/ml 
 
50 or 100 µg/ml 
 
tetracycline 
 
ethanol (70 % (v/v)) 
 
5 mg/ml 
 
10 µg/ml 
 
IPTG H2O 1M 50 µM – 1 mM 
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 2.4 Microbiological Techniques 
 
2.4.1 Sterilisation 
 
All media were vapour sterilised at 121 °C and 1 ba r positive pressure for 20 min. Other 
substances and solutions were either vapour sterilised or – if temperature sensitive – sterilised by 
filtration (pore width 0.2 µm). 
2.4.2 Cultivation of Bacteria 
 
Cells for recombinant protein production were cultivated aerobically as described under “Aerobic 
Cultivation”. E. coli mutants where first grown under conditions where substantial cell growth was 
possible. Once cell mass was achieved, cells were shifted to conditions for 45 min where a strong 
phenotype was expected. 
 
Aerobic Cultivation 
Aerobic precultures of E. coli were inoculated from glycerol-stocks or single colonies from a plate 
culture with a sterile toothpick or pipette tip in 100 ml of LB containing the respective antibiotic and 
grown overnight at 37 °C and 200 rpm in baffled fla sks. Aerobic cultures of 100 - 500 ml of LB 
containing the respective antibiotic were incubated at 37 °C and 200 rpm in baffled flasks after 
inoculation with 1/100th volume of preculture.  
LB-agar plates containing the corresponding antibiotic were utilised for plating 10 - 100 µl of a 
bacterial cell suspension with a Drygalski spatula. They were incubated aerobically at 37 °C 
overnight. 
  
For a B. megaterium preculture, a volume of 100 ml of LB supplemented with tetracycline was 
inoculated with a single colony and grown overnight at 37 °C and 100 rpm in baffled flasks. For the 
main culture, 100 ml of LB containing tetracycline were inoculated with 1/50 th volume of preculture 
and grown at 37 °C and 250 rpm in baffled flasks.  
 
 
Anaerobic Cultivation 
Hundred ml of modified glycerol-medium in rubber-stoppered flasks where inoculated with E. coli 
mutants and flushed with sterile nitrogen. Cultures were then incubated at 37 °C and 100 rpm. 
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2.4.3 Determination of Cell Density 
 
The cell density of liquid cultures was determined by measuring the optical density (OD) at a 
wavelength of 578 nm. For cell densities with an OD578 nm ≥ 0.6 dilutions with the respective 
cultivation-medium were prepared before measurement. An OD578 nm of 1 corresponds to 
approximately 1 x 109 cells/ml. 
 
2.4.4 Storage of Bacterial Strains 
 
Strains were kept on agar plates at 4 °C for up to f our weeks. For long term storage glycerol-stocks 
were prepared. Therefore 700 µl of an overnight-culture were mixed with 300 µl of sterile glycerol  
(80 % (v/v)). Stocks were immediately frozen and kept at -80 °C. 
 
2.4.5 Harvesting of Bacterial Cells 
Cells were sedimented by centrifugation for 15 min at 5,000 rpm and 4 °C (Sorvall RC 5B Plus, 
rotor: SLA-3,000) and washed with 50 mM HEPES (pH 7.5). Cell sediments were stored at -20 °C 
until use. 
 
2.4.6 Disruption of Cells 
Sedimented cells were suspended in the lysis-buffer appropriate for the respective enzyme 
preparation (see sections 2.9 - 2.12 below). Then cells were disrupted by a single anaerobic 
passage or by multiple aerobic passages (where applicable) through a French® Press at  
1,200 p.s.i.. Benzonase (Merck, Darmstadt, Germany) was added in a ratio of 1 : 2,000 and 
incubated for 30 min at 17 °C. 
 
2.5 Molecular Biological Techniques 
2.5.1 Preparation of Plasmid DNA (Miniprep) 
Cells of a 2 ml overnight culture were harvested by centrifugation (5 min, 7,000 x g). The 
sedimented cells were resuspended in 150 µl of buffer P1. 300 µl of buffer P2 were added. The 
sample was carefully mixed by inverting the tube and incubated at RT for 2 min. 225 µl of buffer P3 
were added and the sample was carefully mixed again. After centrifugation (25 min at 15,000 x g) 
600 µl of the supernatant were added to 600 µl isopropanol in a fresh tube. Precipitation of plasmid 
DNA was allowed during a 30 min centrifugation step at 4 °C (15,000 x g). The precipitated DNA 
was washed with 70 % (v/v) ethanol. After all traces of ethanol had evaporated, the DNA was 
solubilised in 50 µl H2O. 
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P1 buffer Tris-HCl, pH 8.0 50 mM 
 EDTA 10 mM 
 RNase 200 µg/ml 
 
  
P2 buffer NaOH 200 mM 
 SDS 1 % (w/v) 
 
  
P3 buffer sodium acetate pH 4.8 3 M 
 
 
2.5.2 Electrophoretic Separation of DNA 
 
For the analytical separation of DNA-fragments agarose gels (1 % (w/v) agarose in TAE-buffer) 
were prepared. DNA samples were mixed with DNA loading dye to facilitate loading and to indicate 
the progress of the samples in the gel. GeneRuler™ DNA Ladder Mix or MassRuler™ DNA Ladder 
Mix (MBI Fermentas; St. Leon-Rot; Germany) were used as size standards according to the 
manufacturer’s instructions. Depending on the size of the gel, a voltage of 80 – 100 V was applied. 
The DNA fragments migrate towards the anode with a velocity that is proportional to the negative 
logarithm of their length. After electrophoresis, gels were incubated in an ethidium bromide solution 
for 30 min and briefly rinsed with H2Odeion. The DNA was detected via the fluorescence under UV 
light (λ = 312 nm). 
 
TAE buffer (pH 8.0) Tris-acetate 40 mM 
 EDTA 1 mM 
 dissolved in H2Odeion  
DNA loading dye Bromophenol blue 350 µM 
 Xylene cyanol FF 450 µM 
 glycerol 50 % (w/v) 
 dissolved in H2Odeion  
ethidium bromide solution ethidium bromide 0.1 % (w/v) 
 dissolved in H2Odeion  
 
 2.5.3 Determination of DNA Concentration 
 
Two methods where used to determine the DNA concentration of the prepared plasmid DNA.  
The plasmid was enzymatically linearised and visualised on an agarose gel (see 2.5.2). Using the 
software for gel documentation (Quantity One; Bio-Rad; Munich; Germany), the concentration of 
the respective band in the agarose gel was determined in comparison to two bands of known 
concentration.  
The concentration and purity was also determined by measuring the absorbance at 260 nm and 
additionally at 280 nm to account for protein impurities. For a pure DNA solution, an A260nm of 1 
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corresponded to a concentration of dsDNA of 50 µg/ml. The quality of the DNA solution is deduced 
from the ratio of A260nm to A280nm. With A260nm/A280nm = 1.8 – 2.0, the DNA can be considered as 
pure. 
2.5.4 Amplification of DNA Fragments by Polymerase Chain Reaction 
 
E. coli hemG was amplified by polymerase chain reaction (PCR). The PCR was performed at 50 µl 
scale with 5 µl of polymerase specific 10x buffer, 0.5 µl dNTP-mix (10 mM of each dNTP), 5 µl 
forward and reverse primer each (10 pmol/µl, section 2.2.3), 12.5 U of Biotherm® polymerase, and 
20 ng of pETDuet 1 hemG as DNA-template. After an initial DNA denaturation step  
(95 °C), a cycle consisting of denaturation, primer ann ealing (55 °C), and primer elongation (72 °C) 
was completed 30 times. The reaction was terminated by a final elongation period.  
  
Thermocycler program: 
05 min 95 °C 
01 min 95 °C 
01 min 55 °C   x 30 
45 sec 72 °C 
10 min 72 °C 
  
For the amplification of bchE of C. tepidum, 50 µl assays were set up with with 5 µl of polymerase 
specific 10x buffer, 1 µl dNTP-mix (10 mM each dNTP), 5 µl forward and reverse primer each (10 
pmol/µl section 2.2.3), 12.5 U of Biotherm® polymerase, and 1 µl of C. tepidum cell suspension 
(OD578nm of 0.5)  as DNA template. 
 
Thermocycler program: 
    05 min 95 °C 
    20 sec 95 °C 
    30 sec 59 °C      x 30  
      2 min 72 °C 
      5 min 72 °C 
 
During amplification of the DNA, recognition sequences for restriction endonucleases were inserted 
by the sequence of the specific primers at both ends of the DNA fragment. After PCR, an aliquot of 
the reaction mixture was analysed by agarose gel electrophoresis (2.5.2). The amplified DNA 
fragment was purified using the "QIAquick PCR Purification Kit" according to manufacturer’s 
instructions. 
 
 2.5.5 Restriction of DNA 
 
Restriction of double stranded DNA (vectors and PCR products) was carried out using restriction 
endonucleases. Reaction buffers, concentrations of enzymes, and DNA concentrations as well as 
incubation temperatures were chosen according to manufacturer’s instructions. The restriction was 
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allowed to proceed for 5 h or overnight at 37 °C, fo llowed by heat inactivation of the restriction 
endonucleases according to enzyme-dependent conditions.  
Restriction enzymes in the entire sample were removed by gel electrophoresis (2.5.2). The DNA 
was visualised using the GelStar® Nucleic Acid Gel Stain (Biozym; Hessisch Oldendorf; Germany) 
on a blue light detector (Flu-O-blu) and a yellow filter. The DNA fragment was then excised from 
the gel and purified using the "QIAquick Gel Extraction Kit" according to manufacturer’s 
instructions. 
 
2.5.6 Ligation of DNA-Fragments 
 
In order to avoid re-circularisation of digested vector DNA, the 5’-phosphate groups of linearised 
vectors were removed prior to the ligation reaction. This was achieved by adding Antarctic 
Phosphatase (New England Biolabs) to the sample immediately after restriction (1 U/µg DNA), 
incubation at 37 °C for 30 min followed by heat inacti vation for 15 min at 65 °C.  
In one ligation reaction, 25 – 200 ng of plasmid DNA were used. Insert-DNA was added in excess 
(insert to vector ratio with regard to molar concentrations of 2 : 1 to 10 : 1) to a final volume of  
20 µl. Ligation of vector-, and insert-DNA was carried out according to the manufacturer’s 
instructions using T4 Ligase (New England Biolabs) and the reaction buffer supplied by the 
manufacturer. Additionally, controls without insert and without ligase were carried out. All reactions 
were incubated for 20 min at 25 °C or at 17 °C overn ight.  
 
2.5.7 Transformation of Escherichia coli by the RbCl Method 
 
E. coli DH5α or BL21 (λDE3) cells were grown aerobically in 500 ml vapor sterilised LB. When the 
culture reached an OD578 nm of 0.6 cells were harvested by centrifugation (10 min at 6,000 x g and 
4°C). The cells were suspended in 200 ml TFB1 and incub ated on ice for  
5 min. After subsequent centrifugation (5 min at 3,000 x g and 4°C) cells were suspended in 2 
volumes of TFB2 (referring to the volume of the cell sediment). After being incubated on ice for 30 
min they were divided into 40 µl aliquots. These were either immediately used for transformation or 
stored at -80 °C.  
 
TFB1 potassium acetate 30 mM 
 CaCl2 10 mM 
 MnCl2 50 mM 
 RbCl 100 mM 
 glycerol 15 % (v/v) 
 in H2Odeion; pH 5.8  
   
TFB2 MOPS 10 mM 
 CaCl2 75 mM 
 RbCl 10 mM 
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 glycerol 15 % (v/v) 
 in H2Odeion; pH 6.5  
 
Transformation of chemo-competent cells was applied as standard transformation method. 40 µl of 
RbCl-competent cells were mixed with 1 - 2 µl of DNA solution (50 µg/ml), incubated on ice for 20 
min and subjected to a heat shock for 2 min at 42 °C. Immediately after the transformation the 
sample was cooled on ice for 2 min. Afterwards 1 ml of preheated LB was added and cells were 
incubated at 37 °C for 1 h. 
Depending on the expected colony density, different volumes were streaked onto agar plates 
containing the appropriate antibiotics. Plates were incubated overnight at 37°C. 
2.5.8 DNA Sequence Analysis of Plasmid DNA 
 
The successful modification of DNA was confirmed by sequence determination of the respective 
DNA region based on the principle of the Sanger dideoxy-method (Sanger et al., 1977).  
The sequencing reactions were conducted on site with an ABI PRISM 310 Genetic Analyser 
(Applied Biosystems; Perkin Elmer; Boston; USA). The required preparatory PCR with 
fluorescence-labelled ddNTPs and the purification of the PCR product were carried out as 
described by the manufacturer. The analysis of all sequencing results was done using the 
computer software Sequence Analysis v5.2 (Applied Biosystems), Chromas (technelysium, Austria) 
and Seqman (GATC Biotech; Konstanz; Germany).  
2.5.9 Protoplast Transformation of Bacillus megaterium Cells 
 
Fifty ml of LB was inoculated with an individual B. megaterium WH323 colony and grown overnight 
at 37 °C and 100 rpm in baffled flasks. 1 ml of this  culture was used to inoculate 50 ml of LB. The 
culture was incubated at 37 °C and 250 rpm in a baffl ed flask until it reached an OD578nm of 1.0. 
Cells were sedimented by centrifugation (2,600 x g; 15 min; 4 °C) and resuspended in 5 ml of 
SMMP. After adding 100 µl of freshly prepared sterile lysozyme solution (100 µg of lysozyme/ml 
SMMP), the protoplast suspension was incubated at 37 °C for 30 min and smooth shaking. 
Formation of protoplasts was monitored microscopically. When 80 % of the rod shaped bacterium 
cells had formed coccoid protoplasts, the protoplasts were harvested (1,300 x g; 10 min; RT). The 
supernatant was decanted carefully and the protoplasts were suspended in 5 ml of SMMP. After a 
second washing step, the protoplasts were suspended in 5 ml of SMMP and 750 µl of 87 % (w/v) 
glycerol. They were either used directly for transformation or were frozen and stored in aliquots of 
500 µl at -80 °C for a period of no longer than 2 months .  
Before transformation, protoplasts were tested for viability. Therefore, a 500 µl aliquot of protoplast 
solution was mixed with 2.5 ml of cR5-top agar as described below and was streaked onto a LB-
agar plate without antibiotics. After incubation overnight, a thick film of B. megaterium cells should 
be seen.  
For the transformation of protoplasts, 5 µg of dried plasmid DNA were dissolved in 10 µl of SMMP 
for 20 min at 37 °C. 500 µl of protoplast suspension were mixed with the DNA and transferred into 
1.5 ml of PEG-P solution. 5 ml of SMMP were added after incubation for 2 min at RT and gently 
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mixed with the suspension. The protoplasts were sedimented by centrifugation (1,300 x g; 10 min; 
RT), carefully suspended in 500 µl of SMMP and incubated at 30 °C for 45 min without shaking 
followed by 45 min of smooth shaking at 300 rpm (Thermomixer compact; Eppendorf; Germany). 
Regenerated protoplasts were mixed with 2.5 ml of pre-warmed (42 °C) cR5-top agar and spread 
on a pre-heated LB-agar plate containing the required antibiotics. The plates were incubated at 30 
°C for up to 24 h. Colonies observed after this per iod of incubation were streaked on new LB-agar 
plates containing the required antibiotics. 
 
SMMP 2 x AB3 and 2 x SMM; mixed 1 : 1  
   
2 x AB3 Antibiotic medium No. 3 (Difco) 35 g/l 
2 x SMM (pH 6.5) malic acid 40 mM 
 MgCl2 x 6 H2O 40 mM 
 NaOH 80 mM 
 sucrose 1 M 
 dissolved in H2Odeion, sterilised by filtration  
   
PEG-P solution PEG 6000 40 % (w/v) 
 dissolved in 1 x SMM (pH 6.5)  
   
cR5 top-agar (2.5 ml) solution A 1.25 ml 
 solution B 713 µl 
 8 x cR5-salts 288 µl 
 L-proline (12 % (w/v)) 125 µl 
 D-glucose (20 % (w/v)) 125 µl 
   
solution A (pH 7.3) sucrose 602 mM 
 MOPS 58 mM 
 NaOH 30 mM 
 dissolved in H2Odeion, sterilised by filtration  
   
solution B agar agar 4 % (w/v) 
 Casamino acids 0.2 % (w/v) 
 yeast extract 10 % (w/v) 
 dissolved in H2Odeion 
 
 
8 x cR5-salts K2SO4 11 mM 
 MgCl2 x 6 H2O 394 mM 
 KH2PO4 3 mM 
 CaCl2 159 mM 
 dissolved in H2Odeion  
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2.6 Protein Biochemical Methods 
 
2.6.1 Determination of Protein-Concentration 
 
Concentrations of protein solutions were determined using the Bio-Rad Protein Assay (Bio-Rad, 
Munich, Germany) following the manufacturer’s instructions ("Microassay Procedure" for 1 - 20 µg 
protein). The assay is based on the colourimetric method developed by (Bradford, 1976). Bovine 
serum albumin was used as a standard.  
2.6.2 Concentrating Protein Solutions 
 
Protein solutions were concentrated using Vivaspin 15 ultrafiltration units (Sartorius Vivascience, 
Aubagne Cedex, France; designed for centrifugation) with a molecular weight cut off of 10,000 in 
accordance to the manufacturers instructions. 
2.6.3 Dialysis 
 
Buffer exchange was performed anaerobically at 4 °C us ing dialysis membranes with a molecular 
weight cut off of 14,000. Therefore, 5 ml of protein solution were dialysed for approx. 14 h and then 
twice for 2 h against 250 ml of the respective buffer. 
2.6.4 Electrophoretic Separation of Proteins (SDS-PAGE) 
 
The discontinuous sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
executed as previously described (Laemmli, 1970; Righetti et al., 1990). Protein samples were 
prepared by heating to 95 °C for 5 min in appropriat e amounts of 6 x SDS loading dye. 2 to 18 µl 
samples were loaded onto the gel which was run at 45 mA until the band of bromophenol blue dye 
reached the lower end of the gel. During electrophoresis, proteins were first focussed in the 
stacking gel and subsequently separated according to their relative molecular mass in the running 
gel. The size standards usually employed was the Protein Molecular Weight Marker (MBI 
Fermentas; St. Leon-Rot; Germany). For immunochemical detection of the proteins (section 2.6.5), 
the size standard PageRuler Prestained Protein Ladder (MBI Fermentas; St. Leon-Rot; Germany) 
was used. Subsequently the gels were stained with Coomassie Brilliant Blue G250 and destained 
until distinct protein bands elaborated. For documentation, gels equilibrated in water were scanned 
(ScanMakerX12USI; ScanWizard 5; Microtek; Willich; Germany) and then dried between two 
cellophane foils for storage. 
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running gel (12 % (v/v)) stacking gel (6 % (v/v)) 
acrylamide stock solution 2 ml 500 µl 
buffer for running gel 1.25 ml - 
buffer for stacking gel - 625 µl 
H2Odeion. 1.75 ml 1.375 ml 
10 % (w/v) APS solution 5 µl 3 µl 
TEMED 50 µl 30 µl 
   
acrylamide stock solution acrylamide 29 % (w/v) 
 N,N’-methylenbisacrylamide 1 % (w/v) 
   
buffer for running gel Tris-HCl pH 8.8 1.5 M 
 SDS 0.4 % (w/v) 
   
buffer for stacking gel Tris-HCl pH 6.8 500 mM 
 SDS 0.4 % (w/v) 
   
SDS loading dye Tris-HCl pH 6.8 100 mM 
 glycerol 40 % (v/v) 
 β-mercaptoethanol 10 % (v/v) 
 SDS 3.2 % (w/v) 
 bromophenol blue 0.2 % (v/v) 
   
electrophoresis buffer Tris-HCl pH 8.4 50 mM 
 glycine 380 mM 
 SDS 0.1 % (w/v) 
   
staining solution acetic acid 10 % (v/v) 
 ethanol 25 % (v/v) 
   
Coomassie Brilliant Blue G-250 0.25 % (v/v) 
   
destaining solution acetic acid 10 % (v/v) 
 ethanol 30 % (v/v) 
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2.6.5 Western-Blot 
 
To further analyse protein samples, proteins separated during SDS-PAGE were transferred in a 
semi-dry process onto a PVDF-membrane (Western-Blot). 
Therefore, PVDF-membranes were incubated in methanol for 10 min. Afterwards, in parallel to the 
SDS-gel and blotting paper, they were incubated in transfer-buffer and assembled in the blotting 
apparatus as described by the manufacturer. For one gel, a current of 0.8 mA/cm2 was applied for 
30 min at 10 V. 
  
transfer-buffer Tris-HCl pH 8.5 25 mM 
 
glycine 192 mM 
 
methanol 20 % (v/v) 
   
PBS (pH 7.4) NaCl 137 mM 
 
KCl 27 mM 
 
Na2HPO4 x 7 H2O 100 mM 
 
KH2PO4 20 mM 
 
2.6.6 Immunodetection of Immobilised Proteins 
 
Proteins immobilised on a PVDF-membrane (2.6.5) can be detected by antibodies. The primary 
antibody is directed against an epitope of the protein of interest. The secondary antibody, directed 
against the primary antibody, is coupled to an enzyme which catalyses a detectable reaction. For 
immunodetection of recombinant proteins, non-specific binding sites of the membrane were 
saturated overnight in blocking-solution at 4 °C and  smooth shaking. Incubation with the primary 
antibody was carried out in blocking-solution for 1 h (RT) and slight shaking (Anti-His from mouse 
and Anti-GST from rabbit diluted 1 : 5,000 in blocking solution). The membranes were washed 
three times for 10 min each step with washing-solution. The secondary antibody (Anti-mouse and 
anti-rabbit diluted 1:3,000 in washing-buffer), which is coupled to an alkaline phosphatase, was 
applied and incubated for 45 min. After four washing steps with PBS/Tween®-buffer for 10 min 
each step, membranes were incubated for 5 min in alkaline phosphatase-buffer and exposed to 
staining-solution until bands became visible. During exposure, alkaline phosphatase, the enzyme 
bound to the secondary antibody, catalyses the reaction of 5-brom-4-chloro-3-indolylphosphate 
(BCIP) with nitroblue-tetrazolium (NBT). The resulting insoluble dye precipitates immediately on the 
membrane. Development was stopped with water and the membranes were air dried in the dark. 
 
PBS (pH 7.4) NaCl 137 mM 
 KCl 27 mM 
 Na2HPO4 x 7 H2O 100 mM 
 KH2PO4 20 mM 
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blocking-solution skim milk powder 5 % (w/v) 
 Tween® 20 0.1 % (v/v) 
 PBS 10 % (v/v) 
   
washing-solution skim milk powder 0.5 % (w/v) 
 Tween® 20 0.1 % (v/v) 
 PBS 10% (v/v) 
   
PBS/Tween®-buffer Tween® 20 0.1 % (v/v) 
 PBS 10 % (v/v) 
   
alkaline phosphatase-buffer Tris pH 9.5 100 mM 
 NaCl 100 mM 
 MgCl2 5 mM 
   
staining-solution alkaline phosphatase buffer 10 ml 
 NBT-solution 
(100 mg/ml in 70 % DMF) 
33 µl 
 BCIP-solution 
(50 mg/ml in DMF) 
33 µl 
 
2.6.7 Compliance of Anaerobic Conditions 
 
To ensure strict anaerobic conditions, most work was carried out in an anaerobic chamber. All 
buffers and solutions were subjected to repeated cycles of evacuation and saturation with N2 prior 
to use unless stated otherwise. 
 
Table 5: Anaerobisation of buffers and solutions employed in anaerobic work. 
 
volume [ml] number of cycles of evacuation 
and saturation with N2 
interval [min] 
5 10 1 
200 30 2 
500 60 2 
 
2.6.8 UV-Vis Spectroscopy  
 
UV-Visible Light Absorption Spectroscopy was performed using a V-550 spectrophotometer 
(Jasco, Groß Umstadt, Germany). Spectra from 700 to 250 nm with a scan speed of  200 nm/min 
were recorded. 
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2.7 Determination of Escherichia coli Protoporphyrinogen IX 
Oxidase Activity 
 
2.7.1 Principle of the Activity-Assay 
 
The protoporphyrinogen IX oxidase activity test was developed in our laboratory (Breckau, 2005). 
In this assay, the substrate protoporphyrinogen IX (proto'gen) is enzymatically converted into 
protoporphyrin IX (proto) by E. coli cell-free extract in the presence of fumarate or TTC as electron 
acceptors. Excitation of the product proto at a wavelength of 409 nm results in a fluorescence 
emission at 633 nm detectable by a luminescence spectrometer. Therefore, it is clearly 
distinguishable from the substrate proto'gen since this compound reveals no spectroscopic 
properties. 
2.7.2 Preparation of the Substrate Protoporphyrinogen IX 
 
2.7.2.1 Reduction of Protoporphyrin IX with Sodium Amalgam 
 
The substrate proto'gen was obtained through the reduction of proto (Sigma-Aldrich, Taufkirchen, 
Germany) according to a modified published instruction (Sano and Granick, 1961): 840 µg proto 
were dissolved in 3 ml of 10 mM KOH, 20 % (v/v) of ethanol (final concentration of proto: 500 µM) 
in a stream of N2 and finally reduced with 6 g of 3 % Na-amalgam. When the reaction mixture has 
discoloured after incubation for less than 2 min at 80 °C, it was filtered through glass wool. 50 mM 
of DTT was added and the pH was adjusted to 8 - 8.8 with 20 % (v/v) phosphoric acid. The 
proto´gen solution was aliquoted anaerobically and stored at -20 °C in the dark to avoid 
autooxidation by oxygen and light.  
 
2.7.2.2 Palladium-catalysed Reduction of Protoporphyrin IX with Molecular 
Hydrogen 
 
For this reduction method, a published instruction was modified (Phillips, 2007). All steps were 
performed under anaerobic conditions. 2 mg of proto and 5 mg of palladium (for hydroxylation 
reactions, 10 % on activated charcoal) were suspended in a mixture of 100 µl of H2O and 1.8 ml of 
methanol. After flushing with argon, a hydrogen atmosphere was established. The assay was 
stirred for up to 40 min at RT with occasional notification of fluorescence emission. The colourless 
assay was filtered and the methanol was withdrawn by evacuation. 500 µl of buffer were added to 
the remaining fluid and the assay was frozen at -20 °C in portions of 70 µl.   
2.7.3 Conditions for the Activity-Assay 
 
Determination of E. coli PPO-activity was started under strictly anaerobic conditions at RT in all 
cases. The standard assay mixture contained 25 µl of 10 x assay-buffer and components listed in 
the respective figure legends in a total volume of 250 µl. The reaction was started with the addition 
of 1.5 or 5 µl of proto'gen solution (final concentration of proto'gen were 3 and 10 µM, respectively) 
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or as indicated in 3.8.3 B. To investigate the utilisation of cytochrome oxidases as terminal 
oxidases, the assays were aeriated immediately. The formation of proto at RT was recorded in real 
time for up to one hour with using a luminescence spectrometer. 
 
10x assay-buffer Tris-HCl pH 7.6 500 mM 
 EDTA 10 mM 
 glutathione 50 mM 
 Triton® X-100 3 % (v/v) 
 NaCl 1 M 
   
proto'gen-solution proto'gen 500 µM 
 
Settings of the Luminescence Spectrometer 
Excitation Wavelength 409 nm 
Emission Scan Range 570 - 680 nm 
Scan Speed 200 nm/min 
Slit Width for Excitation 5 nm 
Slit Width for Emission 5 nm 
 
In order to quantify product formation, a calibration curve with different concentrations of chemically 
synthesised proto was prepared. 
 
 
 
Figure 10: Calibration curve of the fluorescence intensities in relation to proto concentrations 
Protoporphyrin IX was dissolved in assay-buffer. In accordance to the calibration curve, 1 nM proto resulted 
in 1.11 fluorescence intensity units. 
 
FU
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2.8 Purification of the Oxygen-Independent Protoporphyrinogen 
IX Oxidase 
2.8.1 Cultivation of Escherichia coli BL21 (λDE3)  
 
Six liters of E. coli BL21 (λDE3) Cultures were grown aerobically as described under 2.4.2 and 
harvested as described under 2.4.5. All purification steps were performed under anaerobic 
conditions. 
 
2.8.2 Isolation of Membrane Fractions of Escherichia coli 
 
The cell sediment was suspended in 20 ml of 50 mM HEPES pH 7.5. After cell disruption (2.4.6), 
cell debris of crude cell extracts of E. coli was removed by centrifugation for 15 min at 20,000 x g 
and 4 °C. The resulting supernatant was subjected to  an additional centrifugation step for 1 h at 
120,000 x g and 4 °C to sediment the membrane fracti on. 
 
2.8.3 Purification of Membrane Fractions performing Sucrose Density 
Gradient Centrifugation 
 
The membrane fraction of E. coli was further separated from soluble proteins by sucrose density 
gradient centrifugation. During centrifugation in a discontinuous 3 step sucrose gradient, protein 
fractions enriched in layers corresponding to their own density. The gradient was prepared by 
layering 3 ml of each sucrose solution (60, 40, and 20 % (w/v), respectively) onto each other. The 
sedimented membrane fraction was suspended in 2 ml of 20 % (w/v) sucrose-solution, layered 
onto the gradient and centrifuged for 2 h at 145,000 x g and 4 °C in a swing out rotor (Beckmann 
SW40Ti). The membrane fraction was enriched in a band on the boundary between the 40 % (w/v) 
and 60 % (w/v) sucrose solution. It was harvested with a Pasteur pipette.  
 
sucrose solution Tris-HCl (pH 7.3) 10 mM 
 MgCl2 100 mM 
 sucrose 20 % (w/v) 
 (added respectively) 40 % (w/v) 
  60 % (w/v) 
 
2.8.4 Solubilisation of Membrane Proteins  
 
Extraction of proteins from membranes of E. coli was performed by suspending the membrane 
fraction in 10 ml solubilisation buffer. Therefore, the suspension was stirred at 4 °C overnight. 
Afterwards, it was centrifuged for 1 h at 120,000 x g and 4 °C.  The supernatant containing 
solubilised proteins was collected. 
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solubilisation buffer Tris-HCl pH 8.0 50 mM 
 KCl 100 mM 
 
2.8.5 Anion Exchange Chromatography 
 
Protein purification was performed by anion exchange chromatography. The positively charged 
matrix diethylaminoethyl-sepharose (DEAE) interacts with negative charges occurring on surfaces 
of proteins. This interaction is interrupted by the presence of salts leading to the elution of 
respective proteins. To obtain best binding properties the supernatant of solubilised proteins (2.8.4) 
was diluted tenfold with DEAE buffer. The sample was applied on a DEAE-sepharose FF gravity 
flow column with a bed volume (CV) of 1 ml equilibrated with the same buffer. Three washing steps 
with 1 CV of buffer were followed by the elution of the proteins. Elution was carried out in steps of 3 
CV with DEAE buffer additionally containing 100 mM NaCl, 150 mM NaCl, 200 mM NaCl and  
500 mM NaCl, respectively. Obtained fractions were separated by SDS-PAGE. The gel was not 
stained afterwards. Lanes of fractions yielding high PPO activity were excised and used for the 
determination of the peptide content (section 2.9.4) 
 
       DEAE buffer       HEPES pH 7.5          50 mM 
 
 
2.9 Recombinant Production, Purification and characterisation of 
Escherichia coli HemG  
2.9.1 Cultivation of Escherischia coli Cells for the Production of HemG 
 
For aerobic recombinant production of HemG in E. coli, LB (6 x 500 ml) containing ampicillin was 
inoculated with 5 ml of a preculture of E. coli BL21 (λDE3) carrying pETDuet-1-hemG in 1 l 
Erlenmeyer flasks. Cultures were grown aerobically at 37 °C and 200 rpm to an OD 578nm of approx. 
0.6. Recombinant expression of hemG was induced by the addition of IPTG to a final concentration 
of 100 µM. Incubation was continued for 4 h at 25 °C and 200 rpm. Afterwards, cells were 
harvested (section 2.4.5). 
 
2.9.2 Cultivation of Bacillus megaterium Cells for the Production of 
HemG 
 
Five 100 ml cultures of recombinant B. megaterium WH323 carrying pC-His1622hemG were grown 
aerobically in LB to recombinantly produce HemG-His6x as described (section 2.4.2). Protein 
production was induced by the addition of 0.5 % (w/v) xylose at an OD578nm of approx. 0.4. Cultures 
were incubated at 250 rpm and 37 °C for six hours. A fterwards, cells were harvested (section 
2.4.5). 
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2.9.3 Affinity-Purification of Recombinant HemG under Anaerobic 
Conditions  
 
Cells cultivated and harvested according to 2.4.2, 2.4.5, 2.9.1 and 2.9.2 and were suspended in 20 
ml of lysis buffer and disrupted (section 2.4.6). After cell disruption, the sample was stirred at 4 °C 
for 1 hour and centrifuged at 100,000 x g and 4 °C f or 1 hour. The supernatant was filtered (filter 
pore width of 0.2 µm) and loaded onto a gravity flow column containing 1 ml of Ni-NTA Superflow 
(Qiagen) resin equilibrated with washing buffer. The column was washed with 6 CV of washing 
buffer. Proteins bound to the resin were eluted with 5 CV of elution buffer. The resulting fractions 
were stored at -20 °C. 
 
 
lysis buffer HEPES pH 7.5 50 mM 
 NaCl 300 mM 
 glycerol 20 % (v/v) 
 Thesit® 2 % (v/v) 
   
washing buffer HEPES pH 7.5 50 mM 
 NaCl 300 mM 
 glycerol 20 % (v/v) 
 imidazole 10 mM 
   
elution buffer HEPES pH 7.5 50 mM 
 NaCl 300 mM 
 glycerol 20 % (v/v) 
 imidazole 500 mM 
 
2.9.4 Mass-Spectrometry 
 
Chromatographically purified fractions of sections 2.8.5 and 2.9.3 were analysed for the protein 
content by LC-MS/MS. This work was done by Dr. Dörthe Becher at the department of 
microbiology from the University of Greifswald, Germany. 
 
2.9.5 Gel Permeation Chromatography of HemG  
 
For gel permeation experiments, a Superdex 200 HR 10/30 column (GE Healthcare, Munich, 
Germany) was equilibrated with GPC buffer and calibrated with marker proteins of relative 
molecular weights: Cytochrome C from bovine heart with Mr of 12,400, carbonic anhydrase with Mr 
of ~29,000, bovine serum albumin with Mr of ~66,000 and alcohol dehydrogenase from yeast with 
Mr of ~150,000. Then 200 µg of purified HemG (2 mg/ml) which had been recombinantly produced 
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in B. megaterium and purified by affinity chromatography (2.9.3) were loaded onto and eluted with 
GPC buffer at a flow rate of 0.5 ml/ min.  
 
GPC buffer HEPES pH 7.5 50 mM 
 NaCl 300 mM 
 glycerol 20 % (v/v) 
 Thesit® 2 % (v/v) 
 
2.9.6 Cofactor Determination by High Performance Liquid 
Chromatography (HPLC) 
 
After analysis of purified HemG (2.9.3) by UV-Vis spectroscopy (section 2.6.8), the protein was 
precipitated by the addition of 5 % (v/v) perchloric acid and centrifuged at 10,000 x g at RT for  
10 min. The supernatant was analysed using a HPLC-system 1500 series (Jasco, Groß Umstadt, 
Germany) and an ODS Hypersil 250 x 4.6 mm column (Techlab, Erkerode, Germany). Isocratic 
separation was performed at a flow rate of 0.5 ml/min at 30 °C. Flavins were detected by 
fluorescence measurements using an excitation wavelength of 430 nm and an emission 
wavelength of 525 nm. Photometric diode array analysis from 200 to 650 nm wavelength was 
performed simultaneously. Flavin-adenin-dinucleotide (FAD) and flavin-mononucleotide (FMN, 
Fluka) were used as standards. 
 
mobile phase  acetonitrile    water triflouric acid phosphoric acid (75 %) 
ratio  14             : 84             : 1.5             :       0.09 
 
2.10 Production and Purification of recombinant Escherichia coli 
Fumarate Reductase  
 
Recombinant production and purification of E. coli fumarate reductase (FRD) was performed 
according to a published protocol (Luna-Chavez et al., 2000) with several modifications. For the 
production, the plasmid pH3 encoding the wildtype FRD (frdA+B+C+D+) was used in the E. coli 
strain DW35 (frdA-B-C-D-). Cultivation under anaerobic conditions led to an overproduction of 
recombinant FRD (Blaut et al., 1989). 
2.10.1 Cultivation of Cells 
 
A 50 ml overnight culture of E. coli DW35 pH3 was grown at 37 °C and 200 rpm in LB contain ing 
100 µg/ml ampicillin. 6 ml of this culture was added to 100 ml of LB (100 µg/ml ampicillin) in an 
anaerobic bottle. The cells were grown anaerobically for approximately 8 h at 37 °C and 100 rpm. 
From this culture, 5 x 1 l of glycerol-fumarate-medium (35 µg/ml amp) in 1 l anaerobic flasks were 
inoculated with each 1 ml. Cells were grown anaerobically at 37 °C and 100 rpm overnight (~13 h) 
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and harvested (section 2.4.5). To separate the bacterial cells from precipitated medium 
components, the cell sediment was washed trice with 50 mM HEPES (pH 7.5). 
 
2.10.2 Preparation of Membrane Fractions and Solubilisation of 
Fumarate Reductase 
 
Sedimented cells (2.10.1) were suspended aerobically in 20 ml of FRD buffer and disrupted twice 
(section 2.4.6). Cell debris was removed by centrifugation for 15 min at 20,000 x g and 4 °C. The 
cell-free supernatant was carefully removed. The membranes were sedimented in an additional 
centrifugation step for 1 h at 120,000 x g and 4 °C.  The sedimented fractions were kept at -20 °C 
until use.  
Membrane proteins were solubilised by suspending the membrane fraction in buffer S and stirring 
at 4 °C for 1 h. Subsequent centrifugation for 1 h a t 120,000 x g and 4 °C followed by the filtration 
of the supernatant was performed to prepare fractions containing the recombinant fumarate 
reductase for purification. 
 
 
FRD buffer Tris-HCl pH 6.8 100 mM 
 EDTA 100 µM 
   
Buffer S HEPES pH 7.5 20 mM 
 EDTA 100 µM 
 Thesit® 2 % (v/v) 
 
2.10.3 Purification of Fumarate Reductase by "Fast Performance 
Liquid Chromatography" (FPLC) 
 
Purification of solubilised fumarate reductase was performed by "Fast Performance Liquid 
Chromatography" (FPLC) using an ÄKTA™-Purifier and a DEAE-Sepharose FF column.  
The column (XK 16/20) with a CV of 25 ml was equilibrated with 5 CV of buffer A. After loading the 
supernatant (flow rate 2 ml/min), the column was washed with 2 CV of buffer A to remove unbound 
proteins. By the addition of 10 % of buffer B (2 CV), loosely bound proteins were eluted. A gradient 
from 10 % to a final concentration of 25 % of buffer B was applied for 3 CV. Remaining proteins 
were eluted with 2 Cv of 100 % of buffer B. The fractions were collected in 5 ml aliquots. Fractions 
containing FRD were identified by SDS-PAGE (2.6.4), pooled and concentrated by ultrafiltration 
(2.6.2). The obtained FRD solution was diluted twofold with 80 % glycerol, flushed with molecular 
nitrogen and stored at –20 °C. 
 
buffer A HEPES pH 7.5 20 mM 
 EDTA 100 µM 
 Thesit® 0.05 % (v/v) 
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buffer B HEPES pH 7.5 20 mM 
 EDTA 100 µM 
 Thesit® 0.05 % (v/v) 
 NaCl 1 M 
 
2.10.4 Determination of Fumarate Reductase-Activity  
 
E. coli FRD activity was assayed under strictly anaerobic conditions according to a protocol 
published earlier (Cecchini et al., 1986). Fumarate-dependent oxidation of reduced benzyl viologen 
was assayed by the decrease of absorption at 550 nm during a time period of 10 min. The standard 
assay mixture had a total volume of 1 ml. For the reduction of benzyl viologen, 20 µl of sodium 
dithionite were added to 980 µl of reaction-buffer. Absorption was measured directly after the 
addition of 7 µg of protein solution. 
 
  
reaction-buffer Tris-HCl pH 8.0 50 mM 
 
EDTA 100 µM 
 
sodium fumarate 20 mM 
 
benzyl viologen 250 µM 
 
  
stock solution sodium dithionite sodium dithionite 10 mM 
 
 
2.11 Production and Purification of recombinant Escherichia coli 
Cytochrome bo Oxidase 
 
To obtain isolated recombinant E. coli cytochrome bo oxidase (Cyo), the E. coli plasmid strain 
GO105 pJRHisA was utilised which is able to recombinantly produce the 4 subunits of Cyo (CyoA, 
B, C and D). In this strain, the sequence for CyoB is fused to a sequence encoding for a His6x-tag 
for purification. The published protocol (Rumbley et al., 1997) was used with minor modifications. 
 
2.11.1 Recombinant Production of Cyo 
 
Fifty ml of LB supplemented with tetracycline and ampicillin were inoculated from a glycerol-stock 
with GO105 pJRHisA and grown overnight at 37 °C and 250 rpm. 2 x 500 ml of LB containing the 
same antibiotics were inoculated with 5 ml of the preculture each and incubated at 37 °C and 200 
rpm. When the culture reached an OD578nm, of 0.6 the cells were harvested (section 2.4.5). 
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2.11.2 Preparation of Membrane Fractions and Solubilisation of Cyo 
 
Sedimented bacterial cells (2.11.1) were suspended in 10 ml of Cyo Buffer and disrupted trice 
(section 2.4.6). Cell debris was removed by centrifugation at 20,000 x g and 4 °C for 20 min. The 
supernatant was subjected to a centrifugation step at 100,000 x g and 4 °C for 1 h and the 
supernatant was discarded. The sedimented membrane fraction was suspended in 10 ml of buffer 
C, stirred for 1 h at 4 °C and centrifuged again at 100,000 x g and 4 °C for 1 h. The obtained 
supernatant was filtered (pore width 0.2 µm) and used for further purification. 
 
 
Cyo buffer  Tris-HCl pH 8 50 mM 
 MgSO4 5 mM 
 benzonase 2 µl 
 Complete mini;  
protease inhibitor cocktail 
1 tablet 
   
buffer C  Tris-HCl pH 8 50 mM 
 Triton® X-100 1 % (v/v) 
 N-octylgucoside 1.25 % (v/v) 
 
2.11.3 Purification of Cyo 
 
Due to the His6x-tag fused to subunit CyoB, an affinity chromatography purification was pursued. 
The protein solution obtained in section 2.11.2 was loaded onto a gravity column wiht a Cv of 1 ml 
Ni-NTA Superflow resin (Qiagen, Hilden, Germany). The resin was equilibrated with buffer D.  After 
loading, it was washed with 4 CV of buffer D. Proteins bound to the resin were eluted with 4 times 
0.5 CV of buffer E. Fractions were analysed by SDS-PAGE (section 2.6.4). Fractions were stored at 
4 °C and -20 °C, respectively.  
 
 
buffer D Tris-HCl pH 8 50 mM 
 Triton® X-100 0.1 % (v/v) 
 NaCl 250 mM 
   
buffer E Tris-HCl pH 8 50 mM 
 Triton® X-100 0.1 % (v/v) 
 NaCl 250 mM 
 imidazole 300 mM 
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2.12 Production and Purification of recombinant Escherichia coli 
Cytochrome bd Oxidase 
 
The E. coli plasmid strain GO105 pTK1 was utilised to obtain recombinant E. coli cytochrome bd 
oxidase (Cyd). The plasmid encodes for both subunits of Cyd. Published instructions were slightly 
modified (Kaysser et al., 1995). 
 
2.12.1 Recombinant Production of Cyd 
 
A glycerol-stock was used to inoculate 50 ml of LB supplemented with tetracycline and ampicillin. 
The cells were grown overnight at 37 °C and 250 rpm.  2 x 500 ml LB containing antibiotics were 
inoculated with 5 ml of preculture each and incubated at 37 °C and 200 rpm. After 24 h, the cells 
were harvested (section 2.4.5). 
 
2.12.2 Preparation of Membrane Fractions and Solubilisation of Cyd 
 
Sedimented bacterial cells (2.12.1) were suspended in 10 ml of Cyd Buffer and disrupted trice 
(section 2.4.6). Centrifugation at 20,000 x g and 4 °C for 20 min removed cell debris. The obtained 
supernatant was again centrifuged at 100,000 x g and 4 °C for 1 h. While the supernatant was 
discarded, the sedimented membrane fraction was suspended in 10 ml of buffer F, stirred for 1 h at 
4 °C and centrifuged again at 100,000 x g and 4 °C f or 1 h. The supernatant was filtered (pore 
width 0.2 µm) and used for further purification. 
 
 
Cyd buffer  Tris-HCl pH 8 50 mM 
 EDTA 15 mM 
 Complete mini;  
protease inhibitor cocktail 
1 tablet 
   
buffer F  Tris-HCl pH 6.8 75 mM 
 EDTA 5 mM 
 KCl 150 mM 
 CHAPS 10 mM 
 
2.12.3 Purification of Cyd 
 
For the purification of the untagged Cyd, anion exchange chromatography on an ÄKTATM-purifier 
system was performed.  
At a flowrate of 1 ml/min, the supernatant obtained in section 2.12.2 was loaded onto a DEAE Fast 
Flow HR 5/5 column with a Cv of 1 ml resin (GE Healthcare, Munich, Germany) which was 
equilibrated with buffer G. After loading, the resin was washed with 5 CV of buffer G. Proteins 
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bound to the resin were eluted with a gradient of 0 - 100 % of buffer H in a total of 20 CV. Aliquots 
of all collected 1.5 ml fractions were analysed by SDS-PAGE  (section 2.6.4). Relevant fractions 
were stored at 4 °C and -20 °C, respectively.  
 
buffer G  Tris-HCl pH 6.8 75 mM 
 EDTA 5 mM 
 KCl 150 mM 
 CHAPS 3 mM 
 
buffer H Tris-HCl pH 6.8 75 mM 
 EDTA 5 mM 
 KCl 500 mM 
 CHAPS 3 mM 
 
2.13 Production, Isolation and Characterisation of Chlorobaculum 
tepidum oxygen-independent Mg-protoporphyrin IX monomethyl 
ester oxidative Cyclase BchE 
 
To obtain recombinant oxygen-independent Mg-protoporphyrin IX monomethyl ester oxidative 
cyclase (BchE) from C. tepidum, E. coli BL21 (λDE3) was transformed with pGEX-6P-1 bchE and 
pGEX6-P-1 bchE His4x. These constructs encode for N-terminal fusion proteins of a glutathione-S-
transferase (GST) tag with the target protein which allows the purification by affinity 
chromatography. 
 
2.13.1 Recombinant Production of BchE 
 
Fifty ml of LB supplemented with ampicillin were inoculated with recombinant  
E. coli BL21 (λDE3) pGEX6-P-1 bchE or E. coli BL21 (λDE3) pGEX6-P-1 bchE His4x (2.1.3) from a 
glycerol stock. The preculture was grown aerobically overnight at 37 °C and 200 rpm. 1 ml of the 
preculture was used to inoculate a 100 ml main culture of LB containing ampicillin which was 
incubated at 37 °C and 200 rpm. After reaching an OD 578nm of 0.6 - 1, recombinant protein 
production was induced by the addition of 500 µM of IPTG. Cells were grown to an OD578nm of 3 
and harvested (2.4.5). 
2.13.2 Isolation of tagged BchE Cyclase 
 
Sedimented bacterial cells were suspended in 25 ml of BchE buffer and disrupted trice (2.4.6). The 
cell lysate was subjected to centrifugation at 120,000 x g and 4 °C for 40 min. The resulting 
supernatant was filtered (pore width 0.2 µm) and loaded onto a gravity column with a Cv of 250 µl 
glutathione sepharose 4 Fast Flow (GE Healthcare, Munich, Germany) equilibrated with buffer K. 
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After loading, the resin was washed with 6 CV of buffer K. Proteins bound to the resin were eluted 
with 6 CV of buffer L. All fractions were stored at 4 °C. 
 
BchE buffer HEPES pH 7.5 20 mM 
 NaCl 500 mM 
 Triton® X-100 0.01 % (v/v) 
 glycerol 20 % (v/v) 
   
PBS: NaCl 137 mM 
 KCl 27 mM 
 Na2HPO4 x 7 H2O 100 mM 
 KH2PO4 20 mM 
   
buffer K 1x PBS  
 glycerol 20 % (v/v)  
   
buffer L Tris-HCl pH 8 50 mM 
 glutathione 10 mM 
 glycerol 20 % (v/v) 
 
2.13.3 PreScission™ Protease Cleavage and second Chromatography 
 
PreScission™ Protease (GE Healthcare, Munich, Germany) specifically cleaves at a certain 
recognition sequence between the GST protein and the target protein. Four units of PreScission™ 
Protease which was also fused to a GST-tag were added to the pooled protein solution (protein 
concentration 500 µg/ml). The cleavage reaction was stirred overnight at 4 °C. 
During cleavage, the protein solution was dialysed against 500 ml of buffer K (section 2.13.2) to 
remove the glutathione. In a second affinity chromatography step on glutathione sepharose, the 
cleaved GST-tag, uncleaved fusion protein and the PreScission™ were removed. 250 µl of 
glutathione sepharose 4 Fast Flow were equilibrated with buffer K and the protein solution was 
loaded. The flow-through containing the target protein BchE was collected and stored at 4 °C. All 
fractions were analysed by SDS-PAGE (section 2.6.4). 
 
2.13.4 Determination of Iron Content 
 
The iron content of recombinant purified BchE was determined colourimetrically with  
o-phenanthroline (Lovenberg et al., 1963). Hundred µl of each protein solution were mixed with 10 
µl of HCl (37 %) and 390 µl H2O. Samples were incubated at 80 °C for 10 min to den ature proteins 
and subsequently cooled on ice for 5 min. Subsequently, 100 µl of a 1 M hydroxylammonium 
chloride solution, 500 µl of an o-phenanthroline monohydrate solution (0.3 % (w/v) in 70 % (v/v) 
ethanol) and 500 µl H2O were added to each sample. Samples were mixed and incubated at RT for 
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30 min. After precipitation of the proteins by centrifugation at 7,000 x g for 10 min, the absorption of 
the supernatant at 512 nm was measured. The iron content of the samples was determined via a 
calibration curve obtained from a series of dilutions of an iron standard (Merck, Darmstadt, 
Germany). 
2.13.5 Chemical Reconstitution of Iron-Sulphur Clusters 
 
To accomplish an optimal incorporation of FeS clusters, an anaerobic chemical reconstitution was 
attempted in accordance to published instructions (Okada and Hase, 2005). For this purpose, 100 
µl of protein solution were mixed with DTT in 50-fold molaric excess and incubated for 10 min. 
Buffer M was added to a final volume of 300 µl. FeCl3 and Na2S were added in 10-fold molaric 
excess and the assay was incubated for 4 h at 17 °C. Af terwards, the assay was dialysed against 
500 ml buffer M and subsequently, UV-Vis spectra (section 2.6.8) were recorded. 
 
 
buffer M Tris-HCl pH 8 50 mM 
 glycerol 20 % (v/v) 
 
2.13.6 Cyclase Activity assays 
 
In order to analyse the activity of oxygen-independent Mg-protoporphyrin IX monomethyl ester 
oxidative cyclase, several different approaches were pursued. The cyclase activity test described 
earlier was used (Gough et al., 2000). 
For in vivo assays, 200 µl of R. capsulatus DSM938 cells (OD578nm of 1, kindly provided by 
Katharina Herbst) were anaerobically supplemented with 8 µM of Mg protoporphyrin IX 
monomethyl ester (MgPME, dissolved in DMSO) and 10 mM of nicotinic acid. The assay was 
incubated for 1h at 17 °C in the dark and centrifuged for 10 min at 10,000 x g and RT. The 
sediment was suspended in stopping solution and centrifuged again. The supernatant was then 
analysed in the luminescence spectrometer and by HPLC. 
To determine the influence of additional components on the activity of oxygen-independent Mg-
protoporphyrin IX monomethyl ester oxidative cyclase, 15 µM of Vitamin B12 or 5 µg of purified 
BchE from C. tepidum were added to the assay. In control reactions, R. capsulatus cells were 
omitted. 
 
For in vitro experiments in a final volume of 200 µl, the assay contained 100 mM of Tris-HCl  
pH 7.5, 30 mM of MgCl2, 10 mM of nicotinic acid, 500 µM of S-adenosyl-methionine, 150 µM of 
Vitamin B12, 8 µM of MgPME, 10 µg of purified BchE from C. tepidum and 0.3 % (v/v) of Triton® X-
100. The assay was anaerobically incubated at 37 °C and  450 rpm for 2 h. Then, 20 µl were 
transferred to 400 µl of stopping solution and centrifuged at 20,000 x g at 4 °C for 5 min. The 
supernatant was analysed via HPLC. 
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In control reactions, MgCl2, nicotinic acid, SAM, Vitamin B12, MgPME, the BchE preparation or 
Triton® X-100 were omitted. Additional controls were supplemented with 8 µM of protochorophyllide 
without the addition of enzyme or MgPME.  
 
stopping solution    acetone    H20 32 % Ammonia 
solution 
ratio  80              : 20              : 1 
 
Settings of the Luminescence Spectrometer 
Excitation Wavelength 440 nm 
Emission Scan Range 500 - 700 nm 
Scan Speed 200 nm/min 
Slit Width for Excitation 5 nm 
Slit Width for Emission 5 nm 
2.13.7 HPLC-Analysis of Cyclase Activity Test Products 
 
For the identification of tetrapyrroles, the reaction products were separated by a 1500 series Jasco 
HPLC sytem. A published separation protocol (Jensen et al., 1999) was used.  
An Ultrasphere ODS (5 µm, 250 x 4.6 mm) C18-reversed phase column (Techlab, Erkerode, 
Germany) was run at 1 ml/min and 30 °C. 20 µl or 50 µl of sample were injected. As eluent A  
0.005 % (v/v) of triethylamine in H20 was used. Eluent B consisted of 100 % of acetonitrile. To 
achieve optimal separation, an elaborate gradient program was developed: 
During a period of 25 min, a gradient from 25 to 40 % of eluent B was applied. Within 2 min, a 
gradient to 100 % of eluent B followed by 8 min of continuous 100 % of eluent B was used to elute 
all retarded compounds. Another gradient was used to return to 25 % of eluent B within 2 min.  
25 % of eluent B were maintained for 8 min to reequilibrate the column.  
Since the tetrapyrroles have different fluorescence characteristics, the fluorescence detector was 
set at an excitation wavelength of 440 nm and an emission wavelength of 635 nm for the first 14 
minutes. After this time period, settings were changed to 420/595 nm. Due to this change, both 
substrate and product could be securely detected within one sample injection. 
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3 Results and Discussion 
 
3.1 Chromatographic purification of oxygen-independent PPO 
from Escherichia coli 
 
The identification of the oxygen - independent PPO of E. coli was one of the central goals 
of this thesis. A classical chromatography strategy was applied to enrich PPO activity 
under anaerobic conditions. Therefore, the established activity test developed by Dr. 
Daniela Breckau was employed (2005). E. coli cells were grown and the cells were lysed. 
For the determination of the anaerobic PPO activity, an anaerobic cell-free extract was 
prepared. In addition to the cell-free extract, the assay contained the substrate proto´gen 
prepared by the chemical reduction of proto. Furthermore, fumarate was applied as 
electron acceptor. 
PPO activity results in the conversion of the colourless proto´gen into the coloured and 
fluorescent proto. The fluorescence emission peaks were detected online with the 
luminescence spectrometer at 633 nm wavelength when an excitation wavelength of 409 
nm is used (fig. 11). 
 
 
Fig. 11: Fluorescence detection of proto formation in cell-free E. coli extracts. 
50 mM TRIS-HCl pH 7.5, 1 mM EDTA, 5 mM glutathione, 0.3 % Triton® X-100, 100 mM NaCl,  
10 µM proto and 10 mM fumarate were mixed with 100 µl of a cell-free E. coli extract in a total volume of 
250 µl and incubated at RT. Fluorescence spectra (exitation wavelength 409 nm) were recorded every 5 
minutes. FU: fluorescence units 
 
 
The assay contains residual amounts of proto (t=0). This is due to incomplete chemical 
reduction of proto during the preparation of the substrate proto´gen. Fluorescence values 
at t = 0 were subtracted from all values obtained thereafter. In most activity tests displayed 
in this thesis, the obtained fluorescence values are indicated as bars. Product 
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concentrations were determined with the help of the calibration curve (fig. 10). The protein 
content of samples was determined by Bio-Rad Protein Assay (Bio-Rad, Munich, 
Germany) and specific PPO activities were calculated where appropiate. 
With this PPO activity test, enrichment of E. coli PPO activity was started by separating 
cytosolic proteins from the membrane fraction. A previously developed protocol for the 
separation of membrane and cytosolic fraction was used. A strong enrichment of PPO 
activity was observed in the membrane fraction after using differential centrifugation in 
combination with a three step sucrose gradient. The membrane fraction was enriched in 
brownish band on top of the 60 % (w/v) sucrose solution.  
While the cell extract had a specific PPO activity of 23 pmol h-1 mg-1 protein,  the 
membrane fraction obtained by the described separation protocol possessed a 
significantly higher specific PPO activity. A specific PPO activity of 114 pmol h-1 mg-1 
protein was observed in fractions prepared using the three-step sucrose gradient (20, 40 
and 60 % sucrose).  
 
To further purifiy the PPO of E. coli, the yet unknown protein had to be extracted from the 
membrane fraction. This can be facilitated by the addition of detergent. In previous 
experiments it was shown that Triton® X-100, Tween® 80 and Thesit® are capable of 
solubilising PPO activitity from the membrane fraction (Breckau, 2005). These detergents 
are mixtures of molecules with differing lengths, hampering subsequent LC-MS/MS 
analysis required for the identification of the protein.  
Therefore, four additional non-ionic detergents were tested, at a concentration of 0.5 % 
(w/v), for their ability to release PPO from E. coli membranes (fig. 12). The compounds 
(undecyl-β-D-maltoside, Digitonin, Cymal 6, and dimethyldodecyl-phosphinoxid) are of 
homogenous composition and should therefore allow for an LC-MS/MS analysis. In 
control experiments either Triton® X-100 or no detergent at all was used in order to 
evaluate the efficiency of extraction by the detergents. 
PPO activity was observed after the extraction with all detergents tested. Interestingly, in 
control experiments where the membrane fraction was stirred in buffer without detergent, 
a high specific PPO activity was detected after extraction as well. The absence of 
detergent in these fractions was a good prerequisite for their further use in LC-MS/MS 
analysis and chromatographic purification steps.  
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Fig. 12: Oxygen-independent PPO activity after solubilisation from cytosolic membranes. 
The PPO activity assay was performed as described (2.7.3) with fumarate. Extractions were performed for  
2 h or as indicated. Used detergents were: Und = undecyl-β-D-maltoside, Dig = Digitonin, Cymal = Cymal 6, 
apo = dimethyldodecyl-phosphinoxid, Triton = Triton® X-100, o/N = overnight. dFU = fluorescence units 
with t = 0 min subtracted from t = 60 min. 
 
 
After extraction of PPO activity without detergent, an anion exchange chromatography on 
DEAE sepharose was performed. The positively charged matrix interacts with negatively 
charged regions occurring on surfaces of proteins. The stepwise increase of salt 
concentrations leads to the interruption of these interactions and the elution of respective 
proteins. The protein fractions obtained were analysed by SDS-PAGE (fig. 13 A) and 
tested for PPO activity (fig. 13 B).  
Detergent 
Percentage 
Time of Treatment 2 h  1 h  2 h  o/N  
without detergent 
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Fig. 13 A: Polyacrylamide gel (12 %) of the proteins obtained after the anion exchange 
chromatography of the solubilised membrane fraction proteins on DEAE sepharose FF.  
Protein fractions of the chromatography were separated by SDS-PAGE, afterwards the gel was stained with 
Coomassie Brilliant Blue. M: Molecular weight marker with relative molecular masses of marker proteins are 
noted at the left. S: solubilised protein sample before chromatography. F: flow through. W: pooled washing 
steps. 100-500: mM concentrations of NaCl in the fractions after chromatography. 
B: PPO activities after DEAE sepharose chromatographic purification.  
The PPO activity assay was performed as described (2.7.3) with TTC as electron acceptor.  
S: solubilised protein sample before chromatography. F: flow through. 100/x-500/x: mM concentrations of 
NaCl in elution fraction x after chromatography. dFU: fluorescence units with t = 0 min subtracted from t = 
60 min. 
 
The SDS-PAGE analysis revealed that most proteins bound to the DEAE material eluted 
at a salt concentrations above 150 mM. In fractions containing ≤ 150 mM NaCl, only few 
proteins were detectable after staining the SDS-PAGE gel with Coomassie Blue. 
However, when tested for PPO activity, the highest activities were observed in fraction 
one eluted with 100 mM NaCl. Significant PPO activity was also detected in the flow 
through fraction. This indicates weak binding of the PPO to the chromatography resin. 
Additionally, PPO activity was observed in all other elution fractions as well. These 
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fractions displayed less than half of the PPO activity when compared to the 100 mM 
fraction. These results might indicate that the PPO extracted from membranes without 
detergent shows no distinct chromatographic behaviour for the employed resin.  
Nevertheless, the majority of PPO activity could be separated from contaminating proteins 
during this purification step. A 1.5 fold enrichment of PPO activity was observed when the 
solubilised and the 100 mM fractions are compared. Twenty µl of the 100 mM fraction 
were applied to an SDS-PAGE and respective lanes were excised. After tryptic digestion, 
the peptide content (see appendix 1) was determined by Dr. Dörte Becher via LC-MS/MS 
analysis (Institut für Mikrobiologie Greifswald, Germany). In this analysis, the peptides of a 
sample are separated by high perfomance liquid chromatography (HPLC) and the 
molecular masses subsequently determined by mass spectrometry.  
Peptide fragments of up to 60 proteins per sample were identified in this analysis. Many 
ribosomal proteins, elongation factor EF-Tu, and few hypothetical proteins were among 
the proteins identified. None of these hypothetical proteins was present in all samples. 
When analysed for their size, the genome context of the corresponding genes or the 
distribution in anaerobic or facultative organisms, all hypothetical proteins had to be 
excluded as candidates for the PPO of E. coli. However, in all analysed fractions, peptides 
derived from HemG were found. HemG was the protein for which the most peptides were 
detected in almost all samples.  
This result supports the proposed participation of HemG in the enzymatic conversion of 
proto´gen to proto described by Sasarman et al. (1993). An additonal protein, assumed to 
be necessary for PPO activity (Panek and O´Brian, 2002), was not found in these 
experiments. Due to these findings it was unclear whether HemG is capable of catalysing 
the PPO reaction alone. To further investigate characteristics of the protein HemG, the 
protein was recombinantly overproduced and purified.  
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3.2 Production and purification of recombinant Escherichia coli 
HemG 
 
E. coli hemG was cloned into the expression vector pET Duet-1 (Novagen, Madison, 
USA) for the recombinant production in E. coli. The vector encodes the fusion protein of 
HemG with an N-terminal polyhistidine-tag (Schröder, 2006). The plasmid mediates 
resistance to ampicillin.  
3.2.1 Overproduction of recombinant HemG in Escherichia coli  
 
The vector pET Duet-1 hemG was transformed (section 2.7.5) into E. coli BL21 (λDE3). 
The recombinant cells were cultivated and HemG production was induced by the addition 
of 100 µM IPTG. The production was monitored by taking samples from the culture at 
defined time points and analysing them by SDS-PAGE. 
 
 
 
Figure 14: Recombinant protein production of E. coli HemG in E. coli.   
Cultures of E. coli BL21 (λDE3) pET Duet-1 hemG were grown at 37°C. Recombinant gene expression was 
induced with 100 µM IPTG. Samples of the cultivation were taken at indicated time points and proteins were 
prepared for SDS-PAGE analysis by lysing the cells by boiling for 5 min in SDS loading dye. The figure 
shows a polyacrylamide gel (12 % (w/v)) of all proteins after separation and staining with Coomassie 
Brilliant Blue. bI: Sample before induction of gene expression by IPTG. 1h, 2h, 3h, 4h: sample taken 1 h, 2 
h, 3 h and 4 h after induction. M: Protein Molecular Weight Marker. The relative molecular masses (Mr x 
1,000) of the marker proteins are given. 
 
Figure 14 shows the recombinant overproduction of HemG. The calculated molecular 
mass of the N-terminal fusion protein (22,127 Da) is in good agreement with the observed 
relative molecular mass of ~ 23,000. 
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It was investigated which effect recombinant overproduction of HemG would have on the 
PPO activity of cell-free extracts. Cells with induced protein production were grown to 
optical densities at 578 nm 0.6, 0.9 and 1.4, respectively. Subsequently, they were 
harvested and disrupted. Then, the standard activity assay was performed. The observed 
activities were compared to PPO activties of E. coli cells harbouring the geneless 
expression vector. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15: PPO-activities of E. coli BL21 (λDE3) after overproduction of homologous HemG.  
PPO-activities of cell lysates of BL21 (λDE3) containing pETDuet-1 (red) were compared to lysates of  
BL21 (λDE3) transformed with pETDuet-1 hemG (blue) overproducing HemG. Recombinant gene 
expression was induced with 100 µM IPTG. Both strains were grown to an OD578nm of 0.6, 0.9, and 1.4, 
respectively. The cells were harvested, lysed and the PPO-activities were recorded for 60 min. TTC was used 
as electron acceptor. dFU: fluorescence units with t = 0 min subtracted from t = 60 min. 
 
In any growth phase, PPO activity was found to be more than 12 times higher in the strain 
overproducing HemG. From these results it was concluded that HemG is essential for 
PPO activity. Either HemG is an essential part of a PPO-catalytic complex where HemG 
concentrations are limiting for the overall PPO activity. Another option is that HemG is 
solely capable to facilitate the PPO reaction in E. coli.  
 
3.2.2 Purification of HemG from Escherichia coli Host Cells 
 
HemG was purified by affinity chromatography to Ni-NTA. Six histidines are located within 
the tag fused to the N-terminus of HemG. Thereby, this tag possesses an affinity towards 
nickel atoms. The metal is immobilized on an inert resin and can thus be used for 
purification of His6x-tagged fusion proteins. Cell-free extract of E. coli recombinantly 
overproducing HemG (section 3.2.1)  was loaded onto the gravity column and stringent 
washing was applied. Proteins retained on the column were eluted by the addition of 
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imidazole. Obtained fractions were analysed by SDS-PAGE (fig. 16 A) and tested for their 
ability to convert proto´gen into proto (fig. 16 B). 
 
 
 
 
 
 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
Fig 16 A: Affinity chromatography of E. coli HemG using Ni-NTA Superflow. 
Fivehundred ml cultures of BL21 (λDE3) pETDuet-1 hemG were grown and recombinant gene expression 
was induced with 100 µM IPTG. Cells were harvested and disrupted anaerobically. The cell-free extract was 
applied to 1 ml Ni-NTA Superflow resin. The column was washed with 6 CV and bound protein was eluted 
with 500 mM imidazole. The picture shows a polyacrylamide gel (12 % (w/v)) of proteins after and staining 
with Coomassie Brilliant Blue. M: Protein Molecular Weight Marker. The relative molecular masses of the 
marker proteins are given. A: Cell-free extract applied to the column. F: flow through. W1-6: Washing steps. 
E1-3: Elution steps. 
B: PPO-activities of fractions from the purification of HemG by affinity chromatography. 
PPO-activities were obtained as described in section 2.7.3. 100 µl of the given purification fractions with 
TTC as electron acceptor were used and the proto formation after 60 min depicted. W4-6: Washing steps 4-6 
of the chromatography. E1-3: Elution steps 1-3 of the chromatography. dFU: fluorescence units with t = 0 
min subtracted from t = 60 min. 
 
As can be observed in the SDS-PAGE analysis of the chromatography (fig. 16 A), HemG 
can be found in the applied sample, but also in the flow through of the column and the 
washing steps. This indicates that a considerable amount of HemG is not retained on the 
column. It was speculated that the His6x-tag is not readily accessible to bind to the nickel 
atoms of the resin but might be concealed by amino acid residues of the HemG protein.  
M  A   F   W1 W2  W3W4 W5 W6  E1  E2  E3       Mr x1,000 
 
116 
 
66.2 
 
45 
 
35 
 
25 
 
0
50
100
150
200
250
300
W4 W5 W6 E1 E2 E3
dF
U
HemG 
Results and Discussion 
 57 
Nevertheless, HemG was found in the elution fractions (E1 - 3). Apparently, the His6x-tag 
of HemG has been properly bound to the affinity matrix in a subset of protein molecules. 
When the mentioned fractions where analysed for PPO activity (fig. 16 B), significantly 
higher activities where found in the elution fractions compared to the washing steps. The 
observed PPO activity correlates with the observed HemG protein amount in the SDS-
PAGE gel. Since the elution fractions still contain several contaminating host proteins, it 
was not clear wether the HemG protein is capable of catalysing the PPO reaction by itself. 
In the case that a putative multi-subunit PPO exists in E. coli , the affinity of HemG to this 
PPO complex would have to be strong enough that the PPO complex remains intact upon 
purification.  
 
In order to find proteins that possibly interact with HemG, the elution fractions obtained 
were analysed for their protein content by LC-MS/MS. Again, ribosomal proteins and the 
elongation factor EF-Tu were found in the samples (appendix 2). Interestingly, fumarate 
reductase and cytochrome bd oxidase subunits were found with many peptides. Fumarate 
reductase and cytochrome bd oxidase are part of the respiratory system of E. coli. 
Fumarate reductase has been postulated by Breckau (2005) and Jacobs and Jacobs 
(1975) to be involved in the electron transfer to fumarate. 
 
To finally determine if HemG is the E. coli PPO, a protein production strategy had to be 
established in a host devoid of such anaerobic PPO system. In our group, the genome 
project “Bacillus megaterium” was started in 2006. The newly available genome sequence 
of this organism revealed a homolog of the hemY gene, but no orthologous gene 
sequence for hemG. Over the years our lab has gained solid experience with this protein 
production system (Biedendieck 2007), making B. megaterium a prime candidate for this 
strategy. 
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3.2.3 Cloning of hemG into Bacillus megaterium Expression Vectors 
 
Two different hemG DNA sequences were used for cloning into B. megaterium expression 
vectors: the original E. coli hemG sequence which was obtained by PCR from the E. coli 
expression vector pETDuet-1 hemG. However, it is known that protein production in  
B. megaterium is sensitive to the codon usage of the target gene (Yang et al., 2007). The 
correlation of the codon occurence within the target gene and the preferred codons of the 
host is indicated as the “codon adaptation index” (CAI). This value can range from 0 (no 
similarity) to 1 (identical codon usage). It was found that recombinant genes with a CAI 
below 0.3 are not expressed in significant amounts in B. megaterium. The original E .coli 
hemG DNA sequence showed a CAI of 0.25. The DNA sequence of hemG was optimised 
with regard to its codon usage for the protein production in B. megaterium with the 
program JCAT (www.jcat.de). The new CAI was 0.99. The artificial hemG gene was 
generated by GeneArt (Regensburg, Germany) encoding for the original amino acid 
sequence of HemG. Both sequences were inserted into expression vectors by the SphI 
and BglII restriction sites. The constructs will lead to recombinant HemG fused to an N- or 
C-terminal His6x-tag. Protoplasts of B. megaterium WH323 were transformed with the 
resulting constructs as described in section 2.5.9. 
 
3.2.4 Overproduction of Escherichia coli HemG in Bacillus megaterium 
 
Recombinant B. megaterium cells either harbouring the original E. coli hemG or the 
artifical hemG were grown in 100 ml cultures. Recombinant protein production was 
induced by the addition of 0.5 % (w/v) of xylose. Proteins of samples taken from the 
cultures 1, 2, and 3 h after induction were analysed by SDS-PAGE (fig. 17). The 
occurrence of a protein with a size corresponding to the calculated size (Mr = 24,500) of 
HemG was observed in strains carrying the artificial gene, but not in cells harbouring the 
original E. coli hemG. It was concluded that HemG cannot be efficiently produced using 
the latter constructs. As mentioned in 3.3.3, this might be due to the low CAI of the original 
hemG gene for the host B. megaterium. 
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Fig. 17: Production of recombinant E. coli HemG in B. megaterium. 
Proteins of 1 ml samples of 100 ml cultures of recombinant B. megaterium were analysed by SDS-PAGE. 
The picture shows a 12 % polyacrylamide gel of prepared proteins after separation and staining with 
Coomassie Brilliant Blue. bI: Sample before induction of gene expression by 0.5 % (w/v) xylose. 1h, 2h, 3h: 
sample taken 1 h, 2 h and 3 h after induction. M: Protein Molecular Weight Marker. The relative molecular 
masses (Mr x 1,000) of the marker proteins are given. 
 
3.3 Verification of PPO activity for Escherichia coli HemG 
 
After production of HemG, the recombinant Bacillus cells were harvested and disrupted to 
analyse the lysates for anaerobic PPO activity with TTC as electron accceptor. In addition 
to the constructs described, a strain containing a vector without target gene was tested as 
a negative control. For this control, O2-independent PPO activity was not detectable (fig. 
18). This is consistent with the genetic backround of B. megaterium (3.2.2) with no 
orthologous hemG sequence. The strain containing the vector with the original hemG 
DNA sequence showed no anaerobic formation of proto. However, in the strain 
overproducing HemG from the artificial codon usage optimised gene, a strong and clearly 
detectable formation of proto could be observed . 
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Fig. 18: Anaerobic PPO activity in B. megaterium strains harbouring no, the original or the artificial 
codon usage optimised hemG genes. 
Standard PPO activity tests were performed with 100 µl of cell lysate and TTC. green: B. megaterium 
transformed with pN-His1622 (control). blue: B. megaterium transformed with pN-His1622 hemG (original). 
red: B. megaterium transformed with pN-His1622 hemG (artificial). FU: fluorescence units 
 
The results indicate that the HemG protein is capable of the conversion of proto´gen to 
proto in cellular extracts of B. megaterium.  Therefore, HemG is concluded to be the PPO 
of E. coli. Although it has been speculated for many years about the participation of HemG 
in this reaction (Panek and O'Brian, 2002; Sasarman et al., 1993), this is the first time 
such a biochemical evidence is provided.  
The prescence of HemG is not limited to E. coli, it can be found in all Enterobacteriaceae 
such as Salmonella, Yersinia and Vibrio species. It is also found in anoxygenic 
phototrophs such as Rhodobacter sphaeroides. It has been reported that R. sphaeroides 
couples the oxidation of proto´gen to the electron transport chain (Jacobs and Jacobs, 
1981), thus presumably producing functional HemG. All these organisms have a demand 
for tetrapyrroles under oxygen-restricted conditions.  
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3.4 Purification of recombinantly produced Escherichia coli PPO 
 
After demonstrating that HemG is the PPO of E. coli, the enzyme was to be biochemically 
characterised. For this purpose, HemG was purified after overproduction in B. megaterium 
using the artificial codon optimised hemG sequence. 
3.4.1 Purification of recombinant HemG by Affinity Chromatography 
 
The construct pC-His1622 hemG (codon optimised) encoding for a C-terminal fusion 
protein of HemG and a His6x tag was utilised for all further purifications. Figure 19 displays 
the affinity purification via Ni-chelating resin and the stability of HemG in solution over 
time. 
 
 
Fig. 19: Affinity purification of HemG-His after production in B. megaterium  
B. megaterium cells transformed with pC-His1622 hemG (codon optimised) of a 400 ml culture were used 
for the purification. The figure shows a 12 % polyacrylamide gel of proteins after separation and staining 
with Coomassie Brilliant Blue. M: Protein Molecular Weight Marker. The relative molecular masses of the 
marker proteins are given. A: Sample applied to the purification. F: flow through. W5: Washing step 5. E1-3: 
Elution steps. 1d, 2d, 5d : HemG 1, 2 and 5 days anaerobically incubated at the temperatures given. 
 
With this protocol, high amounts of HemG were purified. The obtained elution fractions 
were yellow in colour and showed a very high PPO activity. However, purified HemG was 
unstable and prone to degradation.  After 5 days at 17 °C, full length HemG was no longer 
visible in SDS gels stained with Coomassie Brilliant Blue. A decrease in HemG content in 
the fractions was also noted when the protein was stored at 4 °C. Therefore, it was stored 
at -20 °C. Here, only a slight reduction of HemG was ob served. As can be deduced from 
figure 19, HemG was not purified to homogeneity by this purification step. Therefore, a 
subsequent gel permeation chromatography was performed.  
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3.4.2 Gel Permeation Chromatography  
 
Gel permeation chromatography (GPC) separates proteins by their native state size. Big 
proteins get eluted first, while small proteins are retarded longer. A column was applied 
which is suitable for proteins with a Mr of 10,000 to 600,000. First attempts were 
unsuccessful due to the elution of HemG in the void volume (7.7 ml), which indicates a Mr 
of the protein above 600,000. Since HemG has a calculated Mr of 24,500 for a single 
peptide, the protein seemed to form large aggregates in solution (fig. 20). After the 
addition of the detergent Thesit®, HemG could be eluted within the separating range of the 
column (14.37 ml).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20: Gel permeation chromatography of HemG 
Hundred µl of HemG solution (2 mg/ml) were loaded on a Superdex 200 HR 10/30 column and eluted with 
buffers containing no detergent (grey) or 2 % Thesit® (black), with the absorption at 280 nm wavelength 
being recorded. Without detergent, high molecular weight complexes (Mr > 600,000) of HemG were eluted 
in the void volume of the column (V0 = 7.7 ml). After the addition of 2 % Thesit®, HemG was eluted in the 
separating range of the column (14.37 ml).  
 
It seems possible that HemG possesses hydrophobic regions which are responsible for 
the association to the membrane. Consequently, due to these regions HemG is prone to 
aggregation if not masked by detergent molecules. HemG was isolated from B. 
megaterium host proteins by this second purification step as judged by SDS-PAGE  
(fig. 21).  
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Fig. 21: Summary of purification steps performed to isolate HemG 
The picture shows a 12 % polyacrylamide gel of proteins after separation and staining with Coomassie 
Brilliant Blue. M: Protein Molecular Weight Marker. The relative molecular masses of the marker proteins 
are given. A: B. megaterium cell extract. E2: Elution fraction 2 of affinity chromatography. 29: fraction 29 of 
GPC. 
 
3.5 Electron Transfer from HemG in vitro 
 
The O2-dependent PPO, HemY, directly transfers electrons evolving from the reaction 
onto molecular oxygen. In this study, it was to be determined which electron acceptors are 
utilised by HemG. Since HemG could be successfully isolated, investigations concerning 
direct and terminal electron acceptors were performed. 
3.5.1 Direct Electron Acceptors for the HemG catalysed Reaction 
 
To investigate which compounds are capable of directly taking up electrons from HemG, 
activity tests containing HemG and the substrate, proto´gen, together with several 
chemicals were performed. Fumarate, nitrate, oxygen, and TTC, but also menaquinone 
(MQ) and ubiquinone (Q1) were shown to be electron acceptors of the PPO reaction if 
HemG purified from E. coli was used (fig. 22). The utilisation of quinones (MQ an Q1) fits 
well with earlier proposals (Jacobs and Jacobs, 1976). The applied HemG-fraction was 
contaminated with proteins of the E. coli host, among them subunits from fumarate 
reductase (section 3.3.1). It was assumed that activities observed with fumarate, nitrate 
and oxygen derive from the corresponding, co-purified terminal oxidases of E. coli.  
HemG purified from B. megaterium was devoid of PPO activity with fumarate and nitrate, 
but capable of oxidising proto´gen with oxygen, MQ, Q1 and TTC. It is tempting to assume 
that these molecules are indeed direct electron acceptors. However, it should be noted 
that the B. megaterium genome possesses open reading frames (ORF_5403 and 
ORF_6607) with high homologies to cydA and cydB of Bacillus subtilis, which encode 
cytochrome bd oxidase subunits. It might be possible that minor amounts of cytochrome 
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oxidase of B. megaterium adhere to E. coli HemG during the purification process. This 
would explain the reproducible utilisation of oxygen as electron acceptor. If HemG uses 
oxygen directly or the respiratory chains of B. megaterium are used cannot be elucidated 
with these experiments. Therefore, only MQ, Q1 and TTC were assigned with certainty as 
direct electron acceptors of HemG. 
 
 
Fig 22: Electron acceptors for the PPO reaction catalysed by E. coli HemG 
The PPO activity assay was set up and started as outlined in 2.7.3. 30 pmol of purified HemG prepared from  
E. coli or B. megaterium were applied. The electron acceptors were added in the concentrations given. dFU: 
fluorescence units with t = 0 min subtracted from t = 60 min. 
 
3.5.2 Production and Purification of Terminal Oxidases  
 
Next, the role of the terminal oxidases for the PPO reaction was investigated. To 
accomplish this, four E. coli terminal oxidases had to be purified and subsequently applied 
to an in vitro activity assay. 
  
Fumarate Reductase 
Fumarate reductase (FRD) was purified by FPLC as described by Luna-Chavez et al. 
(2000). DW35 pH3 cells overproducing FRD where cultivated in glycerol-fumarate-
medium and harvested. After cell disruption, membrane fractions were prepared and FRD 
extracted with the help of the detergent Thesit®. The solubilised proteins were subjected to 
an anion exchange chromatography on DEAE sepharose. Analysis of these fractions by 
SDS PAGE visualised all subunits (FrdABCD) of the fumarate reductase (fig. 23).  
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Fig. 23: FPLC purification of E. coli fumarate reductase 
The pictures shows a 12 % polyacrylamide gel of proteins after separation and staining with Coomassie 
Brilliant Blue. M: Protein Molecular Weight Marker. The relative molecular masses of the marker proteins 
are given. A: E. coli DW35 pH3 cell extract. F: flow through.  
 
After FPLC purification, obtained fractions were brown in colour, indicating the presence 
of a Fe-S-cluster described for subunit B (Luna-Chavez et al., 2000). The fractions where 
tested for the ability to reduce fumarate. In the assay, reduced benzyl viologen acts as 
electron donor. The molecule is coloured in this fully reduced state, but loses this property 
when oxidised. Applied to the assay, the purified fractions exhibited high fumarate 
reductase activity observable in the decrease of absorption (fig. 24). 
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Fig 24: E. coli fumarate reductase activity test 
The activity of fumarate reductase was assayed anaerobically as described before (Cecchini et al., 1986). 
First, benzyl viologen (250 µM) is reduced by Na-dithionite (10 mM). Then, purified fumarate reductase (7 
µg) is added and the photometric detection started. Reduced benzyl viologen is oxidised by fumarate 
reductase. Electrons abstracted from benzyl viologen are transferred to fumarate (20 mM). During the 
reaction, absorption at 550 nm wavelength decreases, which was monitored for 10 min. AU: Absorbtion 
units. 
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Cytochrome Oxidases 
Cytochrome bo and bd oxidase (Cyo and Cyd, respectively) were purified as described 
(Rumbley et al., 1997; Kaysser et al., 1995). E. coli cells overproducing one or the other 
oxidase where grown and harvested aerobically. Membrane fractions were prepared and 
the enzymes  extracted either by the detergents Triton® X100 and N-octylglucoside or by 
the detergent CHAPS. Since subunit II of Cyo (CyoB) was fused to a His6x-tag, an affinity 
purification of the Cyo complex was performed on Ni-NTA Superflow. Cyd had to be 
obtained by anion exchange chromatography to DEAE sepharose.The fractions of the 
purifications were analysed via SDS-PAGE (fig. 25). In this analysis, three of four subunits 
of cytochrome bo oxidase (CyoABCD) and both subunits of cytochrome bd oxidase 
(CydAB) were visible. 
 
 
 
 
Fig. 25: Purification of Cytochrome bo and bd Oxidase 
The picture shows a 12 % polyacrylamide gel of the proteins after separation and staining with Coomassie 
Brilliant Blue. Cyo: Cytochrome bo oxidase elution fraction 3. Cyd: cytochrome bd oxidase fraction 7 - 9. M: 
Protein Molecular Weight Marker. The relative molecular masses of the marker proteins are given. Observed 
proteins with relative molecular weights corresponding to Cyo or Cyd subunits are marked at the left. 
 
Nitrate Reductase 
Nitrate reductase NarGHI was kindly provided by Rodrigo Arias, CNRS, Marseille, France. 
The newly established protocol for the purification of Nar included the preparation of 
membranes and the extraction of the enzyme with the help of the detergent DDM. 
Currently it is under review to be published. 
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3.5.3 Application of the Terminal Oxidases in PPO in vitro Assays 
 
The obtained E. coli terminal oxidases were each tested for the ability to take up electrons 
from quinones and transferring these electrons onto the terminal electron acceptor. Each 
terminal oxidase and the corresponding terminal electron acceptor were added to HemG 
purified from B. megaterium. 
MQ was applied to assays containing fumarate reductase and nitrate reductase, while the 
assays with cytochrome oxidases were each supplemented with the ubiquinone Q1. Since 
it was shown that quinones act as electron acceptors for the PPO reaction (3.5.1) when 
present in surplus (90 µM), the concentration of the quinones was lowered (1.8 µM). 
Hence, only minor proto formation should be observed when the electron flow terminates 
at the reduced quinones. In order to allow for significant proto formation, the quinones 
need to enter a cycle of being reduced by HemG and being oxidised by the terminal 
oxidases. In this type of assay, the quinones would act as electron “shuttles”, as described 
for the natural respiratory system. 
Since all the applied terminal oxidases have been reported to possess associated 
quinones and prosthetic groups, they were deemed capable of acting as electron 
acceptors as well. Thus they were applied in equimolar concentrations to HemG.  
It was expected that proto formation should only occur when the terminal oxidases are 
functional in the PPO reaction. The reaction was started by the addition of proto´gen and 
the formation of proto was determined after one hour by fluorescence spectrometry  
(fig. 26). 
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Fig. 26: Terminal oxidases tested for the participation in the E. coli PPO reaction catalised by HemG. 
The assay outlined in section 2.7.3 was performed with 30 pmol of HemG and 30 pmol of the specified 
oxidase. The corresponding terminal electron acceptor (10 mM fumarate, nitrate or for cytochrome oxidases: 
air) and 1.8 µM of menaquinone or ubiquinone, respectively, were added. 10 µM proto´gen was applied to 
start the assay and the formation of proto was recorded after 60 min. dFU: fluorescence units with t = 0 min 
subtracted from t = 60 min. w/o : without. 
 
All terminal oxidases tested assisted HemG in the electron dissipation from proto´gen 
towards terminal electron acceptors (fig. 26). Variation in total activities was attributed to 
the quality of the preparation and kinetic properties of the terminal oxidases. Controls 
missing the terminal electron acceptor revealed significantly decreased PPO activity. If the 
assay was devoid of HemG, no activity was detectable. This indicated that neither 
terminal oxidase nor terminal electron acceptors oxidise proto´gen by themselves.  
Under these conditions, the utilisation of oxygen by HemG fractions purified from B. 
megaterium (3.6.1) was insignificant. As mentioned above, good aerobic proto formation 
is only observed in the presence of Cyo and Cyd, respectively.  
Interestingly, the overall PPO reaction seems to be sensitive to inhibition by 
pentochlorophenol (PCP). While assays containing Cyo and Cyd were moderately 
affected (52 and 47 %), tests with fumarate reductase and nitrate reductase were severely 
reduced in proto formation (73 % and 94 %, respectively). PCP is a compound known to 
efficiently occupy the quinone binding sites of some terminal oxidases (Bertero et al., 
2005). Further, omitting quinones from the assay only partially reduces the PPO activity in 
some cases. For example, in the control experiment containing the terminal oxidase Cyo 
without the addition of quinone Q1, still 81 % of proto was formed. As mentioned before, 
terminal oxidases have quinones associated to the membrane-spanning subunits. These 
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quinones seem to adhere to the oxidases during purification. For instance, the solved 
crystal structure of fumarate reductase purified by the same protocol displays 
menaquinone in subunits D and C (Iverson et al., 1999).  
Taken together, the results indicate the utilisation of the qinones associated to terminal 
oxidases. For the transfer of electrons to these quinones a physical interaction of HemG 
and the oxidases seems to be necessary. The prescence of fumarate reductase and 
cytochrome bd oxidase subunits in HemG purifications from E. coli (section 3.2.1) and 
observed activities with corresponding terminal electron acceptors (section 3.5.1) confirm 
this proposal.  
 
3.6 In vivo studies of Escherichia coli mutants 
 
To confirm the results of the in vitro experiments, additional in vivo experiments were 
performed. Cell lysates of E. coli mutants deficient in terminal oxidases were to be 
investigated for their PPO activity. First, the strains were grown under conditions allowing 
for efficient cell growth of the mutants. Afterwards, the cultures were shifted to growth 
conditions which allow for a strong phenotype expression. E. coli DW35, deficient in the 
fumarate reductase, was first grown to an OD578 nm of 2 under aerobic conditions. Then, 
this mutant was incubated anaerobically in medium supplemented with fumarate. 
JCB4023, deficient in functional nitrate reductase, was treated accordingly. Mutants of the 
cytochrome oxidases (DS253, FB20172 and FB 20228) where first grown anaerobically 
and then shifted to aerobic growth. The capability to form proto was compared to E. coli 
BL21 (λDE3), the wildtype strain, grown under the same conditions (fig. 27).  
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Fig 27: PPO activities in E. coli mutants deficient in components of the respiratory chains.  
The activity assay were performed with cell-free extract of the respective strain containing 100 µg whole 
protein. 10 mM fumarate and 10 mM nitrate were used as electron acceptors in anaerobic assays. To test 
wether O2 could be utilised as electron acceptor, aerobic assays were performed. To start the reaction, 10 µM 
proto´gen was applied and the assays incubated in the dark for 60 min at RT. The product formation was 
monitored by luminescence spectrometry. The excitation and emission wavelength were set at 409 nm and 
633 nm, respectively. dFU: fluorescence units with t = 0 min subtracted from t = 60 min 
 
With these experiments, the results of the in vitro experiments could be confirmed. All 
mutants deficient in terminal oxidases were reduced in PPO activity when tested with the 
corresponding terminal electron acceptor. However, only in the case of the Cyo/Cyd 
double mutant, PPO activty was completely abolished. Mutants deficient in either Cyo or 
Cyd retained 73 % and 88 % of wildtype activity. It was speculated that the PPO electron 
flow towards oxygen remains largely intact as long as one cytochrome oxidase is present 
in the cell.  
The mutants deficient in fumarate reductase or nitrate reductase are capable of 
performing PPO activity to some extent (59 % and 53 % of wildtype activity, respectively) 
as well. It is possible that the remaining terminal oxidases (e.g. in DW35: Cyo, Cyd and 
nitrate reductase) take up electrons and transfer them to residual amounts of terminal 
electron acceptors (e.g. in DW35: O2 and nitrate). This PPO activity seems to be 
independent of the electron acceptor added in the experiment.  
The observation that mutants deficient in components of the electron transfer chains 
downstream of HemG are still able to perform the PPO reaction unambigiously underlines 
the redundancy of these respiratory chains in E. coli. The transfer of electrons into the 
respiratory chains allows E. coli to synthesize heme under a variety of environmental 
conditions.  
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3.7 Characterisation of Escherichia coli HemG 
 
Besides the elucidation of electron “disposal” from the reaction, HemG was biochemically 
investigated.  
3.7.1 Size of native enzyme  
 
The purification principle of GPC is the separation of proteins by their native size. 
Therefore, this method can also be utilised to analyse the oligomeric state of HemG. A 
calibration curve with the elution volumes of marker proteins (cytochrome c from bovine 
heart: 18.27 ml; carbonic anhydrase: 17.29 ml; bovine serum albumin: 15.37 ml; alcohol 
dehydrogenase from yeast: 14.77 ml) was prepared. Then, the native molecular weight 
was estimated from the elution volume of HemG (14.44 ml; fig. 28).  
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Fig. 28: GPC calibration curve with marker proteins 
Marker proteins were loaded onto a Superdex 200 HR 10/30 column (GE Healthcare) and eluted with 50 mM 
of HEPES pH 7.5, 300 mM of NaCl, 20 % (v/v) of glycerol and 2 % of Thesit® (v/v) at a flow rate of 0.5 
ml/min. The column was equilibrated with marker proteins of known relative molecular weight (Mr): 
Cytochrome c from bovine heart with 12,400, carbonic anhydrase with ~29,000, bovine serum albumin with 
~66,200 and alcohol dehydrogenase from yeast with ~150,000 relative molecular mass. HemG eluted at a 
volume of 14.44 ml, which corresponded to a relative molecular weight of ~150,000. 
 
 
With the help of the calibration curve, a Mr of 150,000 for the native HemG was 
calculated. Since a monomer of HemG-His6x-tag fusion protein has a calculated mass of 
24,500, a hexameric composition of E. coli PPO was implicated. For HemY a formation of 
a homodimer in several organisms is described (Corradi et al., 2006; Koch et al., 2004), 
with each monomer possessing an active site. It remains to be elucidated if each HemG 
monomer is coordinating one substrate molecule or if hexameric HemG is able to bind 
one proto´gen molecule. 
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3.7.2 Identification of the HemG Cofactor 
 
As mentioned in section 3.5.1, purified HemG appears yellow in colour. UV-Vis spectra 
from the protein (fig. 29) showed peaks at 366 and 433 nm wavelength typical for flavin 
cofactors such as FMN and FAD (Craig et al., 2001; Kleiner et al., 1999). Interestingly, the 
UV-Vis spectrum featured an additional peak at a wavelength of 412 nm which could 
derive from a bound tetrapyrrole (Dailey and Dailey, 1996). The HemG protein was 
precipitated by the addition of trichloric acid (TCA) to find out if the putative flavin is 
covalently or noncovalently bound to HemG. The molecule responsible for the flavin 
spectrum remained in the supernatant after precipitation. This indicated a noncovalent 
binding of the compound. 
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Figure 29: Spectral analysis of HemG for cofactor characterisation 
A UV-Vis spectrum of purified HemG with elution buffer as background was recorded (A). Protein was 
precipitated by trichloric acid and the supernatant was analysed again (B). The spectra indicate the presence 
of a flavin cofactor, with characteristic peaks at 366 and 433 nm for the investigated supernatant.   
 
To determine which flavin was utilised as cofactor by HemG, HPLC analysis was 
performed. Here, molecules are separated due to their hydrophobicity and elute from the 
column at specific retention times. Authentic standards of FAD and FMN had retention 
times of 7.5 and 10.1 minutes, respectively (fig. 30). 
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Figure 30: HPLC analysis of the FMN cofactor of HemG  
HemG was precipitated by the addition of 5 % (v/v) of perchloric acid and a following centrifugation at 
10,000 x g. Fifty µl of the obtained supernatant were injected on an ODS Hypersil 250 x 4.6 mm column. 
Flavins were detected by fluorescence measurements (Ex.: 430 nm; Em.: 525 nm). Authentic standards of 
FAD and FMN showed retention times of 7.5 and 10.1 minutes, respectively. The flavin bound to HemG 
eluted at the retention time of FMN. FU: Fluorescence units. 
 
The flavin of HemG was found to have the identical retention time as determined for the 
FMN standard. This revealed that FMN was a cofactor noncovalently bound to HemG. In 
most investigations of HemY, a noncovalently bound FAD was found associated to the 
enzyme (Koch et al., 2004). FMN can reversibly take up two electrons and two protons, 
leading to FMNH2. Therefore, it is involved in electron transfer reactions (Goni et al., 2008; 
Kim et al., 2007).  
 
3.7.3 Kinetic Parameters of HemG 
 
Kinetic data were obtained for the wildtype PPO of E. coli. To investigate the affinity to its 
substrate proto´gen, the Michaelis Menten constant KM was determined for HemG. The 
maximal velocity Vmax was determined as well. This was achieved by measuring the initial 
constant velocity of protoporphyrin IX formation from protoporphyrinogen IX over a 
substrate range from 2.3 to 92 µM of proto’gen. Interestingly, the use of amalgam-reduced 
substrate resulted in a lag phase of up to 120 sec before reaching maximum turnover 
rates. Additionally, the velocity of the reaction decreased with substrate concentrations 
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above 3 µM (fig. 31 A). This phenomenon was ascribed to the potential toxicity of trace 
amounts of amalgam in the substrate solution. By using substrate reduced by molecular 
hydrogen and palladium (Phillips, 2007), a Michaelis Menten kinetic was observed (fig. 31 
B). Hence, only the kinetic data obtained from latter assays was used to calculate KM and 
Vmax. 
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Fig. 31: Kinetics of the proto formation by E. coli PPO  
The formation of proto was monitored with the luminescence spectrometer with the excitation and emission 
wavelength set at 409 and 633 nm, respectively. 400 nM HemG and 180 µM menaquinone as electron 
acceptor were applied. A: Amalgam-reduced substrate applied in the concentrations given. B: Utilised 
substrate was reduced by molecular hydrogen and palladium (Phillips, 2007). Data generated with the latter 
assays was used for the calculation of  KM and Vmax. FU: fluorescence units. 
 
The ratio of substrate concentration/velocity against the substrate concentrations was 
plotted in a Hanes-Woolf-diagram and linear regression was applied (fig. 32). KM values 
were calculated to be 17.3 µM. The affinity towards the substrate was 15 times lower 
when compared to tobacco HemY (KM of 1.17 µM). On the other hand, the calculated 
maximal velocity Vmax of HemG of 16 µM min-1 mg-1 is 4-fold higher than that of tobacco 
HemY with 4.27 µM min-1 mg-1. 
Fig. 32: Hanes-Woolf-plot of initial velocities of the PPO reaction with hydrogen-reduced substrate  
The initial velocity of proto formation was determined over a broad range of proto´gen concentrations using 
the outlined PPO assay and saturating concentrations for the residual substrates (fig. 31). Proto formation 
followed Michaelis-Menten kinetics. The apparent Km for proto´gen was 17.3 µM, Vmax was determined to be 
16 µM min−1 mg−1. [S]/V: substrate concentration to velocity ratio.  
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Interestingly, mutants of tobacco HemY had turnover rates above the wildtype enzyme, 
indicating that wildtype HemY could have higher turnover rates (Heinemann et al., 2007).  
A high PPO activity would lead to the accumulation of proto which cannot be instantly 
converted by the following enzyme, ferrochelatase. Proto is a molecule that can act as a 
photosensitiser by generating singlet oxygen in the prescence of light. Singlet oxygen 
causes lipid peroxidation and cell death (Lermontova and Grimm, 2006). Consequently, 
one might expect that only minimal amounts of proto exist within the cell.  
On the other hand, slowing down or stopping PPO activity, e.g. by inhibitors (sections 
1.4.1 and 3.7.4), leads to the nonenzymatical accumulation of proto (Lermontova and 
Grimm, 2006). It is generated from proto´gen due to a spontaneous reaction with 
molecular oxygen.  
These findings indicate that accumulation of both substrate or product may harm the 
organism in which they occur. A balance of PPO activity between coproporphyrinogen III 
oxidase (HemN or HemF) and ferrochelatase activities might be essential to prevent cell 
damage. 
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3.7.4 Inhibitors of HemG 
 
There are known inhibitors for HemY, some of which are used as herbicides. Of these 
herbicides, acifluorfen is the best investigated (Corradi et al., 2006).  Inhibitory properties 
for bilirubin, a linear tetrapyrrole, have been reported as well (Ferreira et al., 1988). To 
investigate if acifluorfen or bilirubin function as an inhibitor of HemG-catalysis as well, 
these compounds were applied to the PPO activity assay. 
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Fig. 33: PPO assay with the potential inhibitors bilirubin and acifluorfen 
The PPO assay with 100 nM of HemG, 90 µM of menaquinone as electron acceptor and 10 µM of proto´gen 
was performed as described in section 2.7.3. The inhibitors were applied in the given concentrations. dFU: 
fluorescence units with t = 0 min subtracted from t = 60 min. 
 
 
The obtained data clearly indicate that HemG, in contrast to HemY, is not inhibited by 
acifluorfen. In fact, a reproducible enhancement of the PPO activity was observed. It is 
uncertain why acifluorfen has this stimulating effect. Bilirubin has the same influence on 
HemG as described for HemY (Ferreira et al., 1988). At a concentration of 50 and 250 µM 
bilirubin PPO activity showed a reduction of 45 % and 77 % in the assays. As a 
tetrapyrrole, it might better mimic the substrate than acifluorfen, a diphenyl ether. It may 
therefore efficiently block the substrate binding pocket of HemG. Taken together, these 
results might point towards a different architecture of the active site of HemG in 
comparison to that of HemY.  
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3.8 Model of the Escherichia coli PPO and the Electron Flux to 
Electron Acceptors  
 
From these results a model for the electron flow of the PPO reaction in E. coli was 
assembled (fig. 34). HemG  enzymatically converts proto´gen to proto, probably via 
hydride transfer to FMN. From this flavin, the electrons are transferred to quinones. These 
can be floating freely in the membrane or might be directly associated to terminal 
oxidases. Six electrons need to be abstracted from proto´gen, but one quinone can only 
accept two electrons. The quarternary structure of HemG offers the possibility that 
multiple quinone molecules are oxidised simultaneously. Electron uptake from terminal 
oxidases recycles the quinones. Under anaerobic conditions, electrons are dissipated to 
the terminal electron acceptors fumarate and nitrate by the respective reductases. When 
oxygen is present, it is used as electron acceptor via cytochrome oxidases. This renders 
the E. coli PPO system, with HemG in its center, dependent on oxygen under these 
conditions. Therefore it is proposed to term the E. coli PPO as  “electron transfer chain 
coupled PPO”. 
 
 
 
Fig. 34: Model of E. coli PPO and the electron flux 
 
FMN 
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 As a consequence, a proton motive force can be generated at the terminal oxidases 
during the conversion of proto´gen to proto in organisms possessing the HemG-class of 
PPO´s. Fumarate reductase does not move protons from the cytoplamic to the 
periplasmic side of the membrane in E. coli. However, emerging succinate can used in the 
citric acid cycle, therefore directly coupling the anabolic cofactor biosynthesis (heme 
biosynthesis) to the catabolism. This is an energetic advantage compared to the HemY-
class of PPO´s. In the HemY-mediated reaction, the reducing power is simply lost by 
transferring electrons directly to oxygen. Additionally, the evolving hydrogen peroxide 
needs to be detoxified (Koch et al., 2004). 
The fact that E. coli utilises nitrate reductase and cytochrome oxidases for the synthesis of 
heme is noteworthy since these enzymes require heme as cofactor (Lanciano et al., 2007; 
Zhang et al., 2004). For the E. coli system it becomes apparent that at least one of the 
quinol oxidoreductases has to function, even if no heme is available, to ensure heme 
biosynthesis. In E. coli, fumarate reductase does not possess heme as cofactor (Iverson 
et al., 2002). 
Interestingly, fumarate reductase of Wolinella succinogenes does require heme as 
cofactor (Madej et al., 2006). The sequenced genome of this bacterium encodes genes for 
heme-dependent cytochrome oxidases, but not for a respiratory nitrate reductase. W. 
succinogenes also possesses a gene annotated as hemG with a amino acid sequence 
identity to E. coli hemG of 20.3 %, but no hemY. Thus, W. succinogenes is presumably 
dependent on the respiratory chains to form heme as well. The question arises how W. 
succinogenes facilitates this in the absence of heme. 
This paradox situation possibly comprises a bottleneck for many organisms possessing 
HemG. Together with the relative complexity of the whole PPO system, this could be why 
it is not ubiquitously present in all organisms synthesizing tetrapyrroles. To date, two 
PPOs are known: HemG and HemY. It can be assumed that the HemG-class of PPOs 
has evolved earlier than the HemY-class. Tetrapyrrole biosynthesis has evolved before 
the oxygen-rich atmosphere. Hence proto formation had to develop in the absence of 
oxygen as an electron acceptor, which is possible with HemG. It seems reasonable that 
further mechanisms of the conversion of proto´gen to proto, e.g. in P. aeruginosa, exist in 
nature. Pseudomonas aeruginosa does not possess a gene homologous to hemG and is 
insensitive to deletorious mutations of the gene annotated as hemY (Max Schobert, 
personal communication). It is apparent that P. aeruginosa is capable of synthesizing 
heme, possessing various heme-dependent enzymes (Michel et al., 2007; Rinaldo et al., 
2007). It remains to be determined how P. aeruginosa facilitates the PPO reaction. 
Only few investigated anabolic enzymatic systems make use of the respiratory chains. 
DsbA, an enzyme for disulfide bond formation in the periplasma of procaryots, has been 
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reported (Bader et al., 1999). Here, the electrons emerging from the oxidative covalent 
bonding of two cysteine residues of proteins are transferred to quinones and to terminal 
oxidases via DsbB. A dihydroorotate dehydrogenase involved in pyrimidine synthesis has 
been described to use fumarate, quinones and oxygen as electron acceptors (Norager et 
al., 2002).  
Taken together, the results obtained provide a first insight into the PPO reaction of E. coli 
and probably many other facultative and anaerobic organisms. The energy conserving 
properties and the ability to use a wide variety of electron acceptors are truly fascinating. It 
is certain that further interesting aspects of this enzymatic system will be discovered in 
future research. 
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3.9 The Oxygen-Independent Mg-Protoporphyrin Monomethyl 
Ester Oxidative Cyclase (BchE) 
 
The tetrapyrrole chlorophyll is the central pigment of photosynthesis. Starting from 5-
aminolevulinic acid, heme and (bacterio-) chlorophyll are synthesized via the same 
biosynthesis pathway to produce proto. Two enzymes compete for proto as a substrate: 
Ferrochelatase inserts ferrous iron into proto to perpetuate heme biosynthesis. Proto is 
fed into the (bacterio-) chlorophyll biosynthesis branch by Mg-chelatase, which inserts 
magnesuim into the macrocycle. Further enzymatic steps result in the formation of 
(bacterio-) chlorophyll.  
The second project of this study was the investigation of an enzymatic step in the 
(bacterio-) chlorophyll biosynthesis branch: the addition of a fifth ring to the tetrapyrrole, 
catalysed by the O2-independent cyclase. The bchE gene-product was proposed to 
facilitate this reaction in anoxygenic phototrophs. To investigate this protein, the bchE 
gene of C. tepidum was cloned into the expression vector pGEX-6P-1 
(GE Healthcare, Munich, Germany) for the recombinant overproduction in E. coli. This 
vector construct encoded an N-terminal fusion protein of glutathione-S-transferase (GST)- 
tag and BchE. 
 
3.9.1 Cloning of Chlorobaculum tepidum bchE into pGEX-6p-1 
 
A PCR reaction containing the primers listed in section 2.2.3 amplified bchE from C. 
tepidum cells. The obtained fragment was cut with the endonucleases EcoRI and SalI and 
ligated into the vector pGEX-6P-1 cut with the same endonucleases. For recombinant 
protein production, E. coli BL21 (λDE3) cells were transformed with the obtained 
constructs.   
 
3.9.2 Recombinant production of O2-independent Cyclase  
 
E. coli BL21 (λDE3) harbouring pGEX-6P-1 bchE were cultivated as described in section 
2.13.1. The recombinant protein production was initiated by the addition of 500 µM IPTG. 
Samples were taken during protein production and analysed via SDS-PAGE (fig. 35). A 
protein band with a Mr of ~90,000 emerging after induction corresponded to the calculated 
size of GST-BchE (Mr 90,602).  
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Fig. 35: Recombinant production of C. tepidum BchE in E. coli BL21 (λDE3) 
The picture shows a 12 % polyacrylamide gel of proteins after separation and staining with Coomassie 
Brilliant Blue. E. coli BL21 (λDE3) harbouring pGEX-6P-1 bchE was cultivated as described in section 
2.13.1. The recombinant protein production was initiated by the addition of  
500 µM IPTG. Lane M: Protein Molecular Weight Marker. The relative molecular masses of the marker 
proteins are given. bI: Whole cell sample before induction of gene expression by IPTG. 1h, 2h, 3h: sample 
taken 1 h, 2 h and 3 h after induction.  
 
3.9.3 Purification of O2-independent Cyclase 
 
Cultures of E. coli cells recombinantly overproducing GST-BchE were harvested and cells 
were disrupted by French® Press. After centrifugation at 120,000 x g, GST-BchE was 
anaerobically purified from the supernatant via glutathione sepharose affinity 
chromatography (2.13.2). Analysis of this purification by SDS-PAGE revealed that the 
majority of GST-BchE was found in the sediment after ultracentrifugation (fig. 36). This 
indicated a high amount of insoluble GST-BchE protein. However, besides contaminating 
host proteins, a fraction of GST-BchE was purified as a soluble protein. Two protein bands 
with molecular masses similar to GST-BchE were visible in the SDS-PAGE gel. Upon 
storage at 4 °C degradation of the “upper band” was o bserved. Concurrently the intensity 
of the “lower band” increased (lane 17d). These results indicate that BchE is 
proteolytically degraded during storage. 
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Fig. 36: Affinitiy purification of C. tepidum BchE fused to GST-tag 
The picture shows a 12 % polyacrylamide gel of proteins after separation and staining with Coomassie 
Brilliant Blue. Lane M: Protein Molecular Weight Marker. The relative molecular masses of the marker 
proteins are given. S: Soluble fraction after ultracentrifugation. P: sediment after ultracentrifugation F1+2: 
flow through. W1+2: Washing steps. E1-3: Elution fractions. 2h: sample of E2 after 2 hours. 17d: sample of E2 
17 days at 4 °C. 
 
In a subsequent western blot both bands were detected with an antibody directed against 
the GST-tag (fig. 37). It was concluded that both protein bands contain GST-BchE, with 
the lower band being a stable product of C-terminal degradation. 
 
 
         
 
Fig. 37: Immunodetection of GST-BchE 
Picture of a PVDF membrane after blotting and detection of GST fusion proteins by Anti-GST antibodies. A 
12 % SDS-Page gel was run with samples of the elution fraction 2 of the affinity purification (E2, see above) 
and hemeoxygenase (BphO) from Pseudomonas aeroginosa as positive control (P). Proteins were transferred 
by semidry blotting and detected by Anti-GST antibody. A second antibody directed against the Anti-GST 
antibody and conjugated to alkaline phosphatase was applied. Staining with NBT and BCIP was carried out 
until bands were visible. Lane M: Protein Molecular Weight Marker. The relative molecular masses of the 
marker proteins are given.  
 
3.9.4 Modification of the Construct to Prevent Degradation 
 
For the purification of the full-length fusion protein, a new vector was cloned leading to a 
gene product which possesses an additional His4x-tag located on the C-terminus. After the 
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successful cloning and transformation, the recombinant protein was produced and purified 
as above. SDS-PAGE analysis showed only one band with a relative molecular weight of 
GST-BchE (90,000; fig. 38). This indicated that the C-terminal end of BchE was protected 
from degradation due to the His4x-tag.  
Fehler! 
 
 
 
 
 
 
 
 
 
Fig. 38: Affintiy purification of GST-BchEHis4x 
The picture shows a 12 % polyacrylamide gel of proteins after separation and staining with Coomassie 
Brilliant Blue. Lane M: Protein Molecular Weight Marker. The relative molecular masses of the marker 
proteins are given. S: Soluble fraction after ultracentrifugation. FT: flow through. W1-3: Washing steps. E1-3: 
Elution fractions.  
 
3.9.5 Biophysical and Biochemical Characterisation of O2-Independent 
Cyclase 
 
The fusion protein was subsequently analysed by UV-Vis spectrometry. The spectrum 
revealed a peak at 420 nm wavelength characteristic for [4Fe-4S] clusters (fig 39). Such a 
spectrum was already observed for BchE from Rubrivivax gelatinosus (Ouchane et al., 
2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 39: Spectral analysis of GST-BchE  
A UV-Vis spectrum of purified GST-BchE against elution buffer was recorded. The absorption peak at  
420 nm is marked with an arrow. 
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The iron content was determined colourimetrically with o-phenanthroline after acidic 
denaturation of the protein (Lovenberg et al., 1963) to be 2.6 moles iron per mole fusion 
protein. Together with the bioinformatic predictions of a sequence motif characteristic for 
proteins containing an [4Fe-4S] cluster it was concluded that BchE from C. tepidum 
contains an Fe-S cluster. Since UV/Vis spectroscopic analysis do not allow for the 
identification of the specific Fe-S cluster type, further studies habe to be performed to give 
precise evidence. 
3.9.6 Activity assay of the O2-Independent Cyclase 
 
For many years the analysis of the cyclase enzyme was hampered since no reproducible 
acitivty assay is available. In the present investigations a cyclase assay according to the 
description of Gough et al. (2000) was employed. Fluorescence properties and separation 
behaviour during HPLC analysis were used to detect the tetrapyrrole compounds (fig. 40). 
While Mg-protoporphyrin monomethyl ester was commercially available (Frontier 
Scientific, Logan, USA), protochlorophyllide prepared from a biological source (Suzuki and 
Bauer, 1995) was kindly provided by Johannes Walther.  
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Fig. 40: Detection of Mg-protoporphyrin IX monomethyl ester and protochlorophyllide 
Each compound was dissolved in stopping solution (200 µM, see section 2.13.6) and analysed by 
luminescence spectrometry (A) and HPLC (B) on an Ultrasphere ODS (5 µm, 250 x 4.6 mm) C18-reversed 
phase column. As eluent A, 25 % acetonitrile (v/v) and 0.005 % (v/v) of triethylamine in H20 was used. 
Eluent B consisted of 100 % of acetonitrile. During a period of 25 min, a gradient from 25 to 40 % of 
acetonitrile was applied. Mg-protoporphyrin IX monomethyl ester (MgPME) was excited at 420 nm. The 
emission of light by MgPME was detected by an emission scan at the luminescence spectrometer or at 595 
nm wavelength in the HPLC analysis (red curves). Protochlorophyllide (green) was excited at 440 nm and 
detected at 635 nm wavelength. 
 
Mg-protoporphyrin IX monomethyl ester (MgPME) showed a characteristic double peak 
emission spectrum. In figure 40A, the MgPME spectrum seems to overlap with the single 
emission peak of protochlorophyllide. However, due to the different excitation properties, 
the substrate and product can be clearly distinguished. In the HPLC analysis, both 
compounds did not result in a single peak. It has been described that protochlorophyllide 
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occurs as mono- and divinylvariant in Rhodobacter capsulatus (Suzuki and Bauer, 1995). 
The observed peaks might derive from these to molecules. Nevertheless, the established 
methods allowed the analysis of the tetrapyrrole compounds of the cyclase reaction. 
First assays were performed according to the protocol established by Gough et al. (2000). 
R. capsulatus cells were grown and employed to the assay together with substrate and 
nicotinic acid. After 60 min, the assay was stopped by the addition of a 
acetone/water/ammonia mix. Initial analysis of the cyclase assay was performed by 
fluorescence spectrometry. An emission peak with a maximum of 635 nm wavelength, a 
property for protochlorophyllide, was detectable (fig. 41).  
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Fig. 41: Cyclase activity assay with R. capsulatus cells 
The assay was performed as outlined in 2.13.6. The assays contained the components given for each 
spectrum below. After 60 min, the assay was stopped by the addition of a acetone/water/ammonia mix Initial 
analysis was performed by luminescence spectrometry. Excitation wavelength was set at 440 nm. Blue: 
Control without substrate. Red: Control without nicotinic acid. Green: Assay containing R. capsulatus cells, 
substrate (MgPME) and nicotinic acid. FU: fluorescence units. 
 
From this analysis it was assumed that this assay was capable of monitoring O2-
independent product formation. However, when the samples where analysed by HPLC, 
only peaks derived from the  substrate with retention times of 15-19 min, but no 
protochlorophyllide peaks with retention times of 12.5 - 14min where detectable (fig. 42).  
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Fig. 42: HPLC analysis from cyclase assay performed with R. capsulatus cells. 
The assay containing R. capsulatus cells, substrate (MgPME) and nicotinic acid was stopped and the 
supernatant after centrifugation was analysed by HPLC on a C18 Ultrasphere ODS (5 µm, 250 x 4.6 mm) 
reversed phase column. The column was equilibrated in 25 % (v/v) acetonitrile and 0.005 % (v/v) of 
triethylamine in H20. A gradient from from 25 to 40 % acetonitrile was applied. The fluorescence detector 
was set at an excitation wavelength of 440 nm and 635 nm for emission wavelength for the first 14 minutes. 
After this time period, settings were changed to 420/595 nm. FU: fluorescence units. 
 
In order to analyse these results in detail, further control reactions were performed. 
Interestingly. a control reaction without R. capsulatus cells was not described in the 
publication of Gough et al. (2000). In this control experiment, a peak at 635 nm 
wavelength was observed when analysed by fluorescence spectrometry (fig. 43). 
Apparently, nicotinic acid alone can alter the fluorescence properties of Mg-protoporphyrin 
monomethyl ester towards an emission maximum at 635 nm very similar to 
protochlorophyllide. Due to fluorescence properties of the employed assay conditions, this 
particular approach to investigate the enzymatic activity of the O2-independent cyclase 
was abandoned.  The  published approach (Gough et al., 2000) was found to be unable to 
display BchE activity. 
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Fig. 43: Fluorescence spectra of Mg-protoporphyrin IX monomethyl ester with (blue) and without 
nicotinic acid (red) 
After 60 min, the assay was stopped by the addition of a acetone/water/ammonia mix and centrifuged. The 
resulting supernatant was excited at 440 nm wavelength during luminescence spectrometry analysis. FU: 
fluorescence units. 
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In all further experiments, recombinantly produced BchE was applied as cell extract or 
purified, either truncated from the GST-tag or as GST-fusion protein. In control 
experiments, several ingredients were tested such as Vitamin B12, Triton® X-100 and S-
adenosyl-methionine (section 2.13.6). In all assays, only substrate was detectable when 
analysed by HPLC (fig. 44). 
 
0
200
400
600
800
1000
1200
10 12 14 16 18
retention time [min]
FU
 
Fig. 44: Exemplatory HPLC analyis of in vitro cyclase activity test 
HPLC analysis of the cylase assay was performed as described above. FU: fluorescence units. Only the 
substrate of the cyclase reaction could be detected. 
 
From thes results it was speculated that the protein possibly requires special conditions 
not found in the assays performed. An alternative explanation would be the involvement of 
additional protein subunits in the cyclase reaction. Another possibility why BchE was 
unable to carry out the cyclisation of MgPME is that it cannot be properly folded by the  
E. coli protein synthesis machinery.  
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Summary 
 
The penultimate step of heme biosynthesis – the conversion of protoporphyrinogen IX 
(proto´gen) into protoporphyrin IX (proto) – is catalysed by protoporphyrinogen IX 
oxidases (PPOs). While the O2-dependent enzyme system of eukaryotes and Gram 
positive bacteria is well investigated, little was known about the O2-independent PPO 
found in facultative and anaerobic organisms.  
In this work, the yet unknown O2-independent PPO of E. coli was identified. To achieve 
this, PPO activity was localised in the membranes of E. coli from which it was extracted. 
Further, the PPO activity was purified by classic chromatography from wildtype E. coli 
cells. In LC-MS/MS analysis of the purified fractions, the protein HemG was repeatedly 
found. HemG was recombinantly produced in E. coli which drastically increased PPO 
activity of the corresponding cell lysates. Subsequently, B. megaterium was used to 
recombinantly produce HemG. Afterwards, cell lysates of the host, formerly devoid of 
detectable O2-independent PPO activity, were capable of anaerobic formation of proto. 
These results establish HemG as the O2-independent PPO of E. coli. 
Once identified, the O2-independent PPO was chromatographically purified and 
biochemically characterised. A FMN cofactor was identified by HPLC analysis. Gel 
permeation chromatography experiments indicated a hexameric oligomerisation state of 
native HemG. Kinetic data was obtained, yielding a Km value of 17.3 µM and a maximal 
velocity rate of 16 µM min-1 mg-1 HemG. 
Besides the PPO itself, the proposed electron transfer properties towards the respiratory 
chains were investigated. First, menaquinone and ubiqinone were shown to be able to 
take up electrons from HemG. Then, the purified terminal oxidases fumarate reductase, 
nitrate reductase and cytochrome bo and bd oxidase were applied to PPO activity assays. 
Electrons were found to be transferred from the quinones to the terminal electron 
acceptors fumarate, nitrate and oxygen via the corresponding terminal oxidase. In vivo 
investigations using E. coli mutants devoid of one or two terminal oxidases confirm the in 
vitro findings. Since under certain environmental conditions oxygen is an indirect electron 
acceptor of the PPO reaction in E. coli, it is suggested to use the term “electron transport 
chain coupled” PPO system. 
An additional aim was to study the O2-independent conversion from magnesium 
protoporphyrin IX monomethyl ester to protochlorophyllide during (bacterio-)chlorophyll 
biosynthesis. The protein BchE, proposed in the literature to be capable of the reaction, 
was recombinantly produced, purified and analysed. The possible prescence of a Fe-S 
cluster was observed spectrometrically. The detection of the involved tetrapyrroles by 
HPLC and fluorimetry was established. An activity test in accordance to published results 
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was shown to be useless. Further attempts to observe O2-independent cyclase activity 
with BchE alone proved to be unsuccessful. Consequently, the proposal of O2-
independent cyclase activity for BchE was proven wrong. 
 
 
Outlook 
 
  
As outlined above, the results of this work provided the identification and characterisation 
of the O2-independent PPO. The following questions should be addressed in future 
experiments:  
 
- Investigations on the physical interaction to the terminal oxidases. Interactions   
towards proceeding and following enzymes of the heme and chlorophyll   
pathways should be determined as well. 
- Construction of a E. coli mutant deficient in HemG which is then transformed with   
a genomic library of Pseudomonas aeruginosa. The genome fragment encoding      
the yet unknown PPO of P. aeruginosa should rescue the mutant and enable  
growth. 
- Obtain stuctural data of possibly hexameric HemG. 
 
Concerning the O2-independent cyclisation of Mg-protoporophyrin IX monomethyl ester 
resulting in protochlorophyllide, initial biochemical studies of BchE were performed. 
Further studies have to be carried out to determine its features more closely: 
 
 - Search for additional subunits of the O2-independent cyclase  
▪ by mutagenesis studies of anoxygenic phototrophs 
▪ copurification with tagged BchE from a suitable host 
 - EPR spectroscopy to identify the FeS-cluster in the BchE protein 
 - Screening for conditions for the display of O2-independent cyclase activity 
 - Overproduction of BchE in a anoxygenic phototroph to ensure proper folding of 
             the protein. 
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Appendices 
 
Appendix 1: Peptides found in LC-MS/MS of fractions derived from the 
classic chromatography of PPO activity from Escherichia coli. 
 
Sample 1 from November 7th 2005: 
 
 Reference   MW 
 Scan(s) Peptide MH+ Sp 
1 gi|15804440|ref|NP_290480.1| protoporphyrinogen oxidase   21194,9 
 900 R.TPQTNSYAR.K 1037,50105 864,5 
 3053 R.EIAHLTDKPTLK.- 1365,77364 724,0 
 3733 K.ELGIQADVANVHR.I 1421,74955 1055,9 
 4083 R.IEEPQWENYDR.V 1478,65465 1695,4 
 4089 R.YGHYHSAFQEFVK.K 1612,75430 2249,5 
 4837 R.YGHYHSAFQEFVKK.H 1740,84927 2630,2 
 4981 K.TLILFSTR.D 950,56694 826,2 
 5034 R.EIASYLASELK.E 1223,65180 1203,5 
 5702 R.LNSMPSAFYSVNLVAR.K 1768,90507 2234,6 
 5814 K.EVVYTDWEQVANFAR.E 1826,87079 2688,9 
 7526 R.KEVVYTDWEQVANFAR.E 1954,96575 1678,1 
 7725 R.EIASYLASELKELGIQADVANVHR.I 2626,38351 3332,9 
2 gi|16131220|ref|NP_417800.1| 30S 
ribosomal subunit protein S7    20020,0 
 6812 R.LANELSDAAENK.G 1274,62229 1881,2 
 7433 K.FVNILMVDGK.K 1135,61799 1150,9 
 7459 R.VGGSTYQVPVEVRPVR.R 1742,95479 951,2 
 7615 K.SELEAFEVALENVRPTVEVK.S 2259,18670 1283,5 
 7655 K.STAESIVYSALETLAQR.S 1838,94943 2285,5 
3 gi|133976|sp|P02358|RS6_ECOLI 30S ribosomal protein S6   15675,6 
 2104 R.YTAAITGAEGK.I 1081,55242 1604,6 
 7235 R.FNDAVIR.S 834,44683 750,8 
 7473 K.HAVTEASPMVK.A 1169,59832 1724,2 
 7799 K.AHYVLMNVEAPQEVIDELETTFR.F 2704,32869 1576,8 
4 gi|15803764|ref|NP_289798.1| 30S 
ribosomal subunit protein S9     14857,1 
 1886 K.GGGISGQAGAIR.H 1043,55923 1227,3 
 7251 R.ALMEYDESLR.S 1226,57216 1058,4 
 7286 R.SLEQYFGR.E 999,48942 984,7 
 7999 R.QPLELVDMVEKLDLYITVK.G 2246,23523 1262,9 
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5 gi|16131180|ref|NP_417760.1| 50S 
ribosomal subunit protein L15    14981,3 
 943 R.AAIEAAGGK.I 787,43084 1058,6 
 2061 R.LNTLSPAEGSK.K 1116,58953 232,3 
 2698 R.AAIEAAGGKIEE.- 1158,60009 960,1 
 7309 K.VILAGEVTTPVTVR.G 1454,85771 1948,7 
6 gi|15803823|ref|NP_289857.1| 30S 
ribosomal subunit protein S4     23469,9 
 2683 K.AALELAEQR.E 1000,54219 702,7 
 2909 R.RIYGVLER.Q 1005,58399 671,2 
 3234 R.IYGVLER.Q 849,48288 496,1 
 3373 R.LSDYGVQLR.E 1050,55784 1241,6 
7 gi|15804576|ref|NP_290617.1| 50S 
ribosomal subunit protein L7/L12    12296,1 
 6863 K.DLVESAPAALK.E 1113,61502 1324,1 
 6940 K.ALEEAGAEVEVK.- 1244,63687 1730,1 
 8247 K.DQIIEAVAAMSVMDVVELISAMEEK.F 2721,33952 1652,9 
8 gi|15804792|ref|NP_290833.1| 50S 
ribosomal subunit protein L9     15769,9 
 6868 R.DIADAVTAAGVEVAK.S 1429,75330 2936,9 
 7244 K.LAEVLAAANAR.A 1098,62658 2183,5 
 7272 K.INALETVTIASK.A 1259,72054 1804,7 
9 gi|15803848|ref|NP_289882.1| 30S 
ribosomal subunit protein S10    11736,5 
 7181 R.LIDQATAEIVETAK.R 1501,81081 2666,2 
 7204 R.LVDIVEPTEK.T 1142,63033 932,5 
 7977 R.LDLAAGVDVQISLG.- 1370,75257 685,2 
10 gi|15803825|ref|NP_289859.1| 30S 
ribosomal subunit protein S13    13100,3 
 7267 K.FVVEGDLR.R 934,49926 679,3 
 7293 K.AILAAAGIAEDVK.I 1241,70998 2352,6 
 7557 K.HAVIALTSIYGVGK.T 1428,82093 1283,0 
11 gi|15799705|ref|NP_285717.1| 30S 
ribosomal subunit protein S20    9685,3 
 6910 K.ANLTAQINK.L 972,54727 989,9 
 7055 K.VYAAIEAGDK.A 1036,53095 838,2 
 7237 K.AFNEMQPIVDR.Q 1319,64125 1273,9 
12 gi|15803846|ref|NP_289880.1| 50S 
ribosomal subunit protein L4   22087,4 
 8081 K.DMALEDVLIITGELDENLFLAAR.N 2561,31673 3904,2 
 8134 K.LKDMALEDVLIITGELDENLFLAAR.N 2802,49576 2504,6 
13 gi|15803845|ref|NP_289879.1| 50S 
ribosomal subunit protein L23    11200,0 
 6449 K.EGQNLDFVGGAE.- 1235,55387 1399,5 
 7937 K.LFEVEVEVVNTLVVK.G 1716,97821 2275,1 
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14 gi|15803830|ref|NP_289864.1| 30S 
ribosomal subunit protein S5    17604,3 
 7291 R.VFMQPASEGTGIIAGGAMR.A 1892,93571 2200,9 
 7540 R.AVLEVAGVHNVLAK.A 1419,83183 1962,3 
15 gi|15803833|ref|NP_289867.1| 30S 
ribosomal subunit protein S8   14127,5 
 1986 K.AVVESIQR.V 901,51016 917,8 
 8182 K.VMAGLGIAVVSTSK.G 1332,75555 1684,6 
16 gi|15803824|ref|NP_289858.1| 30S 
ribosomal subunit protein S11    13845,8 
 7193 K.STPFAAQVAAER.C 1247,63788 544,1 
 7494 R.KSTPFAAQVAAER.C 1375,73284 1782,3 
17 gi|15834432|ref|NP_313205.1| 30S 
ribosomal subunit protein S18    8987,4 
 7120 R.FTAEGVQEIDYK.D 1399,67399 2097,3 
 7452 R.FTAEGVQEIDYKDIATLK.N 2041,04881 1364,5 
18 gi|15803843|ref|NP_289877.1| 30S 
ribosomal subunit protein S19    10431,2 
 7216 K.LGEFAPTR.T 890,47304 687,4 
 7711 K.KGPFIDLHLLK.K 1280,77252 1165,5 
19 gi|15803831|ref|NP_289865.1| 50S 
ribosomal subunit protein L18    12770,5 
 1808 R.VQALADAAR.E 914,50541 770,4 
 7070 K.LQELGATR.L 887,49451 719,7 
20 
gi|9911115|sp|P27307|YIJC_ECOLI 
Hypothetical transcriptional 
regulator yijC  
   
 7909 R.AFTEAQAEAMVTIVFSAGAEALDVGVEQR.R 3010,48263 2222,5 
21 gi|15803712|ref|NP_289746.1| orf, hypothetical protein     
 8058 K.LTEMITAPVEALGFELVGIEFIR.G 2548,37312 2527,2 
22 gi|15800345|ref|NP_286357.1| orf, hypothetical protein     
 7687 K.VMGQALPELVDQVVEVVQR.H 2109,13725 2482,5 
23 gi|15804286|ref|NP_290325.1| heat 
shock protein   15746,1 
 7680 R.KFQLAENIHVR.G 1354,75899 2138,1 
24 gi|15799851|ref|NP_285863.1| 30S 
ribosomal subunit protein S2      
 6486 R.SQDLASQAEESFVEAE.- 1739,76063 2479,2 
25 gi|15803822|ref|NP_289856.1|   36471,1 
 7887 K.EGVQEDILEILLNLK.G 1725,96329 1840,1 
26 
gi|15801465|ref|NP_287482.1| 
DNA-binding protein HLP-II (HU, 
BH2, HD, NS) 
  15512,0 
 2003 R.REEESAAAAEVEER.T 1575,72452 1569,5 
Appendices 
 102 
 
27 gi|15803128|ref|NP_289159.1| 50S 
ribosomal subunit protein L19     
 7517 R.VFQTHSPVVDSISVK.R 1642,87990 1683,6 
28 
gi|15801863|ref|NP_287883.1| 
phage shock protein, putative inner 
membrane protein 
   
 988 R.SELSQSEQQR.L 1191,56002 1660,9 
29 gi|15803836|ref|NP_289870.1| 50S 
ribosomal subunit protein L24     
 6761 R.DDEVIVLTGK.D 1088,58338 1597,0 
30 gi|15832810|ref|NP_311583.1| RecA protein     
 1605 K.EGENVVGSETR.V 1176,54912 781,1 
31 
gi|15799710|ref|NP_285722.1| 
probable FKBX-type 16KD 
peptidyl-prolyl cis-trans isomerase 
  16052,9 
 1212 K.LDDGTTAESTR.N 1165,53314 1432,9 
32 
gi|15803862|ref|NP_289896.1| 
FKBP-type peptidyl-prolyl cis-trans 
isomerase 
  20821,7 
 4771 K.FNVEVVAIR.E 1046,59931 1500,9 
33 gi|15833433|ref|NP_312206.1| 30S 
ribosomal subunit protein S3     
 4238 K.EFADNLDSDFK.V 1300,56919 866,1 
34 gi|15802128|ref|NP_288150.1| 50S 
ribosomal subunit protein L20    
 7398 K.ILADIAVFDK.V 1104,62994 800,5 
35 
gi|15800773|ref|NP_286787.1| 
integration host factor (IHF), beta 
subunit 
   
 1364 K.TGDKVELEGK.Y 1075,56298 1080,0 
36 gi|15804178|ref|NP_290217.1| 50S 
ribosomal subunit protein L28    
 7426 K.GIDTVLAELR.A 1086,61535 1336,7 
37 gi|15804575|ref|NP_290616.1|   17682,4 
 7190 K.QAIVAEVSEVAK.G 1243,68924 813,9 
38 gi|15803726|ref|NP_289760.1| 50S 
ribosomal subunit protein L21    
 7407 K.IGVPFVDGGVIK.A 1200,69869 883,5 
39 gi|15804102|ref|NP_290141.1| cold 
shock protein 7.4   7380,6 
 6468 K.GPAAGNVTSL.- 886,46287 887,6 
40 gi|16131057|ref|NP_417634.1| 30S 
ribosomal subunit protein S15     
 2559 R.YTQLIER.L 922,49926 735,1 
41 gi|15799779|ref|NP_285791.1|     
 1406 R.NAADEDRDALR.A 1245,58182 513,4 
42 gi|15803607|ref|NP_289640.1| 30S 
ribosomal subunit protein S21    
 2669 K.AGVLAEVR.R 814,47813 557,0 
 
Sample 2 from November 7th 2005: 
 Reference   MW 
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 Scan(s) Peptide MH+ Sp 
1 gi|15804440|ref|NP_290480.1| protoporphyrinogen IX oxidase   21194,9 
 409 K.MSGGETDTRK.E 1081,49425 752,5 
 1481 R.TPQTNSYAR.K 1037,50105 689,1 
 2873 R.EIAHLTDKPTLK.- 1365,77364 833,6 
 3329 R.YGHYHSAFQEFVKK.H 1740,84927 2408,5 
 4759 K.FLMNSQWR.P 1081,52476 758,1 
 4771 R.IEEPQWENYDR.V 1478,65465 1961,0 
 5326 K.TLILFSTRDGQTR.E 1507,82272 283,2 
 5330 K.ELGIQADVANVHR.I 1421,74955 907,9 
 6182 R.YGHYHSAFQEFVK.K 1612,75430 2277,3 
 7519 K.TLILFSTR.D 950,56694 860,9 
 7858 K.EVVYTDWEQVANFAR.E 1826,87079 2529,6 
 7897 R.KEVVYTDWEQVANFAR.E 1954,96575 2992,4 
 7974 R.IEEPQWENYDRVVIGASIR.Y 2274,15132 1090,1 
 8282 R.EIASYLASELK.E 1223,65180 1036,7 
 8883 R.EIASYLASELKELGIQADVANVHR.I 2626,38351 3329,1 
 8886 R.LNSMPSAFYSVNLVAR.K 1768,90507 2440,4 
2 gi|15799851|ref|NP_285863.1|   26708,8 
 975 K.AGVHFGHQTR.Y 1109,55990 867,3 
 2381 R.NKVHIINLEK.T 1207,71573 1230,9 
 2386 K.LENSLGGIK.D 930,52547 558,2 
 2412 K.VHIINLEK.T 965,57784 675,8 
 2989 R.LKDLETQSQDGTFDK.L 1724,83374 2658,9 
 3423 K.DLETQSQDGTFDK.L 1483,65471 1899,5 
 4935 R.ELEKLENSLGGIK.D 1429,78969 533,5 
 6798 R.SQDLASQAEESFVEAE.- 1739,76063 2087,1 
 7909 K.TVPMFNEALAELNK.I 1576,80396 754,0 
 8234 R.WLGGMLTNWK.T 1205,61358 737,5 
 9598 R.AVTLYLGAVAATVR.E 1404,82093 1772,6 
3 gi|15833433|ref|NP_312206.1| 30S 
ribosomal subunit protein S3     25984,0 
 1641 R.LGGAEIAR.T 786,44683 1102,7 
 2370 R.PGIVIGK.K 683,44504 866,0 
 4583 K.GEILGGMAAVEQPEKPAAQPK.K 2121,10087 1383,9 
 5050 R.ADIDYNTSEAHTTYGVIGVK.V 2154,03495 1732,4 
 5225 K.EFADNLDSDFK.V 1300,56919 776,4 
 5518 K.LVADSITSQLER.R 1331,71652 1891,2 
 6766 K.VVADIAGVPAQINIAEVR.K 1835,03852 852,4 
 7874 R.KVVADIAGVPAQINIAEVR.K 1963,13349 1755,2 
 8286 R.LGIVKPWNSTWFANTK.E 1861,99593 1692,6 
4 gi|15803823|ref|NP_289857.1| 30S 
ribosomal subunit protein S4     23469,9 
 2388 R.RIYGVLER.Q 1005,58399 833,1 
 2808 K.AALELAEQR.E 1000,54219 1085,9 
 3317 R.REGTDLFLK.S 1078,58914 666,3 
 3723 R.LSDYGVQLR.E 1050,55784 1340,2 
 6567 R.VVNIASYQVSPNDVVSIR.E 1960,04982 1740,1 
 7439 K.GNTGENLLALLEGR.L 1456,77543 1972,8 
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 8540 R.LKGNTGENLLALLEGR.L 1697,95446 2372,2 
 9467 R.SDLSADINEHLIVELYSK.- 2046,03898 1344,7 
5 gi|15804574|ref|NP_290615.1| 50S 
ribosomal subunit protein L1   24730,5 
 1301 R.GATVLPHGTGR.S 1065,57997 549,9 
 2854 R.VAVFTQGANAEAAK.A 1376,71685 2304,3 
 3224 K.VGTVTPNVAEAVK.N 1284,71579 660,0 
 4621 R.VVGQLGQVLGPR.G 1222,72663 2018,6 
 6824 K.AAGAELVGMEDLADQIK.K 1730,86293 1776,2 
 7066 K.QYDINEAIALLK.E 1390,75766 335,9 
 9050 K.FVESVDVAVNLGIDAR.K 1703,89628 1141,6 
6 gi|16131220|ref|NP_417800.1|   19988,7 
 2754 R.LANELSDAAENK.G 1274,62229 1883,9 
 2914 R.LANELSDAAENKGTAVK.K 1730,89192 1959,9 
 4046 R.VGGSTYQVPVEVRPVR.R 1742,95479 988,0 
 5735 K.FVNILMVDGKK.S 1263,71296 1646,2 
 6647 K.FVNILMVDGK.K 1135,61799 1206,6 
 8493 K.SELEAFEVALENVRPTVEVK.S 2259,18670 2029,7 
 8708 K.STAESIVYSALETLAQR.S 1838,94943 2647,1 
7 gi|15803847|ref|NP_289881.1| 50S 
ribosomal subunit protein L3     22244,4 
 790 K.MAGQMGNER.V 993,42406 1113,3 
 1173 R.VTKPEAGHFAK.A 1184,64223 554,5 
 4117 K.GAVPGATGSDLIVKPAVK.A 1679,96905 701,6 
 4393 R.VTVQSLDVVR.V 1115,64190 1464,9 
 7883 R.IFTEDGVSIPVTVIEVEANR.V 2188,14959 2950,7 
 9029 R.LAEGEEFTVGQSISVELFADVK.K 2368,19185 2115,6 
8 gi|15803765|ref|NP_289799.1| 50S 
ribosomal subunit protein L13    16019,4 
 1331 K.TFTAKPETVK.R 1121,62010 736,9 
 4411 K.RDWYVVDATGK.T 1309,65353 1232,1 
 5169 K.QATFEEMIAR.R 1195,57758 372,6 
 5668 R.DWYVVDATGK.T 1153,55242 1155,2 
 6670 K.AEYTPHVDTGDYIIVLNADK.V 2234,09755 1985,2 
9 gi|15803835|ref|NP_289869.1| 50S 
ribosomal subunit protein L5     20302,4 
 6682 R.EQIIFPEIDYDKVDR.V 1879,94362 1215,5 
 6689 K.LMTEFNYNSVMQVPR.V 1828,87205 2137,3 
 6757 K.LLDNAAADLAAISGQK.P 1570,84351 2000,8 
 6768 R.EQIIFPEIDYDK.V 1509,74715 876,6 
 6931 K.LLDNAAADLAAISGQKPLITK.A 2123,20705 1113,9 
10 gi|15803846|ref|NP_289880.1| 50S 
ribosomal subunit protein L4   22087,4 
 2082 R.SGGVTFAAR.P 865,45264 810,9 
 7488 R.DATGIDPVSLIAFDK.V 1561,81081 1674,8 
 9229 K.DMALEDVLIITGELDENLFLAAR.N 2561,31673 3512,7 
 9591 K.LKDMALEDVLIITGELDENLFLAAR.N 2802,49576 2360,2 
11 gi|15803862|ref|NP_289896.1| FKBP-type peptidyl-prolyl cis-trans isomerase    20821,7 
 6445 K.FNVEVVAIR.E 1046,59931 1530,0 
 7576 K.DVFMGVDELQVGMR.F 1595,75563 2188,7 
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 8009 R.FLAETDQGPVPVEITAVEDDHVVV DGNHMLAGQNLK.F 3857,90144 1706,2 
 9422 K.DLVVSLAYQVR.T 1262,71031 757,3 
12 gi|15803830|ref|NP_289864.1| 30S 
ribosomal subunit protein S5     17604,3 
 3566 K.AYGSTNPINVVR.A 1290,68008 1075,2 
 3727 K.SVEEILGK.- 874,48802 626,5 
 6466 R.VFMQPASEGTGIIAGGAMR.A 1892,93571 1806,7 
13 gi|16128009|ref|NP_414556.1| DnaJ    
 2023 K.IPAGVDTGDR.I 1000,50580 799,3 
 3678 K.EAYEVLTDSQK.R 1282,61614 1448,3 
 6710 K.QLLQELQESFGGPTGEHNSPR.S 2324,12656 2230,8 
14 gi|16130966|ref|NP_417542.1| hypothetical protein     
 2783 R.VNQSDISDAQIK.K 1317,66448 1526,5 
 3267 R.DDSHGYELIK.A 1176,55314 813,2 
 7490 R.LVILDILSR.D 1041,66666 888,2 
15 gi|33347453|ref|NP_414968.2| putative polymerase/proteinase    
 4129 R.DNQIVTLTASR.D 1217,64844 1610,9 
 8844 K.NIADAVNSVLTDTIADMSQDTSIH EFIK.Q 3048,48302 1267,7 
16 gi|15803458|ref|NP_289491.1| putative transport protein   30858,7 
 5511 K.QILTNIIQSEDR.I 1429,76453 783,9 
 6464 R.LNELGASSINFVVR.V 1518,82747 2057,1 
17 gi|15804522|ref|NP_290562.1| heat 
shock protein hslVU    
 5125 R.IAEAAWQVNESTENIGAR.R 1958,95664 961,7 
 5448 K.PSDLIPELQGR.L 1224,65828 586,3 
18 gi|16128190|ref|NP_414739.1| putative lipoprotein     
 5656 K.IVELEAPQLPR.S 1264,72596 918,1 
 8565 K.LKDGVGLLPTVLDVVENPK.N 2006,15322 1739,2 
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19 gi|15832425|ref|NP_311198.1| NADH dehydrogenase I chain B     
 4402 R.LYDQMLEPK.W 1136,56562 1089,1 
 5274 K.QEIVTDPLEQEVNK.N 1641,83301 1104,4 
20 gi|15803871|ref|NP_289905.1|   23607,4 
 5260 R.IAQTLLNLAK.Q 1084,67247 1104,7 
 6663 K.VGNLAFLDVTGR.I 1261,68991 1398,4 
21 gi|15799779|ref|NP_285791.1|     
 2222 K.GLGAGANPEVGR.N 1097,56980 1352,0 
 5286 R.LDEFETVGNTIR.A 1393,69579 1774,6 
22 gi|15803764|ref|NP_289798.1| 30S 
ribosomal subunit protein S9      
 1726 K.GGGISGQAGAIR.H 1043,55923 1290,8 
 4593 R.ALMEYDESLR.S 1226,57216 990,7 
23 gi|586658|sp|P37620|DCRB_ECOLI DcrB protein precursor     
 5078 K.MQQLDSIISAK.G 1233,65075 819,9 
 6616 K.LSFSLPADMTDQSGK.L 1596,75740 729,7 
24 gi|15834157|ref|NP_312930.1|   43268,3 
 3479 K.ALEGDAEWEAK.I 1218,56371 1471,5 
 5174 K.VGEEVEIVGIK.E 1171,65688 1863,3 
25 gi|133976|sp|P02358|RS6_ECOLI 30S 
ribosomal protein S6   15675,6 
 1535 K.HAVTEASPMVK.A 1169,59832 1176,1 
 2138 R.YTAAITGAEGK.I 1081,55242 1694,1 
26 gi|16128083|ref|NP_414632.1|     
 2159 R.VLVVGGSQGAR.I 1042,60037 1099,5 
 6377 R.TDVLALPLPQQR.L 1350,77398 559,5 
27 gi|15800320|ref|NP_286332.1| alkyl hydroperoxide reductase, C22 subunit   20730,4 
 8895 R.ATFVVDPQGIIQAIEVTAEGIGR.D 2384,28200 1853,9 
28 gi|15833970|ref|NP_312743.1| transcription termination factor Rho    46956,6 
 9190 K.SGEDIFGDGVLEILQDGFGFLR.S 2384,17687 2888,7 
29 gi|15803733|ref|NP_289767.1|   19546,1 
 8911 K.SAMVLEDLIGQFLYGSK.G 1870,96191 2577,8 
30 gi|16132234|ref|NP_416345.1| ProQ     
 5742 K.AGQNAMDATVLEITK.D 1561,78903 1987,8 
31 
gi|15799710|ref|NP_285722.1| probable 
FKBX-type 16KD peptidyl-prolyl cis-trans 
isomerase 
  16052,9 
 8208 R.LGDASLSEGLEQHLLGLK.V 1880,01237 494,3 
32 gi|16130591|ref|NP_417163.1|     
 9020 R.ALAINPDILLMDEAFSALDPLIR.T 2511,35272 1567,1 
33 gi|15803119|ref|NP_289150.1| orf, hypothetical protein    
 5350 K.NADLPLAQAAIDR.F 1367,72775 1035,3 
34 gi|16128998|ref|NP_415553.1| putative 
oxidoreductase component     
 8799 R.QPQDPLLVPLFTLIR.E 1750,02617 1267,6 
35 gi|33347775|ref|NP_418098.2| putative    
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transcriptional regulator  
 9181 R.MFDSLIEFIEDSLITR.I 1928,96739 2803,1 
36 gi|30064007|ref|NP_838178.1| hypothetical protein     
 5710 K.QLTAQAPVDPIVLGK.M 1549,89482 973,8 
37 gi|15803822|ref|NP_289856.1| RNA polymerase, alpha subunit     
 8860 K.EGVQEDILEILLNLK.G 1725,96329 1541,1 
38 gi|16131180|ref|NP_417760.1| 50S 
ribosomal subunit protein L15     
 5032 K.VEGGVVDLNTLK.A 1243,68924 1382,0 
39 gi|15830966|ref|NP_309739.1| phosphoribosylpyrophosphate synthetase    
 4259 R.LYTSLGDAAVGR.F 1222,64263 1181,8 
40 gi|15834295|ref|NP_313068.1|     
 5707 K.VILVGNLGQDPEVR.Y 1508,84312 995,0 
41 gi|15803741|ref|NP_289775.1|    26766,1 
 2265 R.DSMGQSLSGGER.R 1223,53209 1459,2 
42 
gi|15804335|ref|NP_290374.1| membrane-
bound ATP synthase, F1 sector, delta-
subunit 
   
 3366 R.AGDMVIDGSVR.G 1119,54628 1134,7 
43 gi|15804523|ref|NP_290563.1| heat shock protein hslVU    
 4210 R.ALLENTELSAR.E 1216,65319 1846,5 
44 gi|16130438|ref|NP_417008.1| hypothetical protein     
 6684 K.SDVTPALSEMMQMK.I 1567,71646 1260,4 
45 gi|15804336|ref|NP_290375.1| membrane-bound ATP synthase, F0 sector, subunit b     
 3400 K.EIADGLASAER.A 1131,56404 1099,8 
46 gi|16130861|ref|NP_417435.1| hypothetical protein    
 3075 K.NLSESNDYVPR.P 1293,60697 928,0 
47 gi|16128183|ref|NP_414732.1| hypothetical protein    
 3441 K.ATVNVADLDR.N 1073,55856 1159,2 
48 gi|15801211|ref|NP_287228.1| acyl carrier protein    8616,2 
 3578 K.IIGEQLGVK.Q 956,57751 555,8 
49 gi|15802999|ref|NP_289029.1|   26959,7 
 3720 K.LAEAGIPTQMER.L 1315,66746 640,2 
50 gi|15800457|ref|NP_286469.1| peptidoglycan-associated lipoprotein    18794,2 
 4348 R.GTPEYNISLGER.R 1335,65392 420,6 
51 gi|9911115|sp|P27307|YIJC_ECOLI Hypothetical transcriptional regulator yijC     
 3138 K.TAIIPGNVKDE.- 1156,62083 816,3 
52 gi|1723853|sp|P25894|YGGG_ECOLI Putative metalloprotease yggG     
 2142 K.ATIAPANSEYAK.R 1235,62664 487,4 
53 gi|15800772|ref|NP_286786.1| 30S 
ribosomal subunit protein S1      
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 3143 K.SESAIPAEQFK.N 1206,60009 534,1 
 
Sample 3 from April 12th 2006 
 
 Reference   MW 
 Scan(s) Peptide MH+ Sp 
1 gi|15804440|ref|NP_290480.1| protoporphyrinogen oxidase    21194,9 
 3599 - 3643 R.IEEPQWENYDR.V 1478,65465 970,6 
 4933 R.EIASYLASELK.E 1223,65180 1050,5 
 4935 K.TLILFSTR.D 950,56694 683,1 
 5656 K.EVVYTDWEQVANFAR.E 1826,87079 2487,8 
 7479 R.YGHYHSAFQEFVKK.H 1740,84927 1352,2 
2 gi|15833970|ref|NP_312743.1| transcription termination factor Rho    46956,6 
 7397 K.NTPVSELITLGENMGLENLAR.M 2271,16492 1315,6 
 7821 K.SGEDIFGDGVLEILQDGFGFLR.S 2384,17687 2748,8 
3 gi|15804576|ref|NP_290617.1| 50S 
ribosomal subunit protein L7/L12    12296,1 
 6700 K.DLVESAPAALK.E 1113,61502 864,7 
 6784 K.ALEEAGAEVEVK.- 1244,63687 1802,9 
4 gi|16131180|ref|NP_417760.1| 50S 
ribosomal subunit protein L15    14981,3 
 7092 K.VILAGEVTTPVTVR.G 1454,85771 1658,6 
 7122 K.AANIIGIQIEFAK.V 1387,79438 1697,2 
5 gi|16130579|ref|NP_417151.1| hypothetical protein   16064,0 
 6612 K.ATVTGDGLSQEAK.E 1276,63794 1805,0 
 6733 K.SGDTLSAISK.Q 978,51022 1195,5 
6 gi|15804286|ref|NP_290325.1| heat shock protein   15746,1 
 7291 R.IAIAVAGFAESELEITAQDNLLVVK.G 2614,43381 2474,8 
7 
gi|15802128|ref|NP_288150.1| 50S 
ribosomal subunit protein L20, and 
regulator  
  13497,9 
 7486 K.ILADIAVFDKVAFTALVEK.A 2063,17871 1672,0 
8 gi|15803764|ref|NP_289798.1| 30S 
ribosomal subunit protein S9    14857,1 
 7643 R.QPLELVDMVEKLDLYITVK.G 2246,23523 1397,5 
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9 gi|15803845|ref|NP_289879.1| 50S ribosomal 
subunit protein L23   11200,0 
 7240 K.LFEVEVEVVNTLVVK.G 1716,97821 1893,8 
10 gi|16130123|ref|NP_416690.1| 50S ribosomal 
subunit protein L25   10694,4 
 7206 K.AEFYSEVLTIVVDGK.E 1669,86833 2610,1 
11 gi|15803210|ref|NP_289242.1| carbon storage 
regulator    
 7324 R.RVGETLMIGDEVTVTVLGVK.G 2116,16822 1973,9 
12 gi|15803823|ref|NP_289857.1| 30S ribosomal 
subunit protein S4    
 7167 R.SDLSADINEHLIVELYSK.- 2046,03898 1703,4 
13 gi|15803833|ref|NP_289867.1| 30S ribosomal 
subunit protein S8, and regulator    
 7083 K.VMAGLGIAVVSTSK.G 1332,75555 2625,3 
14 gi|15834432|ref|NP_313205.1| 30S ribosomal 
subunit protein S18    
 7157 R.FTAEGVQEIDYKDIATLK.N 2041,04881 1364,0 
15 gi|15800564|ref|NP_286576.1| global 
regulator, starvation conditions     
 7223 R.QVIQFIDLSLITK.Q 1517,89376 1274,9 
16 gi|15804792|ref|NP_290833.1| 50S ribosomal 
subunit protein L9     
 7075 K.INALETVTIASK.A 1259,72054 1343,8 
17 gi|16131470|ref|NP_418056.1| PTS system, 
mannitol-specific enzyme IIABC component    
 2738 R.FGEEEDDIAR.L 1180,51167 1220,3 
18 gi|16128616|ref|NP_415166.1| RlpA    
 979 K.AEASTLQQR.L 1003,51670 1128,0 
19 gi|16131771|ref|NP_418368.1| essential cell division protein   35753,4 
 890 R.GAEQAETVR.A 960,47450 907,0 
20 gi|133976|sp|P02358|RS6_ECOLI 30S 
ribosomal protein S6   15675,6 
 6725 R.YTAAITGAEGK.I 1081,55242 1501,6 
21 gi|15803566|ref|NP_289599.1| orf, hypothetical protein    
 7087 R.ISDDLYVFK.D 1099,56700 643,2 
22 gi|15800357|ref|NP_286369.1| putative alpha helical protein   18767,4 
 6671 R.TEVDELTR.A 962,47892 620,9 
23 gi|15804102|ref|NP_290141.1| cold shock protein 7.4   7380,6 
 6364 K.GPAAGNVTSL.- 886,46287 849,9 
24 gi|15834020|ref|NP_312793.1| Sec-independent protein translocase    
 1457 K.TSQDADFTAK.T 1083,49529 1028,6 
25 gi|16130441|ref|NP_417011.1| putative 
membrane protein    
 5869 R.LTLNAEQSPAQ.- 1171,59534 955,5 
26 gi|15799860|ref|NP_285872.1| histone-like protein   17659,3 
 1606 R.METDLQAK.M 935,45026 705,7 
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27 
gi|15799862|ref|NP_285874.1| (3R)-
hydroxymyristol acyl carrier protein 
dehydratase 
   
 7237 R.FPFLLVDR.V 1006,57203 653,9 
28 gi|2506612|sp|P45571|YBCJ_ECOLI Hypothetical protein ybcJ     
 863 K.VDGAVETR.K 846,43157 984,8 
29 gi|16131320|ref|NP_417905.1| hypothetical protein    
 6660 R.VLQSQPGER.N 1013,53743 473,8 
 
Sample 4 from April 12th 2006 
 
 Reference   MW 
 Scan(s) Peptide MH+ Sp 
1 gi|15800564|ref|NP_286576.1| global 
regulator, starvation conditions    
 4724 R.YAIVANDVR.K 1020,54727 1319,4 
 5389 K.DDDTADILTAASR.D 1363,63358 2538,7 
 5633 K.ATNLLYTR.N 951,52581 1125,7 
 5671 K.ATVELLNR.Q 915,52581 1494,0 
 6049 R.AVQLGGVALGTTQVINSK.T 1755,99632 2437,4 
 6054 K.AIGEAKDDDTADILTAASR.D 1932,95089 1923,9 
 6240 K.KATVELLNR.Q 1043,62077 728,4 
 6840 R.QVIQFIDLSLITK.Q 1517,89376 1906,1 
 7047 K.FLWFIESNIE.- 1297,64632 1728,2 
 7368 R.DLDKFLWFIESNIE.- 1768,87923 777,3 
2 gi|15804440|ref|NP_290480.1| protoporphyrinogen oxidase   21194,9 
 1028 R.TPQTNSYAR.K 1037,50105 710,3 
 3708 R.IEEPQWENYDR.V 1478,65465 864,0 
 5118 R.EIASYLASELK.E 1223,65180 946,8 
 6448 R.LNSMPSAFYSVNLVAR.K 1768,90507 1022,5 
 6471 K.EVVYTDWEQVANFAR.E 1826,87079 2874,8 
 6560 R.KEVVYTDWEQVANFAR.E 1954,96575 1146,7 
 6772 R.YGHYHSAFQEFVK.K 1612,75430 2140,2 
 6938 R.EIASYLASELKELGIQADVANVHR.I 2626,38351 2901,1 
 8683 R.YGHYHSAFQEFVKK.H 1740,84927 1762,4 
3 gi|16130343|ref|NP_416912.1|    
 863 K.SLVSDDKK.D 891,47819 502,7 
 5045 K.MVAPVDGTIGK.I 1087,58161 604,2 
 5690 K.LSGSVTVGETPVIR.I 1414,79002 904,1 
 6294 K.STLTPVVISNMDEIK.E 1646,86695 1200,4 
 6828 K.VGDTVIEFDLPLLEEK.A 1816,95787 2464,6 
 6883 R.VKVGDTVIEFDLPLLEEK.A 2044,12125 1353,2 
 7162 K.DTGTIEIIAPLSGEIVNIEDVPDVVFAEK.I 3083,60345 3197,2 
4 gi|15834157|ref|NP_312930.1| protein 
chain elongation factor EF-Tu     
 3206 K.ALEGDAEWEAK.I 1218,56371 1339,9 
 5909 K.VGEEVEIVGIK.E 1171,65688 1215,5 
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 6100 K.FESEVYILSK.D 1214,63033 863,3 
 6499 R.TTDVTGTIELPEGVEMVMPGDNIK.M 2546,23643 2400,1 
 6984 K.ILELAGFLDSYIPEPER.A 1962,02187 931,5 
 7109 R.AIDKPFLLPIEDVFSISGR.G 2117,16412 1480,3 
  5 gi|10955180|ref|NP_052173.1| beta-lactamase   31477,2 
 1805 R.VDAGQEQLGR.R 1072,53816 2022,6 
 6065 R.VGYIELDLNSGK.I 1307,68416 1506,6 
 6254 R.IHYSQNDLVEYSPVTEK.H 2021,98146 1847,0 
 6481 R.SALPAGWFIADK.S 1275,67320 654,6 
 6567 K.LLTGELLTLASR.Q 1286,76783 1492,8 
6 gi|15800357|ref|NP_286369.1| putative 
alpha helical protein   18767,4 
 2495 R.TEVDELTR.A 962,47892 621,6 
 5685 R.DIDALVEQAR.E 1129,58478 1714,1 
 6972 R.DLEEFAMSYEESLKEESDSVFMR.V 2771,20625 2815,4 
 7203 K.ESLWQELADITDKTQLEWR.E 2361,17212 873,4 
7 gi|16130187|ref|NP_416755.1| Ais    
 5673 K.VYLDGEFVNH.- 1192,56331 809,7 
 6618 R.ELGNAFSADIPDFDLYSSNTVR.T 2431,14121 1124,9 
 6646 R.DATFKPDYLDGLVMHVEK.G 2078,02630 2595,8 
8 gi|15800320|ref|NP_286332.1| alkyl hydroperoxide reductase, C22 subunit    20730,4 
 5951 K.YAMIGDPTGALTR.N 1365,68311 1081,5 
 6532 K.EGEATLAPSLDLVGKI.- 1612,87923 794,3 
 7497 R.ATFVVDPQGIIQAIEVTAEGIGR.D 2384,28200 1915,7 
9 
gi|15800563|ref|NP_286575.1| 
periplasmic glutamine-binding protein; 
permease 
   
 6415 K.NVDLALAGITITDER.K 1600,85408 1160,0 
 6716 K.LVVATDTAFVPFEFK.Q 1683,89924 1437,9 
 6763 R.ADAVLHDTPNILYFIK.T 1829,97961 1425,2 
10 gi|15800464|ref|NP_286476.1| phosphoglyceromutase 1    
 867 K.YGDEQVK.Q 838,39412 720,2 
 5757 R.YYLGNADEIAAK.A 1327,65286 1138,0 
 6693 K.LLKEEGYSFDFAYTSVLK.R 2110,07430 1316,9 
11 gi|15799860|ref|NP_285872.1| histone-like protein   17659,3 
 1684 R.METDLQAK.M 935,45026 655,7 
 5946 K.TGVSNTLENEFK.G 1338,65359 739,3 
 6726 K.IAIVNMGSLFQQVAQK.T 1746,95710 1623,9 
12 gi|15803692|ref|NP_289726.1| putative periplasmic protein   19997,7 
 1063 K.AAADIASR.V 774,41044 940,5 
 5911 K.VLLVGQSPNAELSAR.A 1553,86458 1362,7 
 5995 R.SQLLTSDLVK.S 1103,63067 1002,4 
13 gi|15803832|ref|NP_289866.1| 50S 
ribosomal subunit protein L6     
 1872 R.YADEVVR.T 851,42576 645,0 
 2480 R.TLNDAVEVK.H 988,53095 604,8 
 5589 K.APVVVPAGVDVK.I 1150,68304 862,7 
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14 gi|15803846|ref|NP_289880.1| 50S 
ribosomal subunit protein L4    
 7742 K.LKDMALEDVLIITGELDENLFLAAR.N 2802,49576 1971,1 
 7790 K.DMALEDVLIITGELDENLFLAAR.N 2561,31673 3400,3 
15 gi|15804576|ref|NP_290617.1| 50S 
ribosomal subunit protein L7/L12    
 3012 K.ALEEAGAEVEVK.- 1244,63687 1663,7 
 8220 K.DQIIEAVAAMSVMDVVELISAMEEK.F 2721,33952 2579,4 
16 gi|15801846|ref|NP_287864.1| thiol peroxidase   17806,2 
 5986 K.DLSDVTLGQFAGK.R 1350,68997 2411,3 
 6576 R.NAEFLQAYGVAIADGPLK.G 1876,98034 2505,6 
17 gi|16130338|ref|NP_416907.1| ZipA    
 6758 K.LMLQSAQHIADEVGGVVLDDQR.R 2394,20818 1391,2 
 6847 K.DFTTPGVTIFMQVPSYGDELQNFK.L 2734,30690 1970,6 
18 gi|16131220|ref|NP_417800.1| 30S 
ribosomal subunit protein S7     
 6819 K.SELEAFEVALENVRPTVEVK.S 2259,18670 1285,2 
 7031 K.STAESIVYSALETLAQR.S 1838,94943 1645,9 
19 gi|30063856|ref|NP_838027.1| lipoprotein-34   36801,6 
 1123 K.SATDAANAAQNR.A 1189,55560 1439,6 
 1636 R.LDEDEQYR.G 1067,46399 1006,1 
20 gi|16132194|ref|NP_418793.1| OsmY    
 2069 K.GVEGVTSVSDK.L 1077,54224 902,3 
 5853 K.LLADDIVPSR.H 1098,61535 1141,5 
21 gi|16131266|ref|NP_417847.1| DamX     
 1339 K.TAGNVGSLK.S 846,46796 541,0 
 4718 K.AVSTLPADVQAK.N 1199,66303 558,8 
22 gi|15803847|ref|NP_289881.1| 50S 
ribosomal subunit protein L3     
 6849 R.LAEGEEFTVGQSISVELFADVK.K 2368,19185 2909,5 
23 gi|15802128|ref|NP_288150.1| 50S 
ribosomal subunit protein L20    
 7090 K.ILADIAVFDKVAFTALVEK.A 2063,17871 2125,4 
24 gi|15804508|ref|NP_290548.1| triosephosphate isomerase   26936,8 
 6719 K.TQGAAAFEGAVIAYEPVWAIGTGK.S 2407,22924 3021,3 
25 gi|15803764|ref|NP_289798.1| 30S 
ribosomal subunit protein S9     
 7352 R.QPLELVDMVEKLDLYITVK.G 2246,23523 1458,4 
26 gi|133976|sp|P02358|RS6_ECOLI 30S 
ribosomal protein S6   15675,6 
 7227 K.AHYVLMNVEAPQEVIDELETTFR.F 2704,32869 1339,0 
27 gi|15803836|ref|NP_289870.1| 50S 
ribosomal subunit protein L24    
 6247 K.EAAIQVSNVAIFNAATGK.A 1803,95994 1789,9 
28 gi|15803726|ref|NP_289760.1| 50S 
ribosomal subunit protein L21    
 7029 K.LDIATGETVEFAEVLMIANGEEVK.I 2578,29566 1426,7 
29 gi|15833970|ref|NP_312743.1|   46956,6 
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 7176 K.NTPVSELITLGENMGLENLAR.M 2271,16492 1520,6 
30 gi|15804286|ref|NP_290325.1| heat 
shock protein   15746,1 
 6744 R.GANLVNGLLYIDLER.V 1659,90645 2601,3 
31 gi|15803848|ref|NP_289882.1|   11710,4 
 
7960 R.LDLAAGVDVQISLG.- 1370,75257 675,8 
32 gi|15802817|ref|NP_288844.1| 
  
11280,8 
 
7517 R.IDDDLTLLSETLEEVLR.S 1974,02774 1286,4 
33 gi|15803833|ref|NP_289867.1| 30S 
ribosomal subunit protein S8    
 
6215 K.VMAGLGIAVVSTSK.G 1332,75555 2710,4 
34 gi|16131215|ref|NP_417795.1| bacterioferrin    
 
6943 R.ILFLEGLPNLQDLGK.L 1669,95233 1612,4 
35 gi|15834432|ref|NP_313205.1| 30S 
ribosomal subunit protein S18    
 
6362 R.FTAEGVQEIDYKDIATLK.N 2041,04881 1198,2 
36 gi|15802070|ref|NP_288092.1| 
superoxide dismutase   21234,5 
 
6352 K.DALAPHISAETIEYHYGK.H 2014,98688 876,9 
37 gi|15803210|ref|NP_289242.1| carbon 
storage regulator    
 
6807 R.RVGETLMIGDEVTVTVLGVK.G 2116,16822 1239,7 
38 gi|15803825|ref|NP_289859.1| 30S 
ribosomal subunit protein S13    
 
4778 K.AILAAAGIAEDVK.I 1241,70998 2391,8 
39 gi|15803823|ref|NP_289857.1| 
  
23436,6 
 
8635 R.SDLSADINEHLIVELYSK.- 2046,03898 1382,9 
40 gi|15803877|ref|NP_289911.1| peptidyl-prolyl cis-trans isomerase A    20400,4 
 
6770 R.TADKDSATSQFFINVADNAFLDHGQR.D 2868,35473 1385,3 
41 gi|2495538|sp|P77717|YBAY_ECOLI Hypothetical protein ybaY precursor    
 
6656 K.VALPPDAVLTVTLSDASLADAPSK.V 2351,27043 1153,5 
42 gi|15803725|ref|NP_289759.1| 50S 
ribosomal subunit protein L27    
 
6359 R.FGGESVLAGSIIVR.Q 1404,78454 1610,3 
43 gi|15803128|ref|NP_289159.1| 50S 
ribosomal subunit protein L19    
 
6509 R.LQAFEGVVIAIR.N 1315,77325 1748,6 
44 gi|16130123|ref|NP_416690.1| 50S 
ribosomal subunit protein L25    
 
6866 K.AEFYSEVLTIVVDGK.E 1669,86833 1596,0 
45 
gi|16128561|ref|NP_415110.1| 
oxygen-insensitive NAD(P)H 
nitroreductase 
  
 
 
2357 K.LVVDQEDADGR.F 1216,58042 978,4 
46 gi|15800816|ref|NP_286832.1| 
  
37159,7 
 
5579 K.DGSVVVLGYTDR.I 1280,64811 1535,4 
47 gi|16131470|ref|NP_418056.1| 
  
 
 
2828 R.FGEEEDDIAR.L 1180,51167 1196,1 
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48 gi|16131180|ref|NP_417760.1| 50S 
ribosomal subunit protein L15    
 
6502 K.AANIIGIQIEFAK.V 1387,79438 1357,5 
49 gi|16130441|ref|NP_417011.1| putative 
membrane protein    
 
3436 R.LTLNAEQSPAQ.- 1171,59534 1253,9 
50 gi|15833303|ref|NP_312076.1| protein 
chain initiation factor IF-2    
 
986 R.LAAEEQAQR.E 1015,51670 1059,0 
51 gi|16128119|ref|NP_414668.1| putative 
carbonic anhdrase    
 
2400 R.DLDVTATNR.E 1004,50071 1195,1 
52 gi|16130245|ref|NP_416813.1| ArgT 
  
 
 
5916 K.GSPIQPTLDSLK.G 1255,68924 452,6 
53 gi|15799694|ref|NP_285706.1| 
chaperone Hsp70    
 
2189 K.ASSGLNEDEIQK.M 1290,61720 984,3 
54 gi|16128616|ref|NP_415166.1| RlpA 
  
 
 
1021 K.AEASTLQQR.L 1003,51670 1329,0 
55 gi|134659|sp|P00448|SODM_ECOLI Superoxide dismutase [Mn] (MnSOD)    
 
1959 K.LDQLPADK.K 899,48327 938,7 
56 gi|15803639|ref|NP_289672.1| orf, hypothetical protein    
 
1922 R.LGETGDAIAK.Q 974,51530 1267,7 
57 gi|15800203|ref|NP_286215.1| 
  
 
 
6742 K.LVTDELVIALVK.E 1312,80863 1643,4 
58 gi|16128174|ref|NP_414723.1| UDP-N-acetylglucosamine acetyltransferase    
 
1121 R.GTVQGGGLTK.V 917,50507 463,7 
59 gi|15834020|ref|NP_312793.1| Sec-independent protein translocase    
 
1555 K.TSQDADFTAK.T 1083,49529 858,5 
60 gi|16128655|ref|NP_415205.1| 
  
 
 
5771 K.IVVSPAAGTIVK.I 1154,71434 367,6 
 
Appendix 2: Peptides found in LC-MS/MS of fractions from the 
overproduction of HemG in Escherichia coli. 
 
Sample 1 from January 1st 2006 
 
 Reference   MW 
  Scan(s) Peptide MH+ Sp 
1 gi|16131979|ref|NP_418578.1|FrdA    
  3544 R.AAIAAAQANPNAK.I 1210,65386 1494,7 
  4857 R.AATAGNGNEAAIEAQAAGVEQR.L 2099,01120 2263,0 
  4567 R.ANAVVM*ATGGAGR.V 1190,59462 1721,4 
  4807 R.ANAVVMATGGAGR.V 1174,59972 1019,3 
  5858 R.GDVVYLDLR.H 1049,56259 865,8 
  5247 R.GEGGILVNK.N 886,49926 964,3 
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  5341 R.GLVAM*NM*M*EGTLVQIR.A 1810,88594 825,3 
  3909 R.LAGEQATER.A 974,49015 763,3 
  6541 R.LGSNSLAELVVFGR.L 1461,80600 799,4 
  6428 R.RPDGSVNVR.R 999,53302 459,2 
  5163 R.TPELM*QK.T 862,43387 319,0 
  5292 R.YLQDYGM*GPETPLGEPK.N 1910,88404 1338,2 
  5385 R.YLQDYGMGPETPLGEPK.N 1894,88914 1859,0 
2 
gi|15800816|ref|NP_286832.1| outer 
membrane protein 3a    
  4592 K.AQGVQLTAK.L 915,52581 273,6 
  4849 K.DGSVVVLGYTDR.I 1280,64811 1361,3 
  4799 K.GIKDVVTQPQA.- 1155,63681 800,2 
  5538 R.IGSDAYNQGLSER.R 1409,66555 1356,5 
  5850 K.SDVLFNFNK.A 1083,54694 838,0 
3 
gi|16130152|ref|NP_416719.1| outer 
membrane protein 1b    
  6441 R.DAGINTDNIVALGLVYQF.- 1922,98582 1442,0 
  5336 K.FQDVGSFDYGR.N 1290,57494 368,0 
  5812 K.INLLDDNQFTR.D 1348,68555 629,4 
  4135 R.TDAQNTAAYIGNGDR.A 1566,71429 818,0 
  5401 K.YVDVGATYYFNK.N 1439,68416 1334,0 
4 
gi|15830995|ref|NP_309768.1| CoA-
linked acetaldehyde dehydrogenase    
  5736 R.EYASFTQEQVDK.I 1444,65907 356,3 
  5383 K.IAELAGFSVPENTK.I 1475,77404 778,2 
  6457 R.ILINTPASQGGIGDLYNFK.L 2021,07022 1145,8 
5 
gi|15804747|ref|NP_290788.1| 
fumarate reductase     
  4190 R.TADQGTNIQTPAQMAK.Y 1674,81156 987,2 
  2945 - 3367 R.TADQGTNIQTPAQM*AK.Y 1690,80646 885,1 
  6419 K.VEALANFPIER.D 1258,67901 876,2 
6 
gi|15800564|ref|NP_286576.1| global 
regulator    
  5397 R.AVQLGGVALGTTQVINSK.T 1755,99632 1257,4 
  6538 R.QVIQFIDLSLITK.Q 1517,89376 1219,2 
  6369 R.YAIVANDVR.K 1020,54727 930,6 
7 
gi|15802089|ref|NP_288111.1| 
murein lipoprotein    
  5592 K.IDQLSSDVQTLNAK.V 1531,79623 1217,2 
  4781 K.VDQLSNDVNAMR.S 1361,64779 1441,3 
  3971 K.VDQLSNDVNAM*R.S 1377,64269 1139,4 
8 
gi|15834157|ref|NP_312930.1| 
protein chain elongation factor EF-
Tu    
  5668 R.AFDQIDNAPEEK.A 1376,63285 960,7 
  5399 R.AGENVGVLLR.G 1027,58947 759,4 
  5659 K.FESEVYILSK.D 1214,63033 485,4 
9 
gi|16130579|ref|NP_417151.1| 
hypothetical protein    
  4746 K.ATVTGDGLSQEAK.E 1276,63794 849,2 
  5572 K.SGDTLSAISK.Q 978,51022 947,9 
  6207 K.TATPATASQFYTVK.S 1485,75839 381,5 
10 
gi|15802193|ref|NP_288215.1| 
glyceraldehyde-3-phosphate 
dehydrogenase A    
  5098 R.GASQNIIPSSTGAAK.A 1401,73323 670,3 
  5538 R.VPTPNVSVVDLTVR.L 1495,84787 1675,9 
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11 
gi|16128752|ref|NP_415305.1| 
MoaD    
  5964 R.ELVGTDATEVAADFPTVEALR.Q 2204,10812 2112,1 
12 
gi|15802055|ref|NP_288077.1| 
putative outer membrane protein    
  4866 R.VVLASNGSQVTVSPR.- 1513,83328 295,9 
13 
gi|15803846|ref|NP_289880.1| 50S 
ribosomal subunit protein L4    
  4871 K.DAQSALTVSETTFGR.D 1582,77074 852,9 
14 
gi|15800563|ref|NP_286575.1| 
periplasmic glutamine-binding 
protein 
   
  4974 K.AVGDSLEAQQYGIAFPK.G 1793,90684 942,1 
15 
gi|15804792|ref|NP_290833.1| 50S 
ribosomal subunit protein L9     
  5084 R.DIADAVTAAGVEVAK.S 1429,75330 1172,6 
16 
gi|15804576|ref|NP_290617.1| 50S 
ribosomal subunit protein L7/L12    
  4873 K.ALEEAGAEVEVK.- 1244,63687 1173,5 
17 
gi|15804574|ref|NP_290615.1| 50S 
ribosomal subunit protein L1 
   
  5129 R.VAVFTQGANAEAAK.A 1376,71685 1633,6 
18 
gi|15804734|ref|NP_290775.1| 
GroES    
  5158 K.SAGGIVLTGSAAAK.S 1202,67393 651,3 
19 
gi|15832699|ref|NP_311472.1| 
putative formate acetyltransferase    
  4793 K.AGYAEDEVVAVSK.L 1337,65834 659,9 
20 
gi|16130649|ref|NP_417222.1| 
lipoprotein    
  5096 K.VIETFGASEGGNK.G 1308,64302 1169,0 
21 
gi|16130827|ref|NP_417401.1| 
phosphoglycerate kinase    
  5280 R.VATEFSETAPATLK.S 1464,75805 500,7 
22 
gi|33112659|sp|P21420|NMPC_ECO
LI O    
  5401 K.YVDVGATYYFNK.N 1439,68416 1334,0 
23 
gi|16128548|ref|NP_415097.1| outer 
membrane protein 3b (a) protease 
VII    
  5166 R.VYLAEEGGR.K 993,49999 954,2 
24 
gi|15803871|ref|NP_289905.1| cyclic 
AMP receptor protein    
  5884 R.IAQTLLNLAK.Q 1084,67247 603,4 
25 
gi|16131220|ref|NP_417800.1| 30S 
ribosomal subunit protein S7    
  4587 R.LANELSDAAENK.G 1274,62229 635,9 
26 
gi|15804573|ref|NP_290614.1| 50S 
ribosomal subunit protein L11    
  4630 R.AQLQEIAQTK.A 1129,62116 431,9 
27 
gi|15799705|ref|NP_285717.1| 30S 
ribosomal subunit protein S20    
  5042 K.AFNEM*QPIVDR.Q 1335,63615 392,5 
28 
gi|133976|sp|P02358|RS6_ECOLI 
30S ribosomal protein S6    
  4566 R.YTAAITGAEGK.I 1081,55242 892,4 
29 gi|15804575|ref|NP_290616.1|    
  5568 R.LATLPTYEEAIAR.L 1447,77912 256,8 
30 gi|15803832|ref|NP_289866.1| 50S    
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ribosomal subunit protein L6 
  4918 R.TLNDAVEVK.H 988,53095 398,2 
31 
gi|1169721|sp|P46009|FOCD_ECOL
I     
  5812 K.SLTGSAGGGNNR.M 1090,52357 645,4 
32 
gi|16131619|ref|NP_418207.1| D-
ribose periplasmic binding protein    
  5357 K.ELANVQDLTVR.G 1257,67974 144,4 
 
Sample 2 from November 20th 2006 
 
 Reference   MW 
  Scan(s) Peptide MH+ Sp 
1 gi|16131979|ref|NP_418578.1| FrdA     
  4715 R.AAIAAAQANPNAK.I 1210,65386 1404,7 
  4845 R.AATAGNGNEAAIEAQAAGVEQR.L 2099,01120 3117,3 
  5007 R.ANAVVM*ATGGAGR.V 1190,59462 1812,1 
  5404 R.ANAVVMATGGAGR.V 1174,59972 1350,2 
  6364 R.DADGTTRLEYSDVK.I 1569,73911 632,8 
  5875 R.DDVNFLK.H 850,43051 678,3 
  5194 K.DLVNQDGGENWAK.I 1445,66555 491,0 
  7936 R.FDEHFVLDILVDDGHVR.G 2026,00287 2567,7 
  3752 R.GDVVYLDLR.H 1049,56259 815,0 
  5960 R.GEGGILVNK.N 886,49926 1129,7 
  7734 R.GLVAMNM*MEGTLVQIR.A 1778,89614 2130,9 
  7423 R.GLVAM*NM*M*EGTLVQIR.A 1810,88594 1027,5 
  7456 R.GLVAM*NM*MEGTLVQIR.A 1794,89104 1998,9 
  7391 R.GLVAMNM*M*EGTLVQIR.A 1794,89104 1772,8 
  7734 R.GLVAM*NMMEGTLVQIR.A 1778,89614 1290,9 
  7456 R.GLVAM*NMM*EGTLVQIR.A 1794,89104 2247,2 
  7898 R.GLVAMNMMEGTLVQIR.A 1762,90124 2423,2 
  7734 R.GLVAMNMM*EGTLVQIR.A 1778,89614 2414,4 
  1374 K.ITTLPPAKR.V 996,62004 188,9 
  7552 R.KGNTISTPR.G 973,54252 691,2 
  3684 R.LAGEQATER.A 974,49015 722,8 
  7886 R.LGSNSLAELVVFGR.L 1461,80600 1989,4 
  7685 R.LKDLVNQDGGENWAK.I 1686,84457 1961,8 
  7636 -.M*QTFQADLAIVGAGGAGLR.A 1891,96944 2093,8 
  7272 R.RPDGSVNVR.R 999,53302 711,7 
  3236 R.VYGGEADAADK.A 1095,49529 448,4 
  6674 R.VYGGEADAADKAEAANK.K 1679,78712 1440,7 
  7195 R.YLQDYGMGPETPLGEPK.N 1894,88914 2028,5 
  7142 R.YLQDYGM*GPETPLGEPK.N 1910,88404 2076,9 
2 
gi|15830995|ref|NP_309768.1| CoA-
linked acetaldehyde dehydrogenase    
  4589 R.AAALAAADAR.I 900,48976 1014,6 
  7659 K.AADIVLQAAIAAGAPK.D 1479,85295 2609,0 
  7269 R.AKDFEDAVEK.A 1151,55789 768,8 
  2305 R.AVASVLMSK.T 905,51246 697,9 
  3079 R.DYVEGETAAK.K 1082,50005 660,0 
  6886 R.EAGVQEADFLANVDK.L 1605,77549 715,4 
  5421 R.EYASFTQEQVDK.I 1444,65907 669,4 
  7837 R.FATHGGYLLQGK.E 1291,67935 1398,4 
  7168 K.IAELAGFSVPENTK.I 1475,77404 1245,8 
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  7715 R.ILINTPASQGGIGDLYNFK.L 2021,07022 2069,5 
  5140 K.MAVAESGM*GIVEDK.V 1452,67088 746,8 
  5630 K.M*AVAESGMGIVEDK.V 1452,67088 2513,8 
  6378 K.MAVAESGMGIVEDK.V 1436,67598 2723,0 
  6361 K.M*AVAESGM*GIVEDK.V 1468,66578 1215,5 
  7832 R.NAIIFSPHPR.A 1151,63200 1277,5 
  3038 K.NGALNAAIVGQPAYK.I 1486,80125 816,5 
  7645 K.QILLDTYYGR.D 1241,65246 404,3 
  7750 R.YAEIADHLGLSAPGDR.T 1684,82892 2064,5 
3 
gi|16130152|ref|NP_416719.1| outer 
membrane protein 1b    
  8613 - 8665 R.DAGINTDNIVALGLVYQF.- 1922,98582 1243,5 
  6760 K.DGNKLDLYGK.V 1122,57896 502,2 
  3774 K.DVDGDQTYMR.L 1199,49973 581,0 
  3741 K.DVDGDQTYM*R.L 1215,49463 779,9 
  6518 K.FQDVGSFDYGR.N 1290,57494 1344,2 
  5892 R.GYDDEDILK.Y 1067,48915 617,1 
  7444 K.INLLDDNQFTR.D 1348,68555 1114,4 
  4522 K.NGNPSGEGFTSGVTNNGR.D 1764,78958 1410,7 
  4699 K.NM*STYVDYK.I 1136,49284 552,0 
  6100 K.NMSTYVDYK.I 1120,49794 609,9 
  6914 K.RTDAQNTAAYIGNGDR.A 1722,81540 1202,1 
  4118 R.TDAQNTAAYIGNGDR.A 1566,71429 1934,3 
  7314 R.VAFAGLK.F 705,42939 384,9 
  6910 R.VGSLGWANK.A 931,49959 670,7 
  7093 K.YDANNIYLAAQYTQTYNATR.V 2354,10476 2258,6 
  7307 K.YVDVGATYYFNK.N 1439,68416 1953,2 
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4 
gi|15834157|ref|NP_312930.1| 
protein chain elongation factor EF-
Tu    
  5215 R.AFDQIDNAPEEK.A 1376,63285 1024,8 
  7279 R.AGENVGVLLR.G 1027,58947 874,0 
  7948 R.AIDKPFLLPIEDVFSISGR.G 2117,16412 1299,8 
  5997 K.ALEGDAEWEAK.I 1218,56371 1166,5 
  7566 R.ELLSQYDFPGDDTPIVR.G 1964,96000 963,5 
  7531 K.FESEVYILSK.D 1214,63033 1286,3 
  7927 K.MVVTLIHPIAMDDGLR.F 1780,94482 1160,1 
  7921 R.QVGVPYIIVFLNK.C 1489,87771 490,6 
  7879 K.TTLTAAITTVLAK.T 1303,78314 1939,3 
  6896 K.VGEEVEIVGIK.E 1171,65688 1401,5 
5 
gi|15800564|ref|NP_286576.1| global 
regulator    
  7449 K.AIGEAKDDDTADILTAASR.D 1932,95089 2768,6 
  2298 K.ATNLLYTR.N 951,52581 1133,3 
  6525 K.ATVELLNR.Q 915,52581 1249,1 
  6903 R.AVQLGGVALGTTQVINSK.T 1755,99632 1154,4 
  5070 K.DDDTADILTAASR.D 1363,63358 1271,2 
  6521 - 7113 R.DLDKFLWFIESNIE.- 1768,87923 1298,6 
  7900 R.QVIQFIDLSLITK.Q 1517,89376 1528,0 
  6407 R.TALIDHLDTMAER.A 1485,73660 1701,6 
  6163 R.YAIVANDVR.K 1020,54727 1095,5 
6 gi|16129204|ref|NP_415759.1| OppA    
  5738 K.AQGNMPAYGYTPPYTDGAK.L 2001,90110 1134,3 
  5208 K.AQGNM*PAYGYTPPYTDGAK.L 2017,89600 1163,0 
  4183 K.DPLDNTYTR.N 1094,51128 560,3 
  7673 R.HQGTFDVAR.A 1030,50647 535,1 
  5063 K.IEGVPESNISR.D 1200,62189 267,1 
  7752 K.LTQPEWFGWSQEK.R 1635,78018 441,6 
  6744 K.SPAFDSIM*AETLK.V 1425,69299 1079,3 
  7795 K.SPAFDSIMAETLK.V 1409,69809 1845,3 
  7251 K.WTQPGNIVTNGAYTLK.D 1762,91226 766,5 
7 
gi|16128548|ref|NP_415097.1| outer 
membrane protein 3b (a) protease 
VII    
  4463 R.DDIGSFPNGER.A 1206,53856 716,7 
  7820 K.GWLLNEPNYR.L 1261,63240 388,3 
  7309 R.LGLMAGYQESR.Y 1224,60413 1208,0 
  6032 R.LGLM*AGYQESR.Y 1240,59903 1502,4 
  7738 K.MPYIGLTGSYR.Y 1257,62962 984,1 
  7545 K.NGAGIENYNFITTAGLK.Y 1782,90209 1516,1 
  5712 R.VYLAEEGGR.K 993,49999 777,4 
  6884 K.VYVEGAWNR.V 1093,54252 788,1 
  7447 R.YEDFELGGTFK.Y 1305,59976 1344,7 
8 
gi|15804747|ref|NP_290788.1| 
fumarate reductase    
  7869 K.DFLIATLKPR.- 1173,69902 964,6 
  5316 K.DNLAPDLSYR.W 1163,56913 668,8 
  7710 R.DYTDGMKVEALANFPIER.D 2069,00082 1680,1 
  7605 R.DYTDGM*KVEALANFPIER.D 2084,99572 559,1 
  7202 K.HVDPAAAIQQGK.V 1234,65386 1213,5 
  4055 R.TADQGTNIQTPAQM*AK.Y 1690,80646 974,5 
  4403 R.TADQGTNIQTPAQMAK.Y 1674,81156 1028,3 
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  7433 K.VEALANFPIER.D 1258,67901 1777,1 
9 
gi|15800816|ref|NP_286832.1| outer 
membrane protein 3a     
  4537 K.AQGVQLTAK.L 915,52581 605,8 
  5724 K.DGSVVVLGYTDR.I 1280,64811 1300,8 
  5450 K.GIKDVVTQPQA.- 1155,63681 978,6 
  5854 R.IGSDAYNQGLSER.R 1409,66555 1346,0 
  7743 K.LGYPITDDLDIYTR.L 1654,83228 961,2 
  7883 R.RAQSVVDYLISK.G 1378,76889 1169,3 
  7790 R.RVEIEVK.G 872,51999 350,2 
  7601 K.SDVLFNFNK.A 1083,54694 1027,4 
10 
gi|16131619|ref|NP_418207.1| D-
ribose periplasmic binding protein    
  6450 K.ELANVQDLTVR.G 1257,67974 426,7 
  7260 K.FNVLASQPADFDR.I 1479,72267 523,3 
  7538 K.ILLINPTDSDAVGNAVK.M 1739,95379 1015,3 
  6805 K.LAATIAQLPDQIGAK.G 1509,86352 385,0 
  7100 K.MANQANIPVITLDR.Q 1555,82609 851,0 
  6424 K.SDVMVVGFDGTPDGEK.A 1652,74723 521,8 
  6732 K.VIELQGIAGTSAAR.E 1385,77470 2150,4 
11 
gi|15802193|ref|NP_288215.1| 
glyceraldehyde-3-phosphate 
dehydrogenase A    
  7211 K.AGIALNDNFVK.L 1161,62625 853,9 
  5131 R.FDGTVEVK.D 894,45672 852,0 
  2010 R.GASQNIIPSSTGAAK.A 1401,73323 988,3 
  6969 K.LVSWYDNETGYSNK.V 1675,75984 1239,3 
  6690 K.VGINGFGR.I 819,44716 749,6 
  7890 K.VLDLIAHISK.- 1108,67247 933,3 
  7342 R.VPTPNVSVVDLTVR.L 1495,84787 1733,4 
12 gi|15834378|ref|NP_313151.1|    
  7311 R.AAVEEGVVAGGGVALIR.V 1567,88023 1188,1 
  5266 K.AIAQVGTISANSDETVGK.L 1760,90248 982,6 
  6191 K.AVTAAVEELK.A 1030,57790 563,7 
  5619 K.DTTTIIDGVGEEAAIQGR.V 1845,91886 1565,3 
  3822 R.GQNEDQNVGIK.V 1201,58076 483,1 
  2960 R.GVNVLADAVK.V 985,56767 544,6 
13 
gi|15802089|ref|NP_288111.1| 
murein lipoprotein    
  5816 K.IDQLSSDVQTLNAK.V 1531,79623 1515,7 
  3580 R.LDNM*ATK.Y 808,38692 498,5 
  3374 R.LDNMATK.Y 792,39202 515,0 
  6336 R.SDVQAAKDDAAR.A 1246,60222 1328,4 
  5528 K.VDQLSNDVNAM*R.S 1377,64269 1636,3 
  5443 K.VDQLSNDVNAMR.S 1361,64779 1485,2 
14 
gi|15832893|ref|NP_311666.1| 
enolase    
  7703 K.AVAAVNGPIAQALIGK.D 1492,88459 1361,6 
  6655 K.DAGYTAVISHR.S 1189,59601 1412,4 
  6681 K.IM*IDLDGTENK.S 1264,60893 1383,2 
  6653 K.IMIDLDGTENK.S 1248,61403 870,1 
  7680 K.IQLVGDDLFVTNTK.I 1562,84245 1524,0 
  7165 R.SGETEDATIADLAVGTAAGQIK.T 2118,05608 2969,9 
15 
gi|15833050|ref|NP_311823.1| 
fructose-bisphosphate aldolase class 
II  
   
  1440 R.AGQTSMIAR.L 934,47748 543,3 
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  1414 R.AGQTSM*IAR.L 950,47238 334,8 
  2665 K.ANEAYLQGQLGNPK.G 1502,75978 1230,7 
  7556 K.APVIVQFSNGGASFIAGK.G 1762,94865 1664,7 
  2487 R.DSQEYVSK.K 955,43672 609,0 
16 
gi|16131180|ref|NP_417760.1| 50S 
ribosomal subunit protein L15 
   
  7286 R.GFEGGQMPLYR.R 1254,59357 347,6 
  2562 R.GFEGGQM*PLYR.R 1270,58847 226,9 
  4598 R.LNTLSPAEGSK.K 1116,58953 199,6 
  6599 K.VEGGVVDLNTLK.A 1243,68924 1055,1 
  7281 K.VILAGEVTTPVTVR.G 1454,85771 576,1 
17 
gi|15803853|ref|NP_289887.1| GTP-
binding protein chain elongation 
factor EF-G     
  6971 K.GGVIPGEYIPAVDK.G 1414,75766 407,2 
  6343 K.VEVETPEENTGDVIGDLSR.R 2058,98258 1524,2 
  6630 R.VYSGVVNSGDTVLNSVK.A 1737,90176 1067,3 
  6978 K.YLGGEELTEAEIK.G 1451,72642 1482,6 
18 
gi|15803830|ref|NP_289864.1| 30S 
ribosomal subunit protein S5    
  4972 R.ATIDGLENM*NSPEM*VAAK.R 1922,88337 897,9 
  5749 R.ATIDGLENMNSPEM*VAAK.R 1906,88847 473,5 
  2683 K.AYGSTNPINVVR.A 1290,68008 617,3 
  7468 R.VFMQPASEGTGIIAGGAMR.A 1892,93571 1887,2 
19 
gi|15799694|ref|NP_285706.1| 
chaperone Hsp70    
  4148 K.ASSGLNEDEIQK.M 1290,61720 625,9 
  7561 R.IINEPTAAALAYGLDK.G 1659,89521 1716,3 
  7437 R.QAVTNPQNTLFAIK.R 1544,84312 882,6 
  7407 K.SLGQFNLDGINPAPR.G 1598,82853 674,8 
20 
gi|16130827|ref|NP_417401.1| 
phosphoglycerate kinase    
  6891 R.ADLNVPVKDGK.V 1155,63681 649,9 
  6609 K.SLYEADLVDEAK.R 1352,65800 801,6 
  7729 K.SLYEADLVDEAKR.L 1508,75911 1740,5 
  6322 R.VATEFSETAPATLK.S 1464,75805 1112,0 
21 
gi|16128870|ref|NP_415423.1| 
formate acetyltransferase 1    
  7514 R.DAIPTQSVLTITSNVVYGK.K 2006,08045 949,4 
  7647 K.LATAWEGFTK.G 1123,57824 754,1 
  6997 K.SGVLTGLPDAYGR.G 1305,67974 836,9 
  7213 R.VDDLAVDLVER.F 1243,65286 1940,2 
22 
gi|15800772|ref|NP_286786.1| 30S 
ribosomal subunit protein S1    
  5679 K.AYEDAETVTGVINGK.V 1566,76459 894,7 
  7130 R.DQLLENLQEGMEVK.G 1645,81016 658,9 
  7542 K.GATVELADGVEGYLR.A 1549,78566 743,4 
  5752 K.SESAIPAEQFK.N 1206,60009 349,4 
23 
gi|15802947|ref|NP_288976.1| 
cysteine synthase A    
  3945 K.AEEIVASNPEK.Y 1186,59501 625,7 
  7297 K.ALGANLVLTEGAK.G 1256,72088 1197,4 
  7288 K.NIVVILPSSGER.Y 1283,73178 555,7 
  6520 K.VIGITNEEAISTAR.R 1473,79075 1214,3 
24 
gi|15804792|ref|NP_290833.1| 50S 
ribosomal subunit protein L9    
  5999 R.DIADAVTAAGVEVAK.S 1429,75330 617,7 
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  7069 K.INALETVTIASK.A 1259,72054 951,9 
  2725 K.LAEVLAAANAR.A 1098,62658 1080,5 
  6359 K.VANLGSLGDQVNVK.A 1413,76962 510,2 
25 
gi|30065018|ref|NP_839189.1| 
tryptophanase    
  7633 R.FAENAYFIK.Q 1102,55677 1036,8 
  7811 R.GAEQIYIPVLIK.K 1343,79331 803,8 
  6990 K.GNFDLEGLER.G 1149,55348 1133,9 
  7121 R.SYYALAESVK.N 1130,57282 1194,0 
26 
gi|15834105|ref|NP_312878.1| 
glycerol kinase    
  6625 R.ATLESIAYQTR.D 1252,65319 412,9 
  7407 R.SNTGLVIDPYFSGTK.V 1598,80606 744,1 
  4084 R.SSEVYGQTNIGGK.G 1339,64883 321,2 
  6181 K.YIVALDQGTTSSR.A 1410,72233 1459,5 
27 
gi|15803840|ref|NP_289874.1| 50S 
ribosomal subunit protein L16    
  7699 R.GLAQGTDVSFGSFGLK.A 1583,80640 2277,6 
  7463 K.VLYEMDGVPEELAR.E 1620,79378 756,5 
  6555 K.VLYEM*DGVPEELAR.E 1636,78868 366,0 
28 
gi|16128896|ref|NP_415449.1| outer 
membrane protein 1a    
  4558 R.TNLQEAQPLGNGK.K 1369,70702 657,8 
  1448 R.VGGVATYR.N 822,44683 523,5 
  6448 K.YDANNIYLAANYGETR.N 1847,85587 931,2 
29 
gi|15833433|ref|NP_312206.1| 30S 
ribosomal subunit protein S3    
  1528 R.LGGAEIAR.T 786,44683 718,2 
  6812 K.LVADSITSQLER.R 1331,71652 1717,4 
  7465 K.VVADIAGVPAQINIAEVR.K 1835,03852 545,4 
30 
gi|15832699|ref|NP_311472.1| 
putative formate acetyltransferase    
  5532 K.AGYAEDEVVAVSK.L 1337,65834 2166,2 
  5478 R.FNSLTPEQQR.D 1219,60658 944,1 
  7799 R.VEGGQHLNVNVLR.R 1434,78119 856,3 
31 gi|15829780|ref|NP_308553.1|    
  6312 R.ALSNPDLYEGDGELR.V 1648,78131 846,2 
  5231 R.EILQDSTVTR.N 1161,61099 864,2 
  7237 R.GLIDSSDLPLNVSR.E 1485,79075 1078,2 
32 
gi|15803832|ref|NP_289866.1| 50S 
ribosomal subunit protein L6    
  6046 K.APVVVPAGVDVK.I 1150,68304 624,8 
  5317 R.DGYADGWAQAGTAR.A 1438,63458 1314,5 
  5325 R.TLNDAVEVK.H 988,53095 391,6 
33 
gi|15804574|ref|NP_290615.1| 50S 
ribosomal subunit protein L1    
  6319 K.AAGAELVGM*EDLADQIK.K 1746,85783 339,1 
  5859 R.VAVFTQGANAEAAK.A 1376,71685 868,0 
  7158 R.VVGQLGQVLGPR.G 1222,72663 1753,0 
34 
gi|15804575|ref|NP_290616.1| 50S 
ribosomal subunit protein L10    
  7170 K.AAAFEGELIPASQIDR.L 1687,86498 725,7 
  7349 R.LATLPTYEEAIAR.L 1447,77912 364,3 
  6522 K.QAIVAEVSEVAK.G 1243,68924 851,2 
35 
gi|16130476|ref|NP_417046.1| serine 
hydroxymethyltransferase    
  2482 K.SPFVTSGIR.V 963,52581 709,0 
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  1473 R.VM*QAQGSQLTNK.Y 1320,65761 406,2 
  1451 R.VMQAQGSQLTNK.Y 1304,66271 566,0 
36 
gi|3915453|sp|P76335|YEDS_ECOL
I  
   
  6760 K.DGNKLDLYGK.V 1122,57896 502,2 
  6100 K.NMSTYVDYK.I 1120,49794 609,9 
  4699 K.NM*STYVDYK.I 1136,49284 552,0 
37 
gi|16129338|ref|NP_415895.1| 
putative outer membrane protein    
  6760 K.DGNKLDLYGK.V 1122,57896 502,2 
  6100 K.NMSTYVDYK.I 1120,49794 609,9 
  4699 K.NM*STYVDYK.I 1136,49284 552,0 
38 
gi|16130649|ref|NP_417222.1| 
lipoprotein    
  5749 K.GQAIIATADGR.V 1072,57455 757,6 
  5355 K.IATMGSTGTSSTR.L 1269,61034 664,8 
  5302 K.IATM*GSTGTSSTR.L 1285,60524 460,8 
39 
gi|15799860|ref|NP_285872.1| 
histone-like protein    
  5759 R.M*ETDLQAK.M 951,44516 795,2 
  5889 R.METDLQAK.M 935,45026 367,2 
  6800 K.TGVSNTLENEFK.G 1338,65359 658,3 
40 
gi|15834164|ref|NP_312937.1| RNA 
polymerase beta subunit    
  5023 R.AVAVDSGVTAVAK.R 1187,66303 475,6 
  7255 K.LGPEEITADIPNVGEAALSK.L 2024,05463 919,9 
41 gi|33347763|ref|NP_417963.2| Slp    
  2548 K.GNNQPDIQK.S 1013,50105 294,9 
  7781 K.SFVAVHNQPGLYVGQQAR.F 1971,01952 1374,2 
42 
gi|15803847|ref|NP_289881.1| 50S 
ribosomal subunit protein L3    
  7809 R.IFTEDGVSIPVTVIEVEANR.V 2188,14959 665,5 
  6686 R.VTVQSLDVVR.V 1115,64190 1533,2 
43 gi|16130342|ref|NP_416911.1|    
  5691 R.DALPTEEEQFAAYK.A 1611,75369 223,4 
  4736 K.ISADQVDQEVER.F 1388,66521 1106,0 
44 
gi|15799705|ref|NP_285717.1| 30S 
ribosomal subunit protein S20    
  6849 K.AFNEMQPIVDR.Q 1319,64125 874,3 
  5672 K.AFNEM*QPIVDR.Q 1335,63615 420,0 
45 gi|15801645|ref|NP_287662.1|     
  6062 K.DGEDPGYTLYDLSER.L 1729,75515 1681,0 
  2183 K.LQGIAQQNSFK.H 1233,65861 498,7 
46 
gi|16131389|ref|NP_417974.1| 
glutamate decarboxylase isozyme    
  6062 K.DGEDPGYTLYDLSER.L 1729,75515 1681,0 
  2183 K.LQGIAQQNSFK.H 1233,65861 498,7 
47 
gi|15803846|ref|NP_289880.1| 50S 
ribosomal subunit protein L4    
  5710 K.DAQSALTVSETTFGR.D 1582,77074 663,7 
  7589 R.DATGIDPVSLIAFDK.V 1561,81081 1296,9 
48 
gi|16129562|ref|NP_416121.1| 
hypothetical protein    
  5587 R.IVQSPDVIPADSEAGR.A 1653,84424 800,6 
  4283 R.QIDANQGGNQR.I 1200,57159 170,5 
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49 
gi|15804576|ref|NP_290617.1| 50S 
ribosomal subunit protein L7/L12    
  5602 K.ALEEAGAEVEVK.- 1244,63687 1095,7 
  5544 K.DLVESAPAALK.E 1113,61502 603,8 
50 
gi|15800457|ref|NP_286469.1| 
peptidoglycan-associated lipoprotein    
  6146 R.GTPEYNISLGER.R 1335,65392 354,7 
  6380 K.GVSADQISIVSYGK.E 1423,74274 1307,2 
51 
gi|15803823|ref|NP_289857.1| 30S 
ribosomal subunit protein S4    
  6023 K.AALELAEQR.E 1000,54219 687,8 
  6651 R.LSDYGVQLR.E 1050,55784 1134,0 
52 
gi|16130437|ref|NP_417007.1| 
putative dehydrogenase    
  5824 R.GESAPTTAFGAAVVGGDNGR.V 1833,87258 751,6 
  6209 R.IYLVDQNDR.V 1135,57421 475,4 
53 
gi|15799688|ref|NP_285700.1| 
transaldolase B 
   
  4787 K.ELAESEGAIER.K 1203,58517 355,3 
  4717 K.LYNDAGISNDR.I 1237,58076 1345,0 
54 
gi|15803848|ref|NP_289882.1| 30S 
ribosomal subunit protein S10    
  6611 R.LIDQATAEIVETAK.R 1501,81081 954,2 
  6441 R.LVDIVEPTEK.T 1142,63033 731,4 
55 
gi|15804334|ref|NP_290373.1| 
membrane-bound ATP synthase     
  6942 R.VNAEYVEAFTK.G 1270,63139 1285,3 
  5782 R.VVNTLGAPIDGK.G 1183,66811 968,5 
56 
gi|15804573|ref|NP_290614.1| 50S 
ribosomal subunit protein L11    
  6048 K.AADMTGADIEAMTR.S 1452,64574 640,8 
  5133 R.AQLQEIAQTK.A 1129,62116 669,5 
57 
gi|10955180|ref|NP_052173.1| beta-
lactamase    
  7617 R.QIAEIGASLIK.H 1142,67795 343,8 
  4803 R.VDAGQEQLGR.R 1072,53816 491,4 
58 
gi|15800566|ref|NP_286578.1| outer 
membrane protein X    
  5981 K.FQTTEYPTYK.H 1277,60484 395,9 
  6688 K.NQYYGITAGPAYR.I 1473,71210 726,5 
59 
gi|2506315|sp|P11026|CYDA_ECOL
I Cytochrome D ubiquinol oxidase 
subunit I    
  5878 R.YTPNVADATEAQIQQATK.D 1948,96106 2224,4 
60 
gi|15802055|ref|NP_288077.1| 
putative outer membrane protein     
  6534 K.TQGVELEIR.K 1044,56840 744,5 
61 
gi|16128752|ref|NP_415305.1| 
MoaD    
  7622 R.ELVGTDATEVAADFPTVEALR.Q 2204,10812 2094,4 
62 
gi|15804332|ref|NP_290371.1| 
membrane-bound ATP synthase    
  7584 R.QIASLGIYPAVDPLDSTSR.Q 2003,04440 1092,0 
 
